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The phosphoenolpyruvate: sugar phosphotransferase system (PTS) is responsible 
for the uptake and concomitant phosphorylation of many sugars in several species of 
bacteria. This key system also plays indirect roles in the regulation of other aspects of 
bacterial metabolism and physiology. The first step of the PTS involves the 
phosphorylation of histidine containing phosphocarrier protein (HPr) by enzyme I (E.C. 
2.7.3.9), with phosphoenolpyruvate (PEP) serving as the phosphoryl donor. Enzyme I 
has logically been viewed as a potential target for regulation of the PTS. 
This thesis presents important information regarding the structure and function of 
enzyme I of Escherichia coli and Salmonella typhimurium. Fluorescence polarization 
analysis indicated that the interactions of HPr with enzyme I and HPr with enzyme IIA~'' 
are of low affinity, with a K, of roughly 10 - 100 pM. An enzyme I binding site on HPr 
was determined by a kinetic assay, using site-directed mutants of HPr as substrates for 
enzyme I. Key HPr residues involved in this interaction are Hisl5, Thrl6 ,  Argl7,  
Lys24, Lys27, Lys40, Ser46, Leu47, Lys49, Gln51, and Thr56. This site of interaction 
agreed very well with that found in the NMR solution structure of the complex of HPr 
with the N-terminal domain of enzyme I (Garrett et al., 1999). with a few important 
differences. 
Genes encoding enzyme I mutants were cloned from S. ~phimur ium strains and 
the purified proteins were analyzed. The Argl26Cys mutant was defective in 
phosphotransfer, while the Gly356Ser and Arg375Cys mutants were defective in 
dimerization and PEP-binding. Intragenic complementation was observed between 
purified Argl26Cys and Gly356Ser or Arg375Cys enzymes I, through formation of a 
heterodimer. This heterodimer was unstable, and stability depended upon 
concentrations of the enzyme and of PEP, Other site-directed mutants of E. coli enzyme 
I were comstructed, which showed the importance of the residues Asn352 and Leu355 in 
dimerization, and Arg296 in PEP-binding. The active site mutants His l89Glu and 
His189Asp were also shown to have a small phosphotransfer activity. These data led to 
the conclusions that dimerization and PEP-binding of enzyme I are closely linked 
cooperative events, and that the monomer:dimer equilibrium of enzyme I, with the dimer 
being the most active form, may have significant physiological importance. Regulation 
of the monomer:dimer equilibrium may provide a key target for modulation of the 
activity of enzyme I, and thus regulation of the PTS. 
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1.0 INTRODUCTION 
1.1 The bacterial phosphoenolpyruvate:sugar phosphotransferase system 
(PTS) 
The phosphoeno1pyruvate:sugar phosphotransferase system (PTS ), discovered in 
1964 (Kundig et al., 1964) is the key system responsible for the uptake of carbohydrates 
into many bacterial cells. It catalyzes the transport of many monosaccharides and 
disaccharides across the cytoplasmic membrane, as well as the concomitant 
phosphorylation of the transported sugar. The PTS also influences other aspects of 
bacterial physiology in processes such as catabolite repression, inducer exclusion, and 
chemotaxis. For recent general reviews of the PTS, see Postrna et al. ( 1993) and Postma 
et al. (1996). The P ' S  is found in many prokaryotic species, which emphasizes its 
importance in carbohydrate metabolism. 
1.1.1 Overview and PTS components 
The PTS, regardless of the sugar involved, catalyzes the overall reaction: 
The PTS is composed of several protein components (Figure 1.1), which are involved in 
phosphotransfer reactions. Enzyme I (EI), one of two general cytosolic proteins of the 
PTS, is autophosphorylated, with phosphoenolpymvate (PEP) serving as the phosphoryl 
donor. Phospho-enzyme I then in turn donates its phosphoryl group to the second general 
cytosolic protein, histidinecontaining protein (HPr). A sugar-specific enzyme I1 protein 
is then phosphorylated, with phospho-HPr serving as the phosphodonor. Enzymes II are 
In Out 
MEMBRANE 
Figure 1.1 A schematic illustration of the phosphoenolpynrvate:sugar phospho- 
transferase system, adapted from: Anderson, 1994. 
@ Represents the phosphorylated form. 
multidomain, and in many cases multisubunit proteins which vary in composition (Saier 
and Reizer, 1992). In general, enzymes 11 are composed of a 1IA domain, or  often a 
separate soluble polypeptide, which is phosphorylated by HPr, along with a IIB 
phosphoryl transfer domain and an integral membrane sugar transporter made up of one 
type of subunit (IIC) or two different subunits (IIC and I D ) .  The full role of an intact 
enzyme I1 is to translocate, and simultaneously phosphorylate, a specific sugar. 
1.1.2 Thermodynamic considerations of the PTS 
The phosphate transfer potentials of the phosphoprotein components of the PTS 
are among the highest of al: known biological phosphorylated derivatives (Stock et al., 
1990). The free energy (AGO') of hydrolysis of PEP is -61.5 kJ/mol (Atkinson and 
Morton, 1960), and this energy potential is well conserved in phospho-enzyme I and 
phosp ho-HPr of Escherichia coli and Salmonella typhimu rium, with free energies of 
phosphate hydrolysis of -60.7 kJ/mol and -54.3 kJ/mol, respectively (Weigel et al., 
1982a). Considerable energy is lost in the latter part of the PTS, as the free energy of 
hydrolysis of a typical phosphorylated sugar is much lower at about -12.5 kJ/mol 
(Atkinson and Morton, 1960). However, this energy usage is not wasted as  the sugar is 
both translocated and phosphorylated by the PTS. For example, the net product of PTS- 
mediated glucose transport is glucose-6-phosphate. These phosphorylated sugars are 
readily available for utilization by glycolysis or other processes. In addition, the 
phosphorylation of the sugar sequesters it in the cytoplasm, as the negative charges of the 
phosphoryl group renders it incapable of diffusing out across the plasma membrane. This 
transport and concomitant phosphorylation of sugars by the PTS is accomplished at the 
expense of the conversion of a single molecule of PEP into pyruvate. 
1.1.3 Phosphohistidines involved in the PTS 
Histidine residues are commonly found in active sites of enzymes. In the 
physiological range of pH, histidine is able to either accept or  donate a proton, which 
makes it suitable to participate in various catalytic mechanisms. However, histidine is also 
a site for covalent modification such as, in the case of the PTS, phosphorylation. A 
histidine residue is available for phosphorylation at either of the two nitrogen atoms on the 
irnidazole ring, N ~ '  and N", also called N-1 and N-3, respectively, forming a high energy 
phosphoramidate bond. 
Both E. cdi  and S. typhimuriurn enzymes I are autophosphorylated on His 189 at 
the N'' position (Figure 1 -2). Phospho-enzyme I then catalyzes the phosphory lation of 
HPr at the Ns' position of Hisl5. This phosphoryl group is then transferred to an Nc' 
atom of a histidine in a IIA molecule, and the phosphoryl group is then subsequently 
passed onto an amino acid residue of the IIB molecule, commonly a cysteine, but in some 
cases Ns'-histidine. The phospho group is then transferred to the sugar molecule as it is 
transported into the cytoplasm by the sugar transporter portion of the En complex, 
commonly the IIC domain (Postma et a!. , 1993). 
1.1.4 The PTS operon 
In E. coli and S. typhimuriurn, the genes encoding HPr, enzyme I, and enzyme 
I I A ~ ~ U C O S ~  (IIA~"), pfsH, ptsl, and crr, respectively, are found in a single operon. This 
operon is located at min. 52 on the E. coli chromosome (Cordaro and Roseman, 1972: De 
Reuse et al., 1985; De Reuse and Danchin, 1988). Two promoters, designated PO and 
P 1, separated by 100 base pairs, are located upstream of the transcription initiation site of 
the E. coli PTS operon (Figure 1.3). and control from these promoters can occur 
independently of each other (De Reuse and Danchin, 1991 ). De Reuse et al. (1992) 
identified two sequences, one within each promoter region, which were similar to the 
consensus of the cyclic-AMP (CAMP) activator protein (CAP) binding site. These two 
PEP + :N \ / 
I- Pyruvate 
A y Y  H-N -0 P-'N A+H 
vw>) vEnzyrne I 
Figure 1.2 A schematic representation of the phosphohistidines of enzyme I and HPr of  
the PTS. and the phosphoryl transfer reactions involving the two proteins. 
prsH prsl crr 
I I 8 M 1 
PO PI P2 
Figure 1.3 A diagram of the PTS operon of E. coli. including the three transcribed 
genes and the 5' promoter region. The boxed area represents the operon organization on 
the bacterial chromosome. The shaded regions represent intergenic. nontranslated regions 
of the operon. The horizontal arrows indicate the approximate location of the three 
transcripts, as described in the text. 
CAP binding sites, CAPa and CAPb, are important for the regulation of PTS operon 
expression. However, the transcription of the PTS operon is also complex. Three major 
RNA species have been identified @e Reuse and Danchin, 1988); one tricistronic mRNA 
which encompasses all three genes, ptsH, ptsl, and crr, a second mRNA which includes 
ptsH but is terminated within ptsl, and a third transcript which contains only crr. The first 
two rnRNA species originate from the region upstream of ptsH, involving PO or P 1. The 
mRNA encoding only crr originates from a separate initiation site, P2, within ptsl.  More 
recently. another factor mediating PTS operon expression in E. coli has been identified. 
Mlc (for M n g  large colonies), a transcriptional regulator with multiple targets, binds to 
PO and inhibits transcription (Kim et al.. 1999; Plumbridge. 1999). The exact fbnction of 
Mlc remains to be elucidated. 
1.1.5 Secondary Roles of  the PTS 
In E. coli, the PTS plays an active role not only in sugar transport, but in a 
multitude of other physiological processes, including the regulation of many aspects of 
metabolism (Saier et al., 1990; Postma et al., 1993, 1996; Saier and Reizer, 1994; Saier, 
1996). 
1.1.5.1 The PTS and regulation of carbon metabolism in E. coli 
When E. coli is grown in a liquid medium containing two different carbohydrates, 
the bacteria will preferentially utilize one sugar instead of another as an energy source. 
This phenomenon, known as diauxie, is controlled by regulation processes called 
catabolite repression and inducer exclusion. which directly involve the FTS, and in 
particular the IIA~'' protein (Saier, 1989; Roseman and Meadow. 1990). When E. coli 
cells are grown on a PTS sugar such as glucose, the level of phosphorylation of 1 1 ~ ~ ' '  on 
its active site histidine residue is relatively low. phospho-IIA~", indicative of a PTS that is 
not actively translocating and phosphorylating sugars, is able to bind adenylate cyclase, 
the enzyme which catalyzes the conversion of ATP to cyclic AMP (CAMP), and adenylate 
cyclase is subsequently activated (Liberrnan et a[., 1986; Peterkofsky er al., 1989). The 
CAMP subsequently produced is an important signaling molecule. and may then be bound 
by the cyclic AMP activator protein (CAP), also known as the cyclic AMP receptor protein 
(CRP). The transcription of many inducible carbohydrate catabolic enzymes, such as 
those found in the lactose operon, is positively regulated by the CAMP-CAP receptor 
complex. In the presence of an active PTS, cellular levels of CAMP are relatively low, and 
operons such as the lac operon are repressed. 
This catabolite repression process (Figure 1.4) can only partially explain the 
multitude of effects that growth on PTS sugars exerts on the uptake and catabolism of 
non-PTS substrates. There also exists a second group of phenomena, organized into a 
category termed "inducer exclusion" (Saier and Roseman, 1972; Saier and Crasnier, 
1996). The major protein responsible for inducer exclusion is, once again, 1 1 ~ ~ ' ~ .  An 
unphosphorylated IIAg" molecule. indicative of an active PTS, is able to bind various 
cellular targets including many non-PTS sugar perrneases, such as lactose permease 
(Osumi and Saier, 1982) and maltose permease (Dcan et al.. 1990), resulting in the 
allosteric inhibition of the transporter. Thus the transport of non-PTS substrates can be 
directly inhibited in favour of transport of PTS substrates. Unphosphorylated T I A ~ ' '  also 
binds enzymes responsible for catabolysis of non-PTS substrates, such as glycerol b a s e  
(Postma el al., 1984), resulting in the allosteric inactivation of the enzyme. Phospho- 
I X A ~ ' '  is unable to bind to these protein targets to initiate this process of inducer exclusion. 
Even though UA~"  is the most important regulatory PTS protein, binding 
interactions between other E. coli PTS proteins and metabolic protein targets have also 
been observed. Seok et al. ( 1997), identified and described a novel regulatory interaction 
between HPr and glycogen phosphorylase. Two non-PTS proteins capable of interacting 
with E. coli enzyme I have also been identified. Fox et al. ( 1986) demonstrated a 
phosphoryl exchange between catalytic residues of acetate kinase and enzyme I. More 
Figure 1.4 A schematic illustration of the role of 1 1 ~ ~ ' '  in catabolite repression and 
inducer exclusion in E. coli and other enteric bacteria. 
recently in the same laboratory, Dannelly and Roseman (1996) discovered a novel ATP- 
dependent kinase, with an apparent cofactor requirement for NAD' or NADP*, that 
reversibly phosphorylates enzyme I at its active site residue. In each case, possible links 
between ITS-driven sugar transport and other metabolic pathways were proposed. 
The PTS of E. coli and other enteric bacteria is needed not only for its direct role in 
sugar transport, but also for the overall global regulation of bacterial metabolism. The 
availability of glucose and other preferentially utilized PTS sugars, an important indicator 
of overall energy potential of the cell, is directly sensed by bacteria in the phosphorylation 
state of cytosolic PTS proteins. Other proteins important in metaboiism can then be 
elegantly controlled in part by their interactions with those PTS proteins. 
1.1.5.2 Regulation of carbon metabolism in Gram-positive bacteria 
The preceding section discussed the regulation of carbon metabolism in Gram- 
negative enteric bacteria such as E. coli and S. typhimurium. Grarn-positive bacteria such 
as BaciiZ1u.s subtilis have a much different method of regulation of carbon metabolism 
(Saier et al., 1995). Unlike E. coli, catabolite repression and inducer exclusion in B. 
subtilir does not involve protein:protein interactions of 1 1 ~ ~ " .  Instead, the key regulatory 
PTS protein is HPr. B. subtilis possesses an ATP-dependent regulatory HPr kinase, 
which is able to phosphorylate HPr, not at the active site His15 residue, but rather at the 
Ser46 regulatory residue (Reizer et al., 1993a). High cellular concentrations of key 
metabolites such as glucose-6-phosphate and fructose- 1.6-bisphosphate, indicative of an 
active PTS, allosterically activate the regulatory HPr(Ser) kinase (Deutscher and Saier, 
1983). The consequences of phosphorylation of B. subtilis HPr on Ser46 are many. 
Phosphorylation on Ser46 of B. subtilis HPr strongly inhibits overall PTS activity 
and sugar transport. It was revealed, using studies with site-directed mutants of B. 
subtilis HPr (Reizer et ai., 1989). that the negative charge imparted by phosphorylation 
results in an increased K,,, and a much lower V, for interactions with both enzyme I and 
UA~''. Thus, Ser46 phosphorylation of HPr directly inhibits the PTS as the primary level 
of regulation of carbon metabolism. 
Like TA~" in E. coli, B. subtilis HPr(Ser-P) is also responsible for other 
secondary regulation of carbohydrate metabolism, mediated through protein:protein 
interactions with non-PTS proteins. However, B. subtilis and other Gram-positive 
bacteria do not possess an adenylate cyclase enzyme or significant levels of CAMP. 
Instead, catabolite repression is mediated by a transcription factor called the CcpA protein 
(Henkin, 1996). CcpA binds to a cis-acting element, called CRE (catabolite repression 
element) of many catabolic operons, thereby inhibiting transcription (Kim and Chambliss, 
1997). When CcpA is complexed by HPr(Ser-P), the binding of CcpA to a CRE is 
dramatically enhanced. Through this interaction, Gram-positive bacteria such as B. subtilis 
are capable of catabolite repression. 
Gram-positive bacteria are also capable of regulation of carbohydrate metabolism 
through inducer exclusion and a similar process called inducer expulsion (Saier et al., 
1996), both of which are again mediated by phosphorylation of HPr on Ser46. In several 
Gram-posi ti ve bacteria such as Lactococcus lactis, HPr(Ser-P) binds to and allostericall y 
activates a membrane associated hexose-6-P phosphatase (Ye and Saier, 1995). 
Cytoplasmic sugar-P may then be converted to free sugar which is able to rapidly diffuse 
through the cytoplasmic membrane and out of the cell - hence the name "inducer 
expulsion". In other Gram-positive species, such as hctobacillrrs brevis, the PTS is not 
involved in transport of sugars, but these organisms possess an HPr. In these organisms, 
HPr(Ser-P) is capable of binding to sugar-proton symport permeases, such as lactose 
permease, resulting in their allosteric inactivation (Ye et al., 1994). This inducer exclusion 
process is directly comparable to that mediated by the binding of unphosphorylated 1 1 ~ ~ "  
to iactose permease in E. coli. 
In both Gram-positive and Gram-negative bacterial species, the regulation of 
carbon metabolism is very complex, and this remains an area of intense study. However, 
it is evident that in all cases the PTS plays a direct role in this regulation. The key 
regulatory proteins may be different, IIAg" in Gramnegative species, and HPr in Gram- 
positive species, but the targets of their regulation and the overall global picture of 
regulation of carbohydrate metabolism remains very similar. 
1.1S.3 Involvement of the PTS in chemotaxis in E. coli 
The chemotactic process in bacteria such as E. coli refers to the ability of the 
microorganism to adjust its swimming behaviour in response to chernicd attractants or 
repellents (Armitage, 1999). The general chemotaxis pathway in E. coli (Figure 1.5) 
involves, in part, the activation and autophosphorylation of an ATP-dependent protein 
"sensor kinase" called CheA. CheA, phosphorylated at a histidyl residue, subsequently 
donates its phosphoryl group to the aspartyl residue of the "response regulator" CheY 
(Ninfa et al., 1991), and P-CheY interacts with the flagellar motor to cause the bacterium 
to adjust its swimming pattern. This histidine to aspartate phosphotransfer is a key featwe 
of a large homologous group of signal transduction proteins, collectively called two 
component systems (Appelby et al., 1999). P-CheA can also interact indirectly with the 
integral membrane chemotactic receptors, better known as methyl accepting chernotaxis 
proteins (MCPs). The methylation state of these receptors is then altered, which modifies 
the activity of the receptors (Annitage, 1999). 
Chemotaxis to PTS sugars can occur independently of MCPs and other chernotaxis 
components. However, phosphorylation of CheA and CheY is required. This 
chemotactic pathway requires the interaction of protein components of the PTS with those 
of the general chemotactic pathway (Titgemeyer, 1993). Lux et al. ( 1995) demonstrated a 
direct interaction between enzyme I and Che A, in that enzyme I in its unphosphorylated 
state (indicative of an active PTS) inhibits CheA autophosphorylation. Thus the PTS can 
provide a sensing mechanism for PTS sugars which can be directly transmitted to the 
chemotaxis pathway. However, there is no direct phosphoryl transfer between enzyme I 
Figure 1.5 A schematic diagram of the principal regulatory interactions of chemotaxis. 
and CheA (Johnson et al., 1995), and the exact mechanism of CheA inhibition by enzyme 
I is still under investigation (Lux et al., 1999). Still, the link between the FTS and 
chemotaxis remains certain, and once again emphasizes the utmost importance given by E. 
coli and other bacteria to the acquisition and catabolism of PTS sugars as a primary energy 
source. 
1.2 The sugar-specific enzymes I1 
Many enzymes I1 of the PTS are known, each of which is responsible for 
acquiring a phosphoryl group from HPr and. through a series of phosphoryl transfer 
reactions, transfer it to a specific sugar which the enzyme I1 has transported into the 
cytoplasm. As previously discussed, the enzymes II are a heterologous group of proteins, 
possessing significant differences in structure and function, but they can be grouped into 
several general categories. For reviews of the FTS enzymes II, see Lengeler et al. (1994) 
and Robillard and Broos ( 1999). 
1.2.1 Structural and functional classification of enzymes I1 
The sugar-specific enzymes I1 (Figure 1.6) have a minimum of three domains, 
named IIA, IIB, and IIC (Saier and Reizer, 1992). The IIA domain accepts a phosphoryl 
group from HPr on an N6' atom of a histidine residue. The phosphoryl group is then 
passed to the IIB domain, commonly on a cysteine residue. The IIC domain is 
responsible for the translocation and eventual phosphorylation of the specific sugar. 
These domains may be found on a single polypeptide, as in the case of enzyme IImMn"O' of 
E coli, thus named IIBCA"' The II"' is written in that order to indicate the order of 
domains on the polypeptide from the amino terminus to the carboxy tenninus. The three 
domains may also be found on two separate polypeptides, as in the case of enzyme IIg'ucOse 
of E. coli - IIA'" and lIBCg", or three separate polypeptides, such as enzyme IIcc"Ob'O" of
E. coli - IIA"', 1IBCe', and 11CCe'. In older nomenclature, a soluble, separate IIA 
cytoplasm periplasm 
Figure 1.6 An illustration of the various types of enzymes I1 involved in the E. coli 
PTS. Figure adapted from Lengeler et a!. . 1994. Note: The domains of enzyme IImMn""' 
ai i  shown in the order of phosphotransfer for purposes of clarity, not the order in which 
they are found on the polypeptide chain (see text). 
polypeptide was called an enzyme III or factor 111. Another variant is the addition of a 
fourth domain, IID, as in the case of enzyme 11"""""" of E. coli, which is found in the 
format of IIABm, IIC"", and IID"". On the basis of similarities in domain stmcture and 
sequence homology, most enzymes U can be grouped together into four families (Table 
1.1). Whether with one or more polypeptides, an entire IIABC protein is made up of 
approximately 630 amino acids (Postrna et al., 1993). In E. coli, crr, the gene encoding 
IIA~", is found within the ITS operon (De Reuse and Danchin, 1988), whereas ptsG, the 
gene encoding IICBE'c, is found elsewhere on the chromosome. This gene and all other 
genes encoding enzymes II are found scattered throughout the E. coli chromosome 
(Postma et al., 1993). 
Two exceptions to the general classification of enzymes I1 are important to note. 
The fructose PTS in E. coli and S. rypllimuriurn involves a separate protein called FPr 
(Waygood, 1980; Geerse et aL, 1989). FPr contains an N-terminal 11~'" domain, which 
is grouped within the same family as [IAmt'. FPr also contains a central linker domain and 
a C-terminal domain with homology to HPr. In fact, PTS mediated transport of fructose 
does not involve HPr; instead enzyme I phosphorylates FPr on its "pseudo-HPr" domain, 
followed by interdomain phosphoryl transfer to the IIA portion of FPr, followed by 
intersubunit phosphoryl transfer to the W domain of the IIBCfrc sugar transporter. In 
Rhodobacter capsulatus, PTS mediated transport of fructose involves a multiphosphoryl 
transfer protein (MTP). This large 827 residue soluble protein contains an amino-terminal 
I I A ~  domain, a central HPr-like domain, and a C-terminal domain resembling enzyme I 
(Wu er al., 1990). Indeed, the large complexity amongst enzymes 11, and other PI'S and 
phosphoryl transfer proteins suggests a complex process of evolution for these proteins, 
involving domain shuffling and convergent and divergent modes of evolution (Saier and 
Reizer, 1994; Saier and Reizer, 1996). 
Considering the importance of enzymes Il in bacteria. and their wide variety, it is 
not surprising that these proteins have been the subject of intense investigation. Perhaps 
Table 1.1 Enzymes XI of the different PTSs from various bacteria (Lengeler et al., 1994) 
Number Substrate Organism(s)' Domainsb 
I .  The glucose-sucrose family 
Glucose 
Glucose 
Maltose 
N-Acetyl-glucosamine 
Sucrose 
Sucrose 
~Glucosides 
2. The mannitof-fructose family 
Mannitol 
Mannitol 
Fructose 
Fructose 
3. The lactose-cellobiose family 
Cellobiosc 
Lactose 
Lactose 
4. The mannose family 
Mannose 
L-Sorbose 
Fructose 
5. Separate classification 
Glucitol 
Enteric bacteria 
Bacillus s ubtilis 
Escherichia coli 
En teric bacteria 
Enteric bacteria 
Streptococcus nrutans 
Escherichia coli 
Escherichia coli 
Staphylococcus cantoms 
Enteric bacteria 
Rhodobacte r capsu fatus 
Escherichia coli 
Lactobacillus lactis 
Staphylococcus aureus 
Escherichia coli 
Enteric bacteria 
Bacillus subtilis 
Escherichia coli 
IICB"~, IIA"' 
IICBAE" 
I I C B ~ ~ ' .  I I A ~ = I  
IIBCnaF. IIAnaf 
IIBC"', I1 AF" 
IIBCA" 
ITBCA~F' 
I ICBA~" 
I I C B ~ ' ~ .  I I A ~ I ~  
FPr. IIB'BC'" 
MTP. IIB'BC'" 
llBCC', IICCC', IIACe' 
IICB'u, IIAhC 
IICB'", IIAIaC 
" Enteric bacteria: Escherichia coli, Salmonella typhimurium, Klebsiella pneumoniae. 
FPr comprises IIA'", a receiver domain, and an HPr-like domain. MTP, multiphosphos- 
phoryl transfer protein, contains IIA'~, and HPr-like domain and an Enzyme I-like 
domain. 
the best understood of the enzymes I1 are IILIC of E. coli and B. subtilis, which will be 
described here in further detail. 
1.2.2 Enzyme IIg" 
Enzyme Iig" is probably the most important enzyme II in vivo, and E. coli IIp" is 
also probably the most studied of all enzymes II. To reiterate, it is comprised of a soluble 
IIA subunit and a membrane bound IICB subunit, and each component has been 
investigated separately in detail. 
1.2.2.1 E. coli IIAR" - structure and function 
The highly homologous E. coli and S. typhimurilcrn crr genes, found in the PTS 
operon, encode the UA~" proteins with an approximate mass of 18,250 Da (Meadow er 
al., 1982; De Reuse and Danchin, 1988). The enzymes from these two species can be 
used interchangeably and will not be distinguished in this discussion. IIA~" is 
phosphorylated by HPr at the active site His90 residue (Dorschug et al., 1984). Residue 
His75 of 1 1 ~ ~ "  is also important for enzymatic activity as the His75Gln mutant was found 
to accept a phosphoryl group from HPr, but was not able to phosphorylate IICBg" 
(Presper et ol., 1989). The amino terminus of IIA~'' also appears to be important for full 
activity. During purification of llAg", another form of the enzyme appears on sodium 
dodecyI sulfate (SDS) polyacrylamide gels which migrates faster than the native form. 
This variant was called IIAg'cf,,, due to is electrophoretic mobility, as opposed to the native 
form, IIAg",,, (Meadow and Roseman, 1982). IIA~",, was able to accept a phosphoryl 
group from HPr at a similar rate to IIA~'~,,,,, but catalyzed the phospholylation of IICB~" 
at a greatly diminished rate. It was discovered that conversion of I IA~", , ,~  to I I A ~ ' ' ~ ~ ,  
occurred by the cleavage of the seven N-terminal amino acids of the protein by an 
unidentified membrane associated protease during cell breakage, any potential 
physiological significance of which remains unknown (Meadow er al., 1986). Using 
sugar phosphorylation assays, the H R  Y, for IIA8" was determined to be 0.3 p M  for the 
E. coli proteins (Reizer et ol., 1992). Rate and equilibrium constants for the E. coli 
IIAg":HPr interaction have also been obtained using rapid reaction quenching techniques 
(Meadow and Roseman, 1996), and the rate of phosphorylation is near that of a diffusion- 
controlled process. 
The structure of E. coli 1 1 ~ ~ "  has been solved to 2.1 A resolution by X-ray 
crystallography (Worthylake et al., 199 1 ), and the structure is in agreement with previous 
functional characterization. The protein consists mainly of p-strands, forming an 
anitparallel P-sandwich. The residues His75 and His90 are located in a depression on one 
side of the sandwich, only 3.3 A apart. and are surrounded by hydrophobic residues. The 
structures of phosphorylated and unphosphorylated HAe" were also compared using two- 
and three-dimensional NMR techniques (Pelton et al., 1992; Pelton et al., 1993), and 
revealed little change in secondary or tertiary structure upon phosp hory lat ion, except 
minor changes at the active site. The markedly different properties of phosphorylated and 
unphosphorylated IIAgl' in a variety of protein:protein interactions must be mediated by 
changes in charge distribution and hydrophobicity. 
Further structural studies have been undertaken in order to investigate the role of 
IIAelc in protein:protein interactions. The interaction of IIA~" with one of its targets of 
allosteric inhibition, glycerol kinase, has been studied extensively, culminating with 
several structures of the complex, each solved by X-ray crystallography, in the presence 
of glycerol kinase substrates and/or products (Hurley et aL, 1993; Feese et al., 1994). 
IIA~" binds distant from the active site of glycerol kinase, indicating that long-range 
structural transitions would be required to inhibit glycerol kinase. The active site histidine 
of IIA~" is buried within a mainly hydrophobic region of the interaction, such that 
phosphorylation would directly inhibit binding. The target proteins for binding with IIA~" 
are diverse, and the inclusion of nonspecific hydrophobic interactions and a few specific 
salt bridges in these heterologous binding sites may pennit IIA~" to bind to this wide 
variety of proteins (Feese et al., 1997). 
However, other researchers have more recently attempted to deduce consensus 
binding sequences on target proteins that bind 1 1 ~ ~ ' ' .  Sondej et al. ( 1999) used site- 
directed mutagenesis of the UA~" target protein lactose permease to determine which 
residues of the permease were responsible for the interaction with IIAgIC. Two interacting 
sequences on lactose permease were discovered and compared with interacting residues on 
other interacting proteins. From this analysis, two regions of consensus sequence 
necessary for target proteins to bind 1 1 ~ ~ ' '  were deduced. Other potential target proteins 
containing these interaction sequences were discovered from a database search of the E. 
coli genome. 
Not surprisingly, no tertiary structure of the integral membrane lactose permease 
protein, either native or in complex with IIA8". is available for investigators. As well, no 
tertiary structure of UAg" in complex with its interacting proteins of the PTS, namely HPr 
and IICB 8'c, has been determined. Several researchers have investigated the H P ~ :  1 1 ~ ~ "  
interaction using experiments with B. subtilis proteins, but a description of the structure of 
B. subtilis 1 1 ~ ~ "  protein is needed first. 
1.2.2.2 B. subtilis IIAdc - structure and function 
The B. subtilis enzyme IIgIC exists as part of a single ECBA polypeptide (Zagorec 
et al., 1992). The soluble 1 1 ~ ~ '  domain, consisting of 162 amino acid residues, has been 
separately purified and its structure solved, independently by both by X-ray 
crystallography (Liao et al., 199 1 ) and NMR (Fairbrother et aL , 1992). The protein has 
an antiparallel &barrel structure, with the main eight-stranded Psheet structure forming a 
modified "Greek key" or "jeUyroU'* topology. The two conserved histidine residues, 
His83 and His68, analogous to the E. coli residues His90 and His75, respectively, are 
close to one another in a pocket surrounded by hydrophobic residues. The Ns2 atom of 
His83, the site of phosphorylation, is partially surrounded by solvent and is only 3.2 A 
from the NC' atom of His68. The active site of E. coli HAg" has a remarkably similar 
arrangement of residues, despite differences in overall topology, and there is 
approximately 42% sequence identity between the two proteins (Chen et a!. , 1993a). The 
interaction of each IIAg" with its respective HPr would likely be very similar. 
Herzberg ( 1992) proposed a model for the B. subtilis HP~:IIA~'' interaction and 
phosphotransfer reaction, with proteins from B. subtilis, using high resolution crystal 
structures of each protein linked together with a phosphate 'tether' with trigonal 
bipyramidal geometry. The interaction site was more conclusively determined by Chen et 
al. (1 993b) with NMR chemical shift experiments using "N-labeled 1 1 ~ ~ "  and unlabeled 
HPr. An NMR spectrum of IWg" alone in solution was taken, and then another spectrum 
was taken after the addition of HPr. The investigators compared the spectra and found 
several regions in 1 1 ~ ~ ' '  which undenvent backbone amide "N and 'H shift changes after 
addition of HPr, which indicate the 11~"' residues involved in the interaction. These 
residues included several from the eight-stranded p-sheet and a segment of the f2-loop 
which is close to the active site. Surprisingly, the active site hstidines of IIA~", residues 
68 and 83, did not show an NMR chemical shift after addition of Wr .  
Several laboratories have attempted to solve the structure of IIAg" and HPr, using 
proteins from different bacterial species, different phosphory lation states, and mutant 
proteins, but so far these attempts have been unsuccessful. The interaction between HPr 
and 1 1 ~ ~ ' '  including interacting residues of HPr and kinetics, will be further discussed in 
the Introduction section regarding HPr (Section 1.3). 
1.2.2.3 E. coli lICBg" - structure and function 
The E. coli llCBg" protein is 477 residues in length, encoded by the ptsG gene 
(Emi and Zanolari, 1986). This protein mediates the final steps of the glucose PTS, 
namely the uptake and concomitant phosphorylation of glucose. The active form of the 
IICBg" transporter is a homodimer (Meins et al., 1988). The protein is phosphorylated by 
P-11~~' '  on the Cys42 1 residue of the IIB domain (Peri et al., 1984; Meins et a!., 1993). 
IICBg' is able to catalyze the phosphoryl exchange between P - ~ A ~ ' '  and IIAZ", as well as 
the phosphoryl exchange between glucose-6-phosphate and glucose (Rephaeli and Saier, 
1978), again indicative of a stable phosphorylated IIB intermediate during catalysis. The 
transport and phosphorylation of glucose can also be uncoupled, in that mutants have been 
isolated which are unable to transport glucose but are able to catalyze the phosphorylation 
of intracellular glucose at wild type levels (Buhr et al., 1992; Ruijter et a!. , 1992). More 
recently, a comprehensive study of site-directed mutants of IICBe" has been published 
(Lanz and Emi, 1998), and complementation between two inactive mutants at separate 
sites of the protein suggested the formation of active heterodimers. 
Other research has been devoted to the study of the separated domains, IIB and 
IIC, of the glucose transporter. Buhr et al. (1 994) were able to separately overexpress and 
purify the hydrophilic IIB domain and the transmembrane IIC domain. The structure of 
this protein, residues 386 - 477 of IICB~", has been solved by NMR (Eberstadt et al., 
1996). The protein consists of a four stranded 9-sheet with three a-helices arranged on 
one side of the sheet. On the other side of the psheet is the active site Cys421. These 
residues are on a convex surface of the protein, highly exposed to solvent. Gemmecker et 
al. (1997) characterized the structure of the phosphorylated form of the IIB protein, and 
elucidated the site of interaction between the W protein and 1 1 ~ ~ " .  The IIB binding site 
on IIA roughly coincides with the HPr binding site identified on 11.4~" from B. subfilis 
(Chen el al., 1993b), displaying similar shape complementarity. indicating that IIA"' likely 
possesses overlapping active sites for binding and for phosphoryl transfer between HPr 
and IIBg". 
Little direct structural information regarding the IIC portion of the IICB~'' protein is 
available to date. Considerable structural evidence can be gained from functional analysis 
of the transporter, as previously described. In addition, using alkaline phosphatase 
(PhoA) and fbgalactosidase (LacZ) fusion proteins of IICBB", Buhr and Erni ( 1993) were 
able to generate a membrane topological map of the protein. Corroborating all other 
functional evidence, the model indicated that the amino terminus of the protein faced the 
cytoplasm. followed by eight transmembrane spanning helices, including three 
cytoplasmic and four periplasrnic loops, followed by the hydrophilic, cytoplasmic IIB 
domain. 
1.2.3 Structures of other enzymes I1 
In terms of structure and function, the glucose enzymes I1 from E. coli and B. 
subtilis have undoubtedly been the most well characterized of all enzymes 11. However, 
several other structures of other sugar-specific enzymes I1 are available for analysis 
(Robillard and Broos, 1999). 
1.2.3.1 Structures of other IIA proteins 
The glucose transporter of Mycoplasma capricolum has also been investigated. 
The 1 1 ~ ~ ' '  protein. 154 residues, is encoded by the crr gene in a unique dicistronic operon 
of ptsl-crr (Zhu et al.. 1994). IIA~" was purified and its structure was solved by X-ray 
crystallography to 2.5 A resolution (Huang et al., 1998). Its interactions with M. 
capricolum HPr and IBg" in transition state complexes were also modeled. The 
interactions were mostly hydrophobic with little specific electrostatic interactions, which 
are similar to those observed with binding studies of 1 1 ~ ~ ' '  from other species. 
The structures of two other sugar-specific IIA proteins from E. coli have been 
determined. Crystallographic methods were used to determine the structure of the E. coli 
mannitol-specific IIA domain, IIAml (van Montfort et al.. 1998). The enzyme has a novel 
fold, unlike folds of other sugar-specific IIA proteins discovered so far, with a central five 
stranded Psheet surrounded by mostly a-helical structures. The HA domain of the soluble 
E. coli IIBA"""" protein was also solved by X-ray crystallography (Nunn et al., 1996). 
Superficially it appears to be topologically similar to IIA"' with a central ksheet 
surrounded by a-helices. Its site of phosphorylation is His 10, with no other catalytically 
important active site histidine, unlike other IIA proteins. 
A structure of IIA'"""" from Lactococc~ls lads  has been obtained by X-ray 
crystallography (Sliz et al., 1997). It is a unique IIA protein, which exists as a trimer in 
the unphosphorylated state. Each monomer consists of three helices which pack together 
to form a nine-helix bundle in the trimer. Phosphorylation at the active site His78 likely 
leads to disruption of the bundle and dissociation of the subunits. 
1.2.3.2 Structures of other IIB proteins 
The IIB subunits of a B. subtilis fructose transporter, IIBtev, and an E. coli 
cellobiose transporter, IIB "", have been solved by X-ray crystallography (Sc hnauder et 
al., 1998). Superficially they appear to be similar in structure, with a central P-sheet 
surrounded by a few a-helices. 
1.3 The general PTS protein HPr 
HPr, the histidine containing phosphocarrier protein, is the most well characterized 
of all the proteins of the PTS. It was the first protein initially investigated when the PTS 
was discovered (Kundig et al., 1964). The HPr proteins in E. coli and S. typhimurium are 
identical, with 85 amino acid residues and a molecular weight of 9 109 Da. This small 
protein is readily soluble in aqueous solutions, which makes it amenable to a wide variety 
of in viwo investigations, including structural determination by NMR and X-ray 
crystallography. 
In the PTS, HPr is phosphorylated at the N ~ '  position of the conserved His15 by 
the PEP-dependent protein kinase enzyme I. Phospho-HPr then serves as a phosphoryl 
donor for the I IA domain of a sugar-specific enzyme II. Gram-positive bacteria also have 
an ATP-dependen t regulatory HPr kinase which phosphory lates HPr at the Ser46 residue, 
and this has been previously discussed (Section 1.1.5.2). 
1.3.1 Comparison of HPrs from various organisms 
The gene encoding HPr, ptsH, has been identified in numerous Gram-negative and 
Gram-positive bacteria through genome sequencing or direct investigation. HPr-like 
domains are also found in other PTS proteins, namely FPr of enteric bacteria, and the 
multiphosphoryl transfer protein of Rh. caps~htus. All told, more than twenty sequences 
of HPrs and HPr-like proteins have been identified in prokaryotes to date. 
An alignment of several HPrs and HPr-like proteins (Koch et al., 1996) reveals 
several conserved residues. The catalytic histidine, His15 in all HPrs, is by definition 
strictly conserved, along with the active site residues Gly 13, Arg 17, and Pro 18. Residue 
14 is commonly a leucine or isoleucine, and residue 16 is commonly threonine in Gram- 
negative HPrs and valine in Gram-positive HPrs. Ser46 is a strictly conserved residue, 
and residues surrounding Ser46 are also well conserved. However, phosphorylation of 
Ser46 only occurs in Gram-positive bacteria. 
1.3.2 Structural and functional analysis of HPr 
The structure of HPr has been very well characterized by both NMR and X-ray 
crystallography (Waygood, 1998). In 1986, E. coli HPr was the largest protein to be 
described by two-dimensional NMR approaches (Klevit and Way good, 1986). The 
structure of the protein consisted of a mixed a + p structure folded together to form an 
open-faced &sandwich composed of three a-helices and a four-stranded P-sheet. E. coli 
HPr was subsequently crystallized and investigated by X-ray diffraction (El-Kabbani et 
al., 1987). This structure differed substantially from the one determined by NMR. This 
difference was resolved when the crystal structure was redetermined (Jia er al., 1993). 
This structure (Figure 1.7) was essentially the same as the one seen by NMR, although 
Figmre 1.7 Ribbon diagram of the structure of E. coli HPr, taken from the crystal 
structure of HPr in complex with the Je142 antibody fragment (Prasad et al., 1998), PDB 
accession code 21EL. The side chains of the active site residues His15 and Arg 17 are 
shown in red and blue, respectively. Diagram was produced with SETOR (Evans, 1992). 
some side chain resonance assignments in the NMR structure were not in agreement. This 
HPr structure was also confirmed by site-directed mutagenesis and purification of mutant 
HPr proteins followed by "epitope mapping" using anti-HPr antibodies (Sharma et al., 
1991), and later by the determination of the crystal structure of HPr with one of those 
antibodies (Prasad et al., 1998). X-ray crystallography was also used to obtain the 
structures of HPrs from B. subtilis (Herzberg et al., 1992), Streptococcus faecalis (Jia et 
al., 1994b), and M. capricolum (Pieper et al., 1995). The structure of HPr from 
Sfaphylococcus aureus has also been determined by two-dimensional NMR (Kalbitzer and 
Hengstenberg, 1993). When these structures are compared (Jia er al., 1993a; Waygood, 
1998), they show considerable homology, and all of these structures display the similar 
fold of three a-helices on one face of a four-stranded p-sheet. 
In the structure of HPr, the active site His45 is at the amino terminal end of the 
first helix - 'A'. The effect of the helix dipole, in combination with influences from other 
amino acid side chains in the microenvironment of the active site, results in a relatively low 
pK., 5.6, at the N6' position of His 15 of E. coli HPr (Kalbitzer et al., 1982; Anderson et 
al., 1993). After phosphorylation of HPr, the pK, of His 15, at the NcZ position, increases 
to 7.8 (Kalbitzer et al., 1982; Anderson et al., 1993). These values indicate that at 
physiological pH, unphosphorylated HPr is mostly unprotonated at His 15, which leaves a 
free lone pair of electrons available for the phosphorylation reaction. Phosphorylated HPr 
would be mostly protonated at HislS, which would increase the potential of 
phosphotransfer to a IIASug" (Anderson, 1 994). Phosphorylation of His 15 also results in 
small changes in the orientations of side chains at the active site (van Nuland et oL, 1993), 
which is aiso important for phosphotransfer activity (Waygood, 1998). 
A detailed examination of the active centre of HPr (Anderson, 1994) reveals the 
importance of the conserved His 15 and Arg 17, as well as residues 12 and 16, which are 
not strictly conserved. A kinetic study of Arg 17 mutants of E. coli HPr (Anderson et al., 
1993) helped elucidate the role of the residue. With all mutants tested, both K, and V,
values were affected for the kinetic interaction witb enzyme I, and in general the catalytic 
efficiencies of the mutants were reduced by about 100-fold. The kinetic interactions of 
Argl7 mutants of HPr with enzymes IInaP, Urns", and II"" were more complicated, with 
each IIA protein showing different changes to V, and &,,. These differences indicate that 
the enzymes II do not employ the identical catalytic mechanism, and Argl7 may or may 
not play a role in these interactions. Anderson et al. (1991) d s o  investigated the role of 
the C-terminal Glu85 residue in the active site of E. coli HPr, but it appears that only the 
carboxyl end of the main peptide chain may play a minor role, if any, in the 
phosphotransfer capability of HPr. Indeed, the C-terminal region of HPrs from various 
microorganisms is poorly conserved. 
Surprisingly, it has recently been demonstrated that the presence of a histidine at 
position 15 of E. coli HPr is not essential for activity. Napper et al. (1999) showed that 
His 1 SAsp HPr displayed phosphotransfer activity during interactions with both enzyme I 
and IIAg", albeit at a greatly reduced efficiency. No other His 15 mutant of HPr, including 
Glu, Ser, Thr, and Cys, had phosphotransfer activity. The position of the carboxyl 
oxygen in aspartate is similar to that of the N" position of a histidine side chain, so 
phosphorylation of the two residues would be similar. By the same token, the carboxyl 
oxygen of glutamate can be compared to the Nc2 position of histidine. Thus by analogy, 
the His 189Glu mutant of E. coli enzyme I and the His90Glu mutant of E. coli IIAg' could 
potentially be phosphorylated (Napper, 1999), but this has yet to be tested. It was also 
observed (Napper et al., 1999) that phosphorylation of His l5Asp HPr led to the formation 
of a protein species with a higher isoelectric point, which in turn underwent hydrolysis to 
reform unphosphorylated His 1SAsp HPr. It was proposed that the higher pI form of the 
protein was due to the formation of a cyclic isoimide structure at residue 15. 
The importance of Asnl2 (not a conserved residue) in the activity of E. coli HPr 
was also investigated in this report (Napper et al., 1999). Various mutants at the 12 
position were created and their kinetic interactions with enzyme I were determined. All 
mutants tested produced only mild decreases to V, and Y, for the enzyme I interaction. 
This is not surprising because even though structural evidence indicates that residue 12 
may participate in a hydrogen bond with Hisl5, this interaction is likely weak and of only 
moderate physiological significance (Waygood, 1998; Napper et al., 1999). 
1.3.3 Dearnidation of E. coli HPr 
During the initial purification and characterization of E. coli HPr (Anderson et ul., 
197 l), it was observed that two other protein species which are more negatively charged 
than HPr can appear over time in the preparation. These two species, named HPr-1 and 
HPr-2, and were found to arise from the loss of one and two amide groups, respectively, 
from HPr. HPr-1 has kinetic and phosphohydrolysis parameters similar to HPr, while 
HPr-2 is impaired in both properties (Waygood et al., 1985). It was later revealed that 
Asn38 deamidates to Asp or iso-aspartic acid to form HPr- 1 and HPr- 1 in turn can further 
dearnidate at AsnlZ producing Asp or iso-Asp to form HPr-2 (Sharrna et al., 1993). 
Unlike the phospho-Asp 15 cyclization product, this deamidation proceeds via a previously 
characterized process involving succinirnide ring formation (Geiger and Clarke, 1987). 
Deamidation of HPr is accelerated by increases in pH (buffers above 8.0), and temperature 
(Waygood et al., 1985), and these factors must be monitored during any in vitro 
experiments involving HPr. The deamidation of Asnl2 results in the reduced activity of 
HPr-2, which gave the first indication of the potential importance of residue 12 in the 
active site. 
1.3.4 Protein:protein interactions involving HPr 
In the PTS, HPr interacts with enzyme I as well as the I IA domains of a number of 
sugar-specific enzymes II. Gram-positive bacteria also have a regulatory HPr kinase, and 
Ser46-phosphorylated Gram-positive HPr is involved in complex protein:protein 
interactions with a number of regulatory targets (Section 1.1.5.2). Binding sites on HPr 
for these proteins have been investigated by a number of methods. Anti-HPr antibodies 
have also been developed, and HPr used as a model protein to investigate antibody 
interactions with protein antigens (Anderson, 1995). 
1.3.4.1 Enzyme I binding site on HPr 
Two main methods have been utilized in order to determine the amino acid residues 
of HPr which interact with enzyme I. These methods are structural characterization, 
primarily by NMR, and kinetic analysis by enzyme assays. 
1.3.4.1.1 Characterization of HPr:enzyme I interaction by NMR 
Van Nuland et al. (1995) reported a high resolution NMR structure of 
phosphorylated E. coli HPr. The enzyme I binding site on HPr was also determined in 
this report by plotting the HPr residues that underwent I5N and 'H NMR chemical shift 
displacements when the spectrum of HPr alone in solution was compared with a spectrum 
of HPr in complex with enzyme I. Most HPr residues that exhibited NMR shifts were on 
the surface of the protein, and included the active site region (residues 12 - 17), Gln 2 1, 
Lys24, and residues 47 - 55, which form a loop containing a small helix. 
More recently, the structure of E. coli HPr in complex with a soluble 30 kDa N- 
terminal domain of enzyme 1 (EIN) has been solved by NMR (Garrett et al., 1999). The 
binding of the two proteins involves many hydrophobic interactions. Key HPr residues, 
which made three or more contacts with Em were Thr 16, Arg 17, Ala20, Leu47, Phe48, 
and Thr52. Several electrostatic interactions are also in the binding interaction, involving 
Argl7. Lys24. Lys27. Lys45 and Lys49 of HPr. These residues are almost the same as 
those previously identified (van Nuland et al., 1995), and are found on helices 1 and 2 of 
HPr. This structure was determined in the absence of phosphorylation of HPr and EIN. 
and differences in the HPr:EIN complex during phosphotransfer cannot be ruled out. 
1.3.4.1.2 Kinetic characterization of HPr:enzyme I interaction 
Numerous mutagenesis studies have revealed E. coli HPr residues which may be 
important for the interaction with enzyme I. These residues are those that, when mutated, 
give enzyme I kinetic parameters different than wild type HPr when assayed as a limiting 
substrate for enzyme I. Mutations that affect primarily K, but not V,, for enzyme I 
indicate that these residues are involved in binding and not catalysis. Catalytically 
important residues, affecting both Y, and V, identified to date include Asn12 (Sharrna 
et al., 1993; Napper et al., 1999), His 15 (site of phosphorylation), and Arg 17 (Anderson 
et al., 1993). Residues which, when mutated, affect primarily K, include Ser46 (Napper 
et al., 1996) and Gln5 1 (Sharma et al., 1993). A more comprehensive mutagenic and 
kinetic study to elucidate other HPr residues important for binding enzyme I is presented 
in this thesis. 
1.3.4.2 HPr: I1ASugar interactions 
In contrast to the interaction of enzyme I with HPr, less is known about the 
residues on HPr which interact with various A domains of enzymes I1 of the PTS. The 
structures of several sugar-specific IIA domains from various bacteria have been solved 
(Robillard and Broos, 1999) and in several cases a model of their interaction with HPr 
was also presented. However, to date no structure of HPr in complex with a IIA protein 
has been solved. NMR chemical shift experiments have been used to determine residues 
on HPr which interact with 1 1 ~ ~ '  using proteins from E. coli (van Nuland et al., 1993) 
and B. subtilis (Chen et al., 1993b). The HPr residues that underwent an NMR chemical 
shift afier addition of IIAm", delineating the IIAm" binding site on HPr, were similar in each 
study. Key interacting residues of HPr included the active site (residues 15 - 2 1) and 
residues 47 - 56. Kinetic studies involving mutant HPrs and various enzymes II have 
been undertaken and reveal the direct importance of Arg l'l (Anderson er al., 1993) and 
Ser46 (Napper et al.. 1996), and the indirect importance of Asp69 and Glu70 (Koch el al., 
1996) for interaction with enzymes 11. The enzymes II are a heterotogous group of 
proteins, and their sites of interaction on HPr, and kinetic mechanisms, may not 
consistent. 
1.3.4.3 HPr:antibody interactions 
Four monoclonal antibodies specific to E. coli HPr have been isolated and 
characterized (Waygood et al., 1987). The epitopes of three of the antibodies, Je142, 
Je144, and Je1323, were mapped by measuring their relative binding to a large number of 
site-directed mutants of HPr (Sharma et al., 199 1 ; Sharma, 1992). Binding constants 
were later directly determined by fluorescence polarization (Smallshaw et al., 1998). The 
structure of a complex of the Je142 Fab fragment and HPr has been determined by X-ray 
crystallography (Prasad et al., 1 998), which is in agreement with previous conclusions 
about the Je142 binding site on HPr. 
A very recent communication (Wang et al., 2000) has helped to condense the 
information regarding protein:protein interactions involving HPr. Using NMR chemical 
shift experiments, the authors delineated binding sites on E. coli HPr for its interacting 
proteins, namely the N-terminal domain of enzyme 1, enzyme IIA~", and glycogen 
phosphorylase. All proteins occupy essentially the same binding site on HPr. 
1.3.5 HPr kinetics 
In kinetic terms, HPr may be considered a substrate for phosphodonation by 
enzyme I and a substrate for phosphoacceptance by a sugar-specific IIA protein. In both 
reactions, normal, hyperbolic Michaelis-Menten kinetics can be observed. However, even 
though HPr can most accurately be described as a substrate, or "phosphocanier protein", 
the protein also contains characteristics of an enzyme, as it has an active site, and can 
contribute to the catalysis of a phosphotransfer reaction (Anderson, 1994). 
1.3.5.1 HPrIEnzyme I kinetics 
The phosphorylation of HPr by enzyme I, at the expense of the conversion of PEP 
to pyruvate, proceeds via a ping-pong bi-bi mechanism (Waygood and Steeves, 1980; 
Weigel et al., 1982a; Waygood, 1986) The latter part of the reaction mechanism, 
concentrating on the kinetic interaction with HPr, is shown in equation 1.2. 
kC k3 enzyme I-P + HPr 4- enzyme I-P-HPr + enzyme I + P-HPr ( 1 -2) 
The effects of site-directed mutants of HPr in EI kinetics can be kinetically 
analyzed, and, as stated earlier, mutants in which both K, and V, of enzyme I are 
affected result from a decrease in catalysis, whereas HPr mutants in which only the 
enzyme I K, is affected result from a decrease in binding potential, not catalysis. 
1.3.5.2 HPdEnzyme I1 kinetics 
The kinetics describing the reaction of a sugar-specific enzyme II with HPr are 
more complicated. The complete reaction proceeds via the following equation: 
Each step of this reaction mechanism has rate constants in either direction. The 
interpretation of data from enzyme assays of wild type and mutant HPr substrates in the 
presence of saturating concentrations of sugar is difficult. It is not known which is the 
rate limiting step of the above mechanism under different conditions or in the presence of 
various HPr mutants. In addition, the domain structure, binding interactions, and catalytic 
mechanisms of the sugar-specific enzymes 11 vary considerably (Section 1.2), which 
makes it difficult to apply results gained from the assay of one enzyme II to the mechanism 
of another. 
1.4 The general PTS protein enzyme I 
Enzyme I (enzyme I) catalyzes the initial step of the PTS, which is the 
phosphorylation of the N" nitrogen of His15 of HPr at the expense of the conversion of 
one molecule of phosphoenolpyruvate (PEP) to pyruvate. This reaction proceeds via a 
stable phospho-enzyme I intermediate, with the protein phosphorylated at the Nc' position 
of His189. Enzyme I plays an important role as the first enzyme in the PEP:sugar 
phosphotransferase system, and as such it has been postulated as the major enzyme of 
regulation of the PTS in Gram-negative bacteria, which would indicate that it may be 
important for the regulation of carbon metabolism as well (Chauvin et al., 1996a). 
1.4.1 Comparison of enzymes I and homologs 
Enzymes I have been identified in numerous prokaryotic microorganisms, either 
through direct investigation or genome sequencing projects. Enzymes I have considerable 
homology, and possess areas of high conservation (Reizer et al., 1993) which include the 
active site region surrounding the histidine residue of phosphorylation. Enzyme I 
sequences from E. coli (De Reuse and Danchin, 1988) and S. fyphimuriurn (LiCalsi et al., 
1991) show the most homology, each with 575 amino acid residues which are 97% 
identical. These two enzymes are functionally interchangeable; their HPr substrates are 
identical. 
In addition, two other enzymes with sequence and functional similarity to enzyme I 
are known (Reizer et al., 1993). The best studied of the two homologs is pyruvate 
phosphate dikinase (PPDK), which catalyzes the interconversion of PEP and pymvate 
along with phosphate (Pi) and pyrophosphate (PPi): 
Pyruvate + Pi + ATP PEP + PPi + AMP ( 1-4) 
PPDK genes have been identified in bacteria such as Clostridium symbiosurn (Pocalyko et 
al., 1990), several protists such as Trypanosoma brucei (Bringaud et al., 1998), and a 
wide variety of plants, where the enzyme is most important for the C4 cycle of carbon 
metabolism (Matsuoka, 1995). PPDK employs a reaction mechanism which is similar to 
that of enzyme I, and involves an N'-phosphorylated histidine. This residue is His455 in 
C. symbiosum PPDK (Goss and Wood, 1982), which is the most characterized of all 
PPDKs. 
The other homolog of enzyme I is phosphoenolpyruvate synthetase. This enzyme 
has been poorly studied in comparison to enzyme I and PPDK. It catalyzes the conversion 
of pyruvate to PEP at the expense of the conversion of ATP to AMP + Pi: 
pyruvate + ATP t, PEP + AMP + Pi ( 1.5) 
This reaction also proceeds via a stable N'?-ph~s~hohistidine intermediate 
(Narindrasorasak and Bridger, 1 977). 
An alignment of several representative enzymes I and homologs (Figure 1.8) 
reveals important information. Several areas of sequence conservation are highlighted, the 
most important of which is the region surrounding the active site histidine (residue 256 in 
the alignment numbering). Other areas of conservation are evident, but these regions lie 
only on the C-terminal side of the active site histidine. The sequence alignment reveals no 
significant conservation in the area between the N-terminus of the proteins and the active 
site region. Indeed, all the sequences align poorly in this area, and the alignment varies 
depending on the program and parameters used. The program used for the alignment in 
Figure 1.8 is Match-box, which places heavy emphasis on areas of local similarity, and 
little penalty on the inclusion of gaps in the alignment (Depiereux ef al., 1997). Other 
sequence alignments (Reizer et al., 1993; Pocalyko ei al., 1990) may be different. 
Figure 1.8 Multiple sequence alignment of representative enzymes I and related 
sequences. The alignment program used was Match-Box (Depiereux et al., 1997). 
Sequences are: Ec EI, E. coli enzyme I (De Reuse and Danchin, 1988); St EI, S. 
typhimurium enzyme I (LiCalsi et al., 199 1 ) ;  Bs EI, B. subtilis enzyme I (Reizer et al.,  
1993); Sc EI, Staphylococcus carnosus enzyme I (Kohlbrecher et al.. 1991); Cs  PPDK, 
Clustridiurn symbiosum pyruvate, phosphate dikinase (Pocalyko et al., 1990); Zm PPDK, 
Zea mays pyruvate, phosphate dikinase (Matsuoka et al., 1988); Ec PPS, E. coli 
phosphoenolpyruvate synthetase (Niersbach el al., 1992). Residues in the alignment 
highlighted in black correspond to residues conserved in at least five of the seven 
sequences. The numbers to the left of each sequence indicate the first amino acid in the 
row. The numbers above the alignment correspond to the consensus sequence and not to 
any particular amino acid sequence. The consensus sequence is presented below the 
alignment; residues in capital letters are conserved throughout all seven sequences, those 
in lower case letters are conserved in five or six out of seven sequences. The conserved 
active site histidine, residue 256 in the alignment numbering, is marked with an asterisk 
above the alignment. 
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1.4.2 Dimerization of enzyme I 
E. coli and S. typhimurium enzymes I are functionally interchangeable in vitro and 
in vivo, and will be discussed interchangeably in this and ensuing sections. Enzyme I has 
been purified from both E. coli (Robillard et al., 1979; Waygood and Steeves, 1980) and 
S. typhimurium (Weigel et aL, 1982b). Numerous studies have shown that the active 
form of enzyme I is a homodimer of 63 kDa subunits, which dissociates at low 
temperature (Waygood and Steeves, 1980; Misset et al., 1980; Kukuruzinska et al., 1982; 
Kukuruzinska et al., 1986). This active form of the enzyme has two sites of 
phosphorylation per dimer (Waygood, 1986). 
E. coli enzyme I has been specifically labeled at its C-tenninal cysteine residue 
with a fluorescent pyrene tag (Han et al., 1990). This labeled enzyme was found to be 
functionally identical to the unlabeled enzyme. The labeled enzyme was studied by 
fluorescence anisotropy in order to characterize the monomer/dimer equilibrium (Chauvin 
et al., 1994a) and rnonomer/dimer kinetics (Chauvin et al., 1994b). Ratio of dimer to 
monomer increased as a function of temperature and presence of the ligands PEP and 
Mg2', but conversely decreased slightly if the subunits were phosphorylated. In a range 
of conditions. the association constant K, ranged from 0.5 x 10' M" to 240 x 10' M-' 
(Chauvin et al., 1994a). The kinetics of association is slow, with a measured k, of 3.4 x 
i# M"s-', which is two to three orders of magnitude slower than that measured for most 
other proteins. This association was again influenced by degree of phosphorylation and 
presence of ligands. Dissociation kinetics were similarly slow (Chauvin et al., 1994b). 
The quaternary structure of enzyme I from the Gram-positive bacterium 
Staphylococcus camosus has also been studied (Hubner et al., 1995). and it was found 
that addition of both ~ g "  and PEP favours dimerization. In the absence of those ligands 
the enzyme was primarily in the monomeric state. even at room temperature with high 
concentrations of enzyme I (3 mg/mL). However, Reizer et al. (1 992) report that enzyme 
I from another Gram-positive bacterium, B. subtilis, elutes from a gel filtration column as 
a monomer, independent of temperature, and only a small amount of dimer was observed 
at room temperature after inclusion of PEP during gel filtration chromatography. 
Conversely, purification of enzymes I from the Gram-positive bacteria Streptococcus 
salivarius (Vadeboncoeur et al., 1983), Streptococcus mirtans (Thibault and 
Vadeboncoeur, 1985), and Streptococcus faeculis (Npert at al., 1985) has also been 
reported, and in each case the protein eluted as a dimer from gel filtration columns at 4°C. 
Despite the apparent contradictions amongst studies of enzymes I from Gram- 
positive bacteria, the quaternary structures of enzymes 1 from Gram-negative E. coli and 
S. typhimuriurn are well characterized. The slow association kinetics are consistent with 
the hysteretic behaviour of the enzyme, where the room temperature activity of enzyme I 
preincubated at 4°C slowly increases over time, as a function of the slow association of the 
subunits (Waygood and Steeves, 1980; Misset et al., 1980). The slow monomer/dimer 
transition has been proposed as a target of regulation of enzyme I, and thus in viva 
regulation of the PTS (Waygood et al., 1977; Chauvin et al., 1996a). However, besides 
PEP and Mg2+. no other significant physiological effectors of enzyme I activity or 
dimerization have been found (Saier et al., 1980; Waygood and Steeves, 1980; Misset and 
Robillard, 1982; Weigel et al., 1982). Still, enzyme I remains a candidate for a target of 
regulation, and cellular PEP levels, and/or PEP:pyruvate ratio, may in fact play a primary 
role in the regulation of enzyme I activity (Weigel et al., 1982). 
1.4.3 Domain structure of enzyme I 
Proteolytic cleavage studies of S. ryphimurium enzyme I resulted in the discovery 
of a 30 kDa fragment of the protein that remained resistant to digestion (LiCalsi et aL, 
1991). This fragment was identified as the N-terminal fragment of enzyme I, EIN, which 
contained the active site His 189 residue. EIN was able to accept a phosphoryl group form 
phospho-HPr, but not phosphoenolpyruvate. Thermodynamic studies indicated that the 
N-terminal domain of enzyme I was structurally and thermodynamically distinct from the 
more conformationally unstable C-terminal domain, and that the two domains are likely 
joined by a flexible linker (LiCalsi et al., 199 1 ). With the further utilization of molecular 
biology techniques in the mid- 1990's, several labs sought to separately subclone and 
overexpress EIN. In 1996, two laboratories published reports where the cloning and 
characterization of EIN had been accomplished (Seok et al., 1996a; Chauvin et al., 
1996b). In both cases the cloned fragment had similar characteristics to those identified by 
LiCalsi et of. ( 199 1). Chauvin et al. ( 1 996b) also demonstrated that purified EIN did not 
dimerize, regardless of temperature or inclusion of PEP or Mg2+. Putative functions to the 
N- and C-tenninal domains of enzyme I were then assigned. It was evident that the N- 
terminal domain contained the HPr binding site and the phosphotransferase catalytic site, 
whereas the C-terminal domain contained sites for binding PEP and subunit interaction. 
The sequence alignment of enzymes I with other PEP-utilizing enzymes (Figure 1.8) also 
lends evidence to these functional assignments. The N-terminal domain of enzyme I does 
not align well with PPDK or PEP synthetase (PPS), which would indicate that this region 
may contain the specific HPr-binding sequences. Conversely, the C-terminal domain of 
enzyme I does have homology to PPDK and PPS, and both of these enzymes bind PEP 
and readily form oligomers (Narindrasorasak and Bridger. 1977; Herzberg el al., 1 996). 
Thus it is iikely that the C-terminal domain of enzyme I contains PEP binding and 
oligomerization activities. 
The EIN protein has been further characterized in more recent studies. It was 
observed, through differential scanning calorimetry, that phosphorylation of EIN results in 
a decrease in conformational stability, which may promote phosphotransfer to HPr 
(Nosworthy et al., 1998). Fomenkov et al. (1998) were able to demonstrate 
complementation of ELN by the cloned C-terminal domain of enzyme I (EIC), in that a 
mixture of the two proteins had complete enzymatic activity. This complementation was 
shown by in vitro phosphorylation of proteins followed by autoradiography, and by 
fermentation of ITS sugars by prsl bacterial strains harboring EIN and EIC 
overexpression plasmids. The authors were not able to eficiently overexpress and purify 
EIC from the plasmid construct, citing lethality to the bacteria and sensitivity to protease 
digestion as possible reasons. Other researchers were able to purify a similar M. 
capricolum EIC protein, and it was able to complement EIN using in vitro enzyme assays 
(Zhu et al., 1999). However, tlus activity was on the order of lo6-fold lower than wild 
type enzyme I activity. 
1.4.4 Tertiary structure of enzyme I 
A wealth of information regarding the function and putative structure of enzyme I 
has been gained from studies of purified proteins and protein fragments. Unfortunately, 
to date no laboratory has been able to obtain crystals of enzyme I suitable for X-ray 
diffraction. Furthermore, enzyme I, at -60 kDa, is too large to be studied by modem 
NMR techniques. As a result, no tertiary structure of intact enzyme I is available. 
However, the smaller size (-30 kDa), high solubility, and conformational stability of EIN 
make it more amenable to study by NMR and X-ray crystallography, and the structure of 
this domain has been solved. 
1.4.4.1 Structure of enzyme I N-terminal domain 
The structure of the 259 residue N-tenninal domain of E. coli enzyme I has been 
determined by both multidimensional NMR (Garrett et al., 1997a) and X-ray 
crystallography (Liao et al., 1996). The two structures are very similar, and in each case 
the protein is elliptical in shape, and has two subdomains: an a@ subdomain, consisting of 
residues 1-20 and 148-230 which is cornposed of six P-strands and three a-helices, and a 
second all a subdomain, residues 33-143, consisting of four helices (Figure 1.9). The 
four a-helices of the a-subdomain are arranged as two hairpins in a claw-like 
conformation. The active site His189 is located on the a-subdomain, and faces a cleft 
between the two subdomains. The lV2 atom of His 189 is a hydrogen bond acceptor with 
Figure 1 .9 X-ray crystal structure of E. coli enzyme I N-terminal domain, PDB 
accession code lZYM, with the a-subdomain shown on the bottom and the alfksubdomain 
shown o n  the top. The large number of  acidic residues in the active site (red) are labeled, 
as are the catalytic His 189 (green) and its hydrogen bonding partner Thr168 (yellow). 
Figure displayed in similar orientation to that shown in Liao et al. ( 19%). Diagram was 
produced with SETOR (Evans, 1992). 
the hydroxyl hydrogen of Thr168. The p& of His 189 was determined to be 6.5 (Garrett 
et al., 1997). 
The a@-subdomain of EIN, containing the active site histidine, has sequence 
similarity to C. symbiosum PPDK (Reizer et al., 1993; Figure 1.8). The structure of C. 
symbiosum PPDK has been determined by X-ray crystallography (Herzberg et al., 1996), 
and its phosphohistidine domain contains a topological fold which is very similar to that 
found in the a/&subdomain of EIN. Thus in the intact enzyme I, the dp-subdomain is 
responsible for autophosphorylation, whereas the a-subdomain of enzyme I, not found in 
the structure of PPDK, is responsible for binding and phosphotransfer to HPr (Liao et nl., 
1996). 
This postulate was subsequently proven by a number of methods. The a-helical 
subdomain of intact M. capricolm enzyme I was deleted and the resulting protein 
[enzyme I(AHD)) was subsequently isolated. This protein was not capable of 
phosphotransfer to HPr, but phosphotransfer activity was reconstituted after the addition 
of another separate protein; the isolated a-subdomain of enzyme I (Zhu et al.. 1999). A 
binding site for HPr on EIN was also delineated by NMR chemical shift experiments 
(Garrett et al., 1 997 b), and EIN residues which underwent chemical shift perturbations 
upon addition of HPr were restricted to the a-subdomain. Certainly. the most conclusive 
determination of the interaction site between EIN and HPr appeared when the solution 
structure of the -40 kDa complex of EIN and HPr was reported (Garrett et aL, 1999). It 
is necessary to describe this structure in greater detail. 
The EIN binding site on HPr has been discussed previously (Section 1 .3.4.1.1), 
and is found on helices 1 and 2 of HPr, and the residues of EIN involved in the interaction 
will be described here. Three of the four helices of the a-subdomain of EIN form contacts 
with HPr, and thus the interaction involves only helical structures. The conformations of 
each protein change very little upon complexation. Residues 7 1 to 85 and 1 1 1 to 126 are 
the most important residues of EIN involved in the interaction. This interaction is mainly 
hydrophobic, but several key residues of EIN are involved in electrostatic interactions; 
these are GIu67, Glu68, Glu74, Asp82, and Glu84. There are only three side chain-side 
chain hydrogen bonds, with Glu84, Arg126, and Asp129 the participating residues of 
EIN. 
Garrett et al. (1999) also modeled a transition state of the phosphotransfer 
complex. The hydrogen bond between Thr 168 and His 189 of EIN was removed, and the 
side chain of His 189 was allowed to rotate in order to be linked via a phosphate 'tether' to 
His15 of HPr. In this model, EIN is more conformationally unstable than in the absence 
of phosphorylation, which may promote phosphotransfer to HPr. Unfortunately, the 
phosphorylated state of the EIN/HPr complex is too short lived to be directly investigated 
by NMR, and neither has the structure of phospho-EIN been determined. Therefore, a 
different interaction between EIN, or for that matter intact enzyme I, and HPr during 
phosphotransfer cannot be ruled out. 
1.4.4.2 Structure of enzyme I C-terminal domain 
The C-terminal domain of enzyme I, approximately 30 kDa in size, has an 
unknown tertiary structure. Thermodynamic unfolding and protease digestion 
experiments (LiCalsi et al., 199 1) and study of the reactivity of the thiol groups of its four 
cysteine residues (Han et al., 1990) indicate that the C-terminal domain of enzyme I is 
conformationally unstable. which makes the structure difficult to determine. However, a 
protein with sequence and functional homology, and thus likely stxuctural homology. to 
enzyme I has been structurally characterized by X-ray crystallography. This structure of 
C. symbioswn pyruvate phosphate dikinase can be used as a model for the structure of the 
C-terminal domain of enzyme I. 
1.4.4.2.1 Structure of C. symbiosum PPDK 
X-ray crystallography was used to obtain the three-dimensional structure of the 
dimer of C. symbiosum pyruvate phosphate dikinase (Herzberg et al., 1996). The protein 
is quite large, with a monomer molecular mass of 96 kDa. The protein (Figure 1.10) has 
three structurally and functionally distinct domains, connected by two flexible linkers 
(Carroll et al., 1994). The N-terminal domain, 38 kDa, contains the ATP and P, binding 
sites (McGuire ef al., 1996; McGuire et al., 1998). The middle domain, 18 kDa, is the 
catalytic phosphotransfer domain containing the active site histidine-455, and the final 35 
kDa C-terminal domain contains the pyruvatePEP binding site (Xu et al., 199%). The 
dimer of the protein forms a 'butterfly' conformation (Figure 1.10) with the C-terminal 
domain forming the site of interaction and the other two domains of each subunit facing 
away from each other. The structure of the dimer indicates that the active sites of each 
subunit work independently, and that phosphotransfer between subunits cannot occur. 
The three domains of the monomer are joined by two flexible partly helical linkers. These 
linkers interact with each other to form a pivot which allows the central catalytic domain to 
'swivel' between the N- and C-terminal domains in order for phosphotransfer to occur 
between the remote reaction sites (Herzberg et al., 1996) A similar domain-swiveling 
mechanism can be envisioned for enzyme I. 
The C-terminal domain of PPDK forms an eight-stranded @-barrel, which is a 
structural motif found in PEP/pyruvate binding domains of other proteins such as pyruvate 
kinase (Larsen et al., 1994). Structural modeling and comparison to pyruvate kinase 
indicates that in PPDK, phosphoenolpyruvate would be bound in the centre of the bmel 
(Herzberg et al., 1996). The C-terminal domain also contains the subunit interaction site. 
Through a sequence alignment (Figure 1.8), residues in the C-terminal domain of PPDK 
which are conserved between enzyme I and PEP synthetase are identified; these residues 
are likely important for binding PEP and/or subunit interaction. Using the structure of 
PPDK, combined with sequence comparison, a putative structure of 
Figure 1.10 Space filling diagram of the crystal structure of C. symbiosum PPDK, 
PDB accession code lDIR, shown in "butterfly" arrangement. The N-terminal AT-P/Pi 
binding domains (residues 1-400) are shown in red, the central phosphohistidine domains 
(residues 40 1-504) are shown in blue, and the C-terminal PEP bindingldimerization 
domains (residues 505-874) are shown in two shades of yellow. Diagram was produced 
with SETOR (Evans, 1992). 
the enzyme I C-terminal domain can be fashioned, and when connected to the structure of 
the enzyme I N-terminal domain, a working model of intact enzyme I can be created (Zhu 
et al., 1999). Further structural and functional investigations are needed in order to 
determine the validity of this model. 
1.4.5 Enzyme I kinetics 
As previously discussed, enzyme I participates in a covalent catalysis type of 
mechanism, which can be characterized by ping-pong bi-bi kinetics. However, during 
kinetic studies of the enzyme from E. coli or S. ryphimurium it is important to take into 
account the monomer:dimer hysteresis. In most kinetic studies, the enzyme is first 
preincubated at room temperature in a buffer containing PEP and M~" .  This converts the 
enzyme to an active, phosphorylated dimer, which is then added to the assay mixture 
(Waygood and Steeves, 1980; Weigel er al., 1982). However, Misset and Robillard 
(1982) assayed the enzyme after preincubation in a dilute state at 4°C- and under these 
conditions the assay data did not fit the classical ping-pong bi-bi mechanism. This may be 
attributed to the slow increase in enzyme activity due to the hysteretic behaviour of the 
enzyme. Thus, the enzyme must be preincubated with PEP and Mg2+ at room temperature 
in order to have the enzyme in an active dimeric form with two sites of phosphorylation 
per dimer (Waygood, 1986). With these assay procedures, reliable kinetic data can be 
obtained. E. coli enzyme I has a PEP Y, of 0.18 rnM and an HPr Y, of 9 pM (Waygood 
and Steeves, 1 M O ) ,  while S. typhimurium enzyme I has similar characteristics with K,,,s 
of 0.2 rnM and 5.4 p M  for PEP and HPr, respectively (Weigel et al., 1982b). 
1.4.6 Catalytically important residues of enzyme I 
In contrast to the extensive site-directed mutagenesis work done in order to 
characterize the structure and function of HPr (Anderson, 1994; Waygood, 1998). 
comparably little is known about the residues of enzyme I which are cxucial for catalpc 
function. Seok et al. (1996b) described the importance of the Gly338 residue of E. coli 
enzyme I. Mutants at that residue displayed substantially lower autophosphorylation 
activity, although phosphotransfer to HPr was apparently unaffected. That study also 
described a His l89Gly mutant of enzyme I, which was able to bind PEP but was inactive 
in phosphotransfer, as expected. No other biochemically characterized enzyme I mutants 
are available; however, some information can be gained from work on C. symbiosurn 
pyruvate phosphate dikinase. The importance of residues Cys83 1 (Xu er al., 1995b) and 
Arg561 (Yankie et al., 1995) for the PEPIpyruvate partial reaction has been described. 
Both of these residues are conserved amongst all enzyme I, PPDK, and PEP synthetase 
genes sequenced to date (Figure 1.8), so they almost certainly have importance for enzyme 
I function as well. 
1.5 Aims and objectives 
Modem experimental analysis of HPr, involving the creation of a large number of 
site-directed mutants and complex investigation of their properties, has led to a highly 
detailed pichue of the structure and function of the small phosphocarrier protein. 
However, comparably less is known about the structure and function of the protein 
responsible for phosphorylating HPr, namely enzyme I. Enzyme I undergoes complex 
interactions with its chemical ligands, phosphoenolpyruvate and Mg2+, as well as 
protein:protein interactions during the formation of homodimers and also phosphotransfer 
with HPr. At the start of this research project, no study regarding single amino acid 
mutants of enzyme I or the tertiary structure of enzyme I had been published. Considering 
the refinement of modem molecular biological and biochemical techniques, as well as the 
high solubility and established purification procedures of enzyme I, it was decided to take 
the opportunity to study the structure and function of enzyme I in detail. 
Some time ago two "leaky" mutants of enzyme I, which had low activity and were 
not able to form dimers, and one "tight" mutant of enzyme I which had no activity but was 
able to dirnerize, were briefly investigated using cell extracts and partially purified 
proteins. This project describes the cloning, sequencing, purification, and analysis of 
these enzyme I mutants, as well as other mutants created for this project. The importance 
of the identified amino acid residues for various aspects of enzyme 1 activity will be 
investigated. Also, the intragenic (or interallelk) complementation of the original mutants 
identified during initial studies will be further characterized. These enzyme I proteins will 
be used as a tool to investigate the complex function of enzyme 1, in particular the potential 
role of the monomer:dimer transition of enzyme I, in the in vivo regulation of the PTS. 
In addition, the interaction of enzyme I with its substrate protein of the PTS, HPr, 
will be investigated. The kinetic interactions of enzyme I with the large number of HPr 
mutants already available, as well as other mutants created specifically for this project, will 
be investigated separately in detail. Mutations to HPr residues that affect Km but not 
Vmax of enzyme I indicate that these residues are involved primarily in binding and not 
catalysis. Using this kinetic data, a map of the functional interactions of the binding site 
between enzyme I and HPr will be created. 
2.0 MATERIALS AND METHODS 
2.1 Chemicals and enzymes 
Lists of all specialty enzymes and chemicals used in these experiments are 
provided in Table 2.1 and Table 2.2. 
Table 2.1 List of selected chemical supplies and enzymes 
Ammonium persulfate I Bio-Rad I 
Chemical 
Acrylamide (ultra pure) 
Adenosine-5'-triphosphate 
Agarose, electrophoresis grade 
Agarose, low melting point (LMP) 
E-Amino-N-ca~roic acid 
Supplier 
Bio-Rad 
Roc he 
BRL 
BRL 
Sigma 
l c ~ o r o f o r m  l BDH I 
galactopyranoside (X-gal) 
Bromo~henol blue 
Coomassie Brilliant Blue (R250) 1 Sigma I 
ICN 
1 Dirnethvl sulfoxide 1 Fisher I 
Croecein Scarlet 
2'-Deoxyadenosine-5'-triphosphate 
2'-Deoxycytosine-5'-triphosphate 
2'-Deoxyguanosine-5'-triphosphate 
2'-Deoxythymidine-5'-triphosphate 
Dithiothreitol (DTI') 
I Ethidium bromide 1 Siema I 
ICN 
Amersham-Pharmacia Biotech 
Arnersham-Pharrnacia Biotech I 
Arnersham-Pharmacia Biotech 
Amersham-Pharmacia Biotech 
S i m  
N.N1-Methvlene-bis-acxvlamide 1 BDH 
Ethylenediamine tetraacetic acid (EDTA) 
Fluorescein-5-maleimide 
N-2-Hydroxyethylpiperazine-N'-2- 
ethanesulfonic acid (Hews) 
Sigma 
Molecular Probes, Inc. 
Sigma 
Oxdoacetic acid 1 sigma 
2(N-Morpholino)ethanesulfonic acid (MES) 
Nicotinamide-adenine dinucleotide, reduced 
form (NADH) 
Phenol 1 Roche 
Sigma 
Sigma 
Riboflavin-5-phosphate 
Scintillation cocktail (Formula-963) 
Sodium azide 
Sodium dodecyl sulfate (SDS) 
N,N,N',N1-tetramethylet h y lene-diamine 
(TEMED) 
Urea (analytical grade) 1 ICN 
Bio-Rad 
DuPont-NEN 
Fisher 
Sigma 
Bio-Rad 
Tris-(hydroxymethyl) aminoethane (ultra Sigma 
pure) 
Radiochemicals 
[r3t~]~denosine-51-triphosphate (3000 
Cifmrnol ) 
DuPont-NEN 
[a-35~]2 ' -~eoxy adenosine-5'- triphosphate 
(500 Ci/mrnol) 
[u- ' ' ~ ] ~ - ~ l u c o s e  (304 mCi/mmol ) 
[U- ' ' ~ ] a - ~ e t h y l - ~ - ~ l u c o s e  (280
mCi/rnrnol) 
DuPont-NEN 
DuPont-NEN 
DuPont-NEN 
Chromatographic supplies 
A G  1 -X2 C1- form 
DEAE-Sephadex 
Bio-Rad 
Amersham-Pharrnacia Biotech 
DE8 1 Ion-exchange chromatography paper 
Sephadex G-25, G-50, G- 100, G- 150 
Q-Sepharose 
S-Se~harose 
Su~erdex-75 gel filtration column 
Superose- 12 gel filtration column 
Ultragel AcA44 and AcA54 
Microbiological s u ~ ~ l i e s  
Ampicillin 
Bacto-agar 
Bacto-tryptone 
Bac to-veast extract 
MacConkey agar 
Tetracvcline 
Amersham-Pharmacia Biotech 
Amersham-Pharmacia Biotech 
Arners ham-Pharmacia Biotech 
Amersham-Phannacia Biotech 
Amersham-Phannacia Biotech 
Arnersham-Phannacia Biotech 
BDH 
Sigma 
Difco 
Difco 
Difco 
Siema 
Calf intestinal alkaline phosphatase (CIP) 
Deep Vent DNA Polymerase 
Dpn I endonuclease 
Pfu DNA polymerase 
Promega 
New England Biolabs 
StratageneINew England Biolabs 
Stratagene 
Lactate dehydrogenase (rabbit muscle) 
Restriction endonucleases 
T4 DNA ligase 
T4 Polynucleotide kinase 
T7 DNA mlvmerase 
Sigma 
New England Biolabs/Promega/Amersharn- 
Pharmacia Biotech 
New England Biolabs/Promega/Novagen 
New England Biolabs/Novagen 
Amersham-Pharmacia Biotech 
Table 2.2 Name and address of suppliers 
Amersharn-Pharmacia Biotech 
BDH 
I Bio-Rad 
1 Difco 
1 Fisher 
1 Molecular Probes. Inc. 
Address I 
Amersham-Phannacia Biotech, Baie d'Urf6, Que., 
Canada 
British Drug House, Saskatoon. Sask, Canada 
Bio-Rad Laboratories, Mississauga, Ont., Canada 
Bethesda Research Laboratories, Burlington, Ont., 
Canada 
Difco Laboratories. Detroit. Mich.. U.S .A. I 
DuPont Canada Inc.. Mississauga. Ont. Canada I 
Fisher Scientific Ltd.. Neman. Ont.. Canada I 
ICN Biomedical Canada Ltd., Mississauga, Ont., 
Canada 
Molecular Probes, Inc., Eugene, Org., U.S.A. 
New England Biolabs Ltd., Mississauga, Ont., Canada 
Novaeen. Madison. Wis.. U.S.A. 
Fisher Scientific Ltd., Nepean. Ont., Canada 
Roche Diagnostics Inc., Laval, Que., Canada 
Sinma Chemical Co.. St. Louis. Missouri. U.S.A. 
Chromatographic Specialties Inc ., Brockville, Ont., 
Canada I 
2.2 Non-commercial chemicals and proteins 
Purified E. coli phosphoenolpyruvate carboxykinase was provided by Dr. Hughes 
Goldie, Department of Microbiology, University of Saskatchewan. The Je145 antibody 
was provided by Dr. Jeremy Lee, Department of Biochemistry, Ur?iversity of 
Saskatchewan. Many purified mutant HPr proteins were prepared in the Waygood 
laboratory by Dn. Bill Anderson, Scott Napper, and Sadhana Sharma. 
Phosphoenolpyruvate (monocyciohexyiammonium salt) was prepared by the method of 
Clark and Kirby (1963). 
2.3 Bacterial Strains 
The bacterial strains utilized in this work are listed with their genotypes in Table 
2.3. The E. coli strain ESK 108, possessing no detectable HPr activity, was used for the 
overexpression of mutant HPr proteins. ESK108 was produced by converting the E. coli 
strain CSH4 to prsH by N-methyl-N'-nitro-N-nitrosoguanidine mutagenesis (Waygood et 
al., 1987). This strain (ESK120) was made recA by P1 phage transduction using a 
recA56 mutation from strain JC 10240 (Csonka and Clark, 1980) to produce ESK 108. 
The E. coli strain TP28 1 1, carrying a deletion through the entire pts operon (Levy et al., 
1990), was also used for overexpression of HPr and other PTS proteins. 
The E. coli strain ESK238, containing no detectable enzyme I activity or protein, 
was used for overexpression of mutant enzyme I proteins (Brokx et al., 2000). ESK238 
is a spontaneous ptsl mutant of strain BL21 (Studier et al., 1990) selected by 
streptozotocin resistance (Lengeler, 1980). This strain allows for the IPTG inducible 
expression of enzyme I from a plasmid containing the transcriptional start site for TI RNA 
polymerase, such as pT7-7 (Tabor and Richardson, 1985). This strain was prepared by 
James Talbot. 
Several S. typhimuriurn strains were also used in this work. The strains SB 1476, 
SB1681, and SB1690 were the strains from which mutant ptsl genes were cloned. 
Strains SB 1476 and SB 168 1 are ptsl mutants in wild type S. ryphimurium LT2 (Saier and 
Roseman, 1972) while SB 1690 is a ptsl derivative of strain SB3507, which contains 
np223 (Cordaro and Roseman, 1972). AU S. typhimurium mutant strains were kindly 
provided by Drs. Norman Meadow and Saul Roseman, Johns Hopkins University. 
Baltimore, Maryland. 
Table 2.3 List of bacterial strains, genotypes, and references 
Strain Genotype Reference 
Escherichia coli strains 
DHSaF' F'/endA I hsdRl7 (rim,') supE44 thi- 1 Woodcock et al., 1989 
recA1 gyrA ( N ~ I ' )  reU I ~(1aclZYA- 
ArgF) UI 69 deoR (&0dLac~((acZ)MIS) 
Epicurian recA 1 e n d  1 gyrA96 thi- 1 hsdR17 supE44 S tratagene 
Cali XL 1 - relAl lac [F' proAB lacf%Ml5 
Blue Tn 1 O ( ~ e t ~ ) ]  
ESKlO8 F' trp thi rpsL prsH465 recA56 Waygood et al., 1987 
NovaBlue en& 1 hsdR17 (r,'m;) supE44 thi- I recA l Novagen 
gyrA96 reLAl lac [F' proA'B' 
lacl'%iM5: : ~ n  I o ~ r c ~ ) ]  
TP28 1 1 F-xyl arg H I  ~ l a c X 7 4  aroB i f  vA 
AptsHptsIcrr  an^ 
$almonella typhimurirrm strains 
Levy et al., 1990 
Saier and Roseman, 1972 
Saier and Roseman, 1972 
Cordaro and Roseman, 1972 
Cordaro and Roseman, 1972 
Cordaro et al., 1972 
2.4 Plasmid Vectors 
Plasmid vectors are listed in Table 2.4. 
Table 2.4 List of plasmid vectors 
2.5 Bacterial growth media 
Name 
pETl ld 
pT7-7 
pT7Blue 
pT7Blue-3 
pUC19 
Media preparation was as described by Sambrook er a/. (1989). Liquid Luria- 
Bertani (LB) media was composed of 10 g/L tryptone, 5 g/L yeast extract, and 10 g/L 
NaCl in H20. Solutions were autoclaved at 121°C and 18 psi. Sterile filtered (0.22 pm 
filter) ampicillin was added to the media (100 pg/rnL) after the liquid had cooled to 50 - 
60°C. For solid agar media, 15 g/L of agar was added to the liquid media prior to 
autoclaving. Liquid Terrific Broth (TB) contained 12 g/L tryptone, 24 g/L yeast extract, 
and 4 mUL glycerol, as well as sterile potassium phosphate buffer, pH 7.3, which was 
added to the sterile broth to a final concentration of 90 mM after autoclaving. One litre of 
minimal salts A media contained 4.5 g KH,PO,, 10.5 g K,HPO,, 1 g (NH4)ZS04 and 0.5 
g sodium citrate. These ingredients were mixed in deionized water with 10 mM MgCI, 
Source 
Novagen 
Amersham-Pharmacia Biotech 
Novagen 
Novagen 
Arnersham-Pharmacia Biotech 
and autoclaved. MacConkey agar media (50 g/L) was dissolved in deionized water and 
autoclaved at 12 1 "C and 18 psi. Ampicillin (SO pg/mL) and sugars (5 g/L) were added to 
Reference 
Dubedorff and S tudier, 199 1 
Tabor and Richardson, 1985 
Novagen 
Novagen 
Yanisch-Perron er al., 1985 
the cooled media prior to pouring into petri dishes. 
2.6 Hazardous Materials 
2.6.1 Ethidium Bromide 
Ethidium bromide is a potent mutagen if ingested, inhaled, or  allowed to come in 
contact with skin. Latex gloves were worn at all times when working with ethidium 
bromide to iimit exposure. Ethidium bromide (10 m @ d )  was dissolved in deionized 
water and stored in a brown glass bottle. Solutions containing ethidium bromide and 
agarose gels stained with ethidium bromide were disposed of in a dedicated waste 
container and decontaminated (Quillardet and Hofnung, 1988). 
2.6.2 Phenol 
Phenol is toxic and corrosive if ingested or allowed to come in contact with skin. 
Phenol was prepared by five equilibrations with 1 volume of 0.1 M Tris-HCI buffer, (pH 
8.0) removing the top aqueous layer after each equilibration. The phenol was always used 
in a well-ventilated area and latex gloves were used when handling solutions containing 
phenol. Liquids containing phenol were collected in a glass bottle and disposed of as 
chemical waste. 
2.6.3 Chloroform:isoamyl alcohol 
Chloroform is volatile and toxic when inhaled or ingested. Chloroform was 
always handled in a well ventilated area while wearing latex gloves. Chloroform solutions 
used in DNA plasmid purifications were prepared by mixing 24 volumes of chloroform 
and one volume of isoarnyl alcohol. Samples containing chloroform were collected in a 
glass bottle and disposed of as chemical waste. 
2.6.4 Acrylamide 
Acrylamide, when in the unpolymerized form, is a potent neurotoxin and 
dangerous if inhaled, swallowed, or allowed to come in contact with skin. Acrylamide 
solutions were prepared by dissolving 28.2 g acrylamide and 0.8 g bis-acrylarnide in 100 
rnL deionized water with vigorous mixing and heat. Acrylamide powders were always 
handled in a fumehood and while wearing latex gloves and appropriate face mask to 
minimize exposure. Acrylamide solutions were handled while wearing latex gloves. Any 
unused acrylamide solutions were polymerized by the addition of ammonium persulfate 
and TEMED in order to reduce toxicity, and disposed of in regular waste. 
2.6.5 Sodium Azide 
Sodium azide is hazardous when inhaled or ingested. It also forms explosive 
compounds when combined with heavy metals. Aqueous solutions containing sodium 
azide (0.2% or 0.02% w/v) were prepared while wearing gloves and face mask to 
minimize exposure. Any solutions containing sodium azide were collected in storage 
bottles and disposed of as chemical waste. 
2.7 Mutagenic and PCR primers 
Most mutagenic and PCR primers were synthesized by Dr. F. Georges, Plant 
Bitec hnology Institute, National Research Council, Saskatoon, Saskatchewan. 
2.7.1 Mutagenic and PCR primer design 
Mutagenic primers were designed to introduce a specific mutation at a specific 
location of the DNA template. The sequence of the primer depended on the nature of the 
mutation and the surrounding template, but in general mutagenic primers were designed 
with certain characteristics in mind. Each primer was approximately twenty to twenty five 
nucleotides in length, with the mismatch located at or near the middle of the primer. 
Preference was given for primers with high proportions of the bases G and C. The 
annealing temperature (T,) of each primer was calculated using the formula: 
Tm (OC) = 8 1.5 + 0.4 1 (%GC) - 675lN - (% mismatch) (2.1) 
Where N is the number of nucleotides of the primer. 
Primers used for amplifying ptsl, the gene encoding enzyme 1, by polymerase 
chain reaction (PCR) were also designed with the above characteristics in mind, although 
not all primers contained mismatches. The primers used for cloning S. typhimtirium ptsl 
contained mutations necessary to incorporate Nde I and BnmH I restiction sites. All 
primers utilized in this thesis are listed in Table 2.4. 
Table 2.4 Sequences of primers used for mutagenesis and PCR 
Primers used for PCR clonin~ and subcionine: 
S. typhimurium ptsl cloning: 
ptsI. 1 5'- AAGTAAGC'ITGGCATATGATTTC -3' 
ptsI.2 5'- CAGTAATI'GGATCCGCGTCTC -3' 
E. coli ptsl cloning: 
EM' 5'- GTAAGGTAGGCATATGATTTCAGGC -3' 
EI3' 5'- CGCATCTCGTGGATTAGCAG -3' 
EIC37 subcloning: 
M239*+ 5'- CGAAG'ITATTGATCATATGCGCGCTG -3' 
M239"- 5'- CAGCGCGCATATGATCAATAACTTCG -3' 
Primers used for E. coli enzyme I site directed mutaeenesis: 
R 126C+ 5'- CCTGAAAGAATGTGCGGCTGACG -3' 
R126C- 5'- CGTCAGCCGCACATTCTTTCAGG -3' 
G356S+ 5'- CCTGTTCCTCAGCTGGCGCGCTATC -3' 
G356S- 5'- GATAGCGCGCCAGCTGAGGAACGGG -3' 
R375C+ 5'- CGATCAGCTCTGCGCTATCCTG -3' 
5'- CAGGATAGCGCAGAGCTGATCG -3' 
5'- GGTCTGTATCTTACTGAATTCC -3' 
5'- GGAATTCAGTAAGATACAGACC -3' 
5'- CCGAAAGAAGAGGAGCCGTTCCTCGGC -3' 
5'- GCCGAGGAACGGGGCCTCTT-CGG -3' 
5'- CCGAAAGAAGAGGAGCCGTTCCTCGGC -3' 
5'- GCCGAGGAACGGCTCCTCTTCTTTCGG -3' 
5'- GAGAACCCGTTCGCCGGCTGGCGCGC -3' 
5'- GCGCGCCAGCCGGCGAACGGGTTCTC -3' 
5'- GAGAACCCGTTCGAAGGCTGGCGCGC -3' 
5'- GCGCGCCAGCCTTCGAACGGGTTCTC -3' 
5'- CCGTACTTCCGACACCTCTATCATGG -3' 
5'- CCATGATAGAGGTGTCGGAAGTACGG -3' 
5'- CCGTACTTCCGAAACCTCTATCATGG -3' 
5'- CCATGATAGAGGTTTCGGAAGTACGG -3' 
Primers used for HPr site directed mutagenesis: 
5'- CGGTCTGCACGCCCGCCCTGC -3' 
5'- GCAGGGCGGGCGTGCAGACCG -3' 
5'- CCGCCCTGCTACCCAGTTTGTAAAAG -3' 
5'- c-I-1-r-rACAAACTGGGTAGCAGGGCGG -3' 
5'- GCCCTGCTGCCGCGTITGTAAAAG -3' 
5'- CTTITACAAACGCGGCAGCAGGGC -3' 
5'- CCCAGTITCTAGCAGAAGCTAAGGGC -3' 
5'- GCCCTTAGCTTCTGCTACAAACTGGG -3' 
5'- GTAAAAGAAGCTGCGGGCTTCACTTC -3' 
5'- G A A G T G A A G C C C G C A G C T T r n A C  -3' 
5'- AGCGCGAAAAGCGCGTITAAACTGCAG -3' 
5'- CTGCAGTITAAACGCGCTrITCGCGCT -3' 
5'- CTGTITAAACTGGCGACTCTGGGCC -3' 
5'- GGCCCAGAGTCGCCAGTTTAAACAG -3' 
5'- CAGACGCTGGGCCTGACTCAAGGTACC -3' 
5'- GGTACCTTGAGTCGCGCCCAGAGTCTG -3' 
5'- TGGGCCTGGCTCAAGGTACC -3' 
5'- GGTACCTTGAGCCAGGCCCA -3' 
TSW+ 5'- TCTGGGCCTGCAGCAAGGTACC -3' 
T5W- 5'- GGTACCTTGCTGCAGGCCCAGA -3' 
T56S+ 5'- TGGGCCTGTCTCAAGGTACC -3' 
T56S- 5'- GGTACCTTGAGACAGGCCCA -3' 
2.8 General cloning procedures 
Throughout this thesis work, protocols regarding the manipulation of plasmid 
DNA have been carried out according to standard procedures (Sambrook et al., 1989). 
Several important and often used techniques will be described in this section. 
2.8.1 Isolation of plasmid DNA 
2.8.1.1 Small-scale isolation of plasmid DNA ("mini-prep") 
One colony of the desired cells were transferred from an LB-antibiotic plate to 5 
rnL LB broth containing the appropriate antibiotic, which in almost all cases was ampicillin 
(100 pg1m.L). The broth in a 14 mL round bottom tube, loosely capped, was incubated at 
37°C with shaking at 300 rpm for 10 - 16 h. A 1.5 mL microfuge tube was filled with the 
culture and this was centrifuged at 12,000 g for 1 min. The pelleted cells were 
resuspended in 100 pL of a solution containing 25 mM Tris-HCI buffer (pH 8.0), 50 rnM 
glucose, and 10 rnM EDTA and incubated on ice for 5 rnin on ice. Then 200 p1 of a 
freshly prepared solution of 0.2 N NaOH and 0.1 % SDS was added, mixed by inversion, 
and incubated for 5 - 10 min on ice. After incubation, 150 pL of cold (4°C) 3M potassium 
acetate (pH 5.2) was added and the well mixed solution was incubated on ice for 10 min. 
The microfuge tube was then centrifuged at 12,000 g for 10 rnin at 4OC. The resulting 
supernatant was transferred to another microfuge tube and 200 pL each of buffer 
equilibrated phenol and 24: 1 chlorofonn:isoarnyl alcohol were added. The solution was 
mixed for 2-5 min and centrifuged for 1 min at 12,000 g to separate the phases. The 
upper aqueous layer was transferred to a new microfuge tube and 1 mL ethanol was 
added. After incubation at -20°C for 10 min, the precipitated RNA and plasmid DNA were 
pelleted by centrifugation at 12000 g for 15 min. The pellet was washed twice with 1 rnL 
ice cold 70% ethanol, and dried in a vacuum dessicator. The pellet was then dissolved in 
30 pL TE buffer (10 rnM Tris-HC1 buffer, 1 rnM EDTA, pH 8.0), and 1 pL of DNAse- 
free Ribonuclease A (1 mg1mL) was added. and the solution was left at room temperature 
for 30 min to digest the RNA, before long-term storage at 4°C. 
2.8.1.2 Medium scale plasmid isolation 
One colony of the desired cells was suspended in 5 mL LB broth containing 100 
pg/mL ampicillin. This culture was incubated at 37°C with shaking at 300 rpm until late 
log phase (approximately 8 h). Then 1 rnL of this culture was transferred to 50 rnL LB 
broth + ampicillin in a 250 mL Erlenmeyer flask, and the culture was grown overnight ( 16 
- 18 h) at 37OC with shaking. Forty mL of this culture was transferred to a polypropylene 
Oak Ridge tube, and the cells were centrifuged for 10 min at 4000 g with a JA-20 rotor in 
a J2-HS centrifuge (Beckman-Coulter Inc.). The cell pellet was resuspended in 2.5 mL of 
a solution containing 25 mM Tris-HC1 (pH 8.0), 50 mM glucose and 10 mM EDTA, and 
incubated on ice for 10 min. Then 5 rnL of a freshly prepared solution of 0.2 N NaOH 
and 1% SDS was added, mixed thoroughly, and incubated for 5 rnin on ice. Then 3.75 
mL of 3 M potassium acetate (pH 5.2) was added and the tube was incubated for a further 
10 min on ice. The tube was then centrifuged at 16,000 g for 15 min at 4"C, and the 
supernatant was decanted into a fresh Oak Ridge tube, to which 5 rnL of buffer saturated 
phenol and 5 mL of chlorofonn:isoarnyl alcohol (24: I )  were added. The tube was mixed 
by inversion for 5 rnin and then centrifuged for 5 min at 4000 g to separate the phases. 
The upper aqueous phase was transferred to another Oak Ridge tube, and 20 mL of ice 
cold 95% ethanol was added. The solution was then incubated at -20°C for I h. The tube 
was centrifuged at 16,000 g for 10 min to pellet the precipitated DNA. The pellet was 
washed twice with 10 mL ice cold 70% ethanol, and dried in a vacuum dessicator. The 
pellet was then dissolved in 300 pL TE buffer, and 2 p.L DNAse-free RNAse (10 mg/mL) 
was added. The solution was transferred to a microfuge tube and incubated for 30 min at 
room temperature, before long term storage at 4OC. This solution of DNA was sometimes 
pure enough for certain uses, but most of the time was further purified by precipitation 
with polyethylene glycol. 
The volume of the DNA solution was adjusted to 500 pL by the addition of 200 
pL TE buffer. Then the solution was extracted with a combination of 250 pL phenol and 
250 pL chloroform:isoamyl alcohol (24: 1 ). The microfuge tube was then centrifuged for 
2 min at 12,000 g to separate the phases and the upper aqueous phase was transferred to a 
new microfuge tube on ice. Then 500 pL of a solution containing 1.6 M NaCl and 13% 
(w/v) polyethylene glycol, 8000 average molecular mass (PEG-8000) was added and the 
solution was incubated on ice for 1 h. The solution was then centrifuged at 12,000 g for 
15 rnin to pellet the DNA. The pellet was thoroughly washed three times with ice cold 
70% ethanol, and dried in a vacuum dessicator. The pellet was then dissolved in 300 pL 
of 0. l x  TE buffer ( 1 mM Tris-HC1 buffer, 0.1 mM EDTA, pH 8.0) and stored at 4°C. 
2.8.2 Restriction endonuclease digests 
Plasmid DNA was routinely digested with various restriction endonucleases, in 
order to determine the nature of the plasmid, or in order to cleave circular DNA into linear 
pieces to ligate together into a different arrangement. The procedure is well established 
(Sarnbrook ef al., 1989). and involves the suspension of -1 pg DNA in a total reaction 
volume of 10 - 50 pL. Also included in this restriction digest was the correct buffer used 
for the particular enzyme(s), and 10 - 20 U of the restriction enzyme(s). For double 
digests, a buffer was chosen which gave reasonable activity for each enzyme. Most 
reactions were carried out at 37°C. although some heat stable or heat labile enzymes 
required a different temperature of incubation. Reaction times ranged from 30 min to 2 h . 
Restriction fragments were then routinely separated and analyzed by agarose gel 
electrophoresis, followed by visualization of ethidium bromide stained DNA. 
2.8.3 Agarose gel electrophoresis of DNA 
To each sample DNA solution, whether plasmid DNA, polymerase chain reaction 
(PCR). or restriction digest, gel-loading buffer was added to a final concentration of 8% 
(wh)  sucrose and 0.05% (wh)  bromophenol blue. An agarose gel was previously 
prepared by sealing the ends of a Pharrnacia gel casting tray with labeling tape. Regular or 
low melting point (LMP) agarose gels of 1% (wlv) were prepared by the suspension of 
0.5 g agarose in 50 mL TAE buffer (40 mM Tris-acetate buffer. 1 mM EDTA. pH 8.0) in 
an 125 rnL Erlenmeyer flask. This solution was microwaved until boiling (1 - 2 rnin), and 
the solution was swirled in order to dissolve the agarose. The solution was left to cool to 
-5S°C, and then optionally 1 pL of a 10 mg/rnL solution of etludium bromide was added 
to the agarose before pouring into the gel casting tray with sample application comb. Once 
the gel was solidified, the comb was removed and the prepared samples were applied. 
The gel was then electrophoresed at 100 V for 45 to 60  min in an electrophoresis cell 
containing TAE buffer. The gels which did not yet contain ethidium bromide were then 
stained in a weak solution (-0.5 pg/mL) of ethidium bromide in TAE buffer for 30 min. 
The DNA in the gel was then visualized by exposure to ultraviolet light (254 nm) in a 
transilluminator. A picture of the gel was often taken, using a Polaroid GelCarn with 
hood, with Polaroid Polapan 665PN film, 5-10 s exposure. Small blocks of agarose 
containing the DNA bands of interest were excised from the gel, to be recovered. 
2.8.4 Recovery of DNA from agarose gels 
Several procedures for the isolation of DNA from agarose gel slices have been 
used in this thesis work. Originally, DNA was isolated from Low Melting Point (LMP) 
agarose gels. The gel slice was then added to a rnicrofuge tube containing 300 pL TE 
buffer, and the agarose was melted by incubation at 60°C for 10 min. The DNA was then 
purified from this solution, by one of two methods. One method (Sambrook et al., 1989) 
involved pheno1:chloroform extraction of the solution, followed by precipitation of the 
DNA with ethanol, as in plasmid purification procedures. In, the other method (Qian and 
Wilkenson, 1991), the dissolved gel was placed at -70°C for 10 min, and the frozen gel 
was then slowly melted. The solution was mixed vigorously. and the disrupted agarose 
was removed by centrifugation at 12,000 g for 2 min. The solution containing the DNA 
was then removed, and concentrated by ethanol precipitation if necessary. 
DNA was most recently purified from regular agarose gels. The Agarose Gel 
DNA Extraction kit (RocheA3oehringer-Mannheim) was used. The gel slice was placed in 
a rnicrofuge tube, and 300 pL of agarose gel solubilization buffer plus 10 pL of silica 
matrix was added. The gel was incubated at 60°C with occasional vortexing, and then the 
solution was centrifuged at 12,000 g for 30 s. The supernatant was discarded and 500 pL 
of nucleic acid binding buffer was added to the silica pellet, and the solution was mixed 
for 1 rnin. before centrifuging at 12,000 g for 30 s. The pellet was then washed twice 
with washing buffer, containing 70% ethanol, and the pellet was dried at room 
temperature. The DNA was eluted from the matrix by application of 30 pL TE buffer. 
incubation at 60°C for 10 rnin, followed by centrifugation and transfer of the supernatant 
to a new rnicrofuge tube. This DNA solution was of sufficient purity and concentration to 
use directly in ligation reactions. 
2.8.5 Ligation of fragments into plasmid vectors 
Ligations were commonly done as described (Sambrook et al., 1989). Plasmid 
DNA and insert DNA were linearized with the appropriate restriction enzymes, these 
reactions were electrophoresed on an agarose gel, and then the correct DNA bands were 
excised from the gel and purified. Purified insert DNA was combined with vector DNA at 
a molar ration of approximately 3: 1, along with with the addition of commercial ligase 
buffer (commonly to a final concentration of 50 rnM Tris-HC1 buffer, pH 7.6. 10 mM 
MgCl,, 10 mM D m ,  and 1 mM ATP) and 5U T4 DNA ligase. in a total volume of 10-20 
pL. Ligations were incubated at 16°C or 2Z°C for 1-4 h. Appropriate controls were 
always performed to assess the success of a ligation. The ligations were most commonly 
directly transformed into competent E. coli cell strains after the reaction was complete. 
2-8.6 Transformation of vector DNA 
Plasmid DNA was used to transform cells made competent by treatment with cold 
CaCl, solutions (Sambrook et al., 1989). In this protocol to prepare competent cells, 50 
rnL of LB broth in a 250 mL Erlenmeyer flask was innoculated with 2-5 rnL of an 
ovemight culture. The cells were then grown at 37OC with shaking at 300 rpm until mid- 
log phase was attained, approximately 2 h. The culture was harvested by centrifugation at 
5000 g for 10 min at 4°C. The cell pellet was resuspended in 20 rnL ice cold sterile 0.1 M 
CaCI,, and the cells were left on ice for 20-40 min. The cells were pelleted once more by 
centrifugation, and the pellet was resuspended in 1-2 mL of 0.1 M CaC12. These cells 
were incubated on ice for a minimum of 1 h, up to a maximum of 48 h, before use in a 
transformation. The cells were also commonly stored in aliquots at -70°C after the 
addition of 15% (v/v) glycerol. 
For a transformation. 100 pL of a suspension of competent cells. either freshly 
prepared or taken from frozen stocks, was combined with vector DNA. For 
transformation of purified plasmid. about 0.2 pg plasmid was used; for transformation of 
ligation reactions, 5- 10 pL of the reaction was added to the competent cells. This mixture 
was incubated for 20-40 min on ice, followed by a 2 min heat shock at 42°C and a further 
2 min incubation on ice. In most cases this suspension was then directly spread on to an 
LB agar plate containing 100 pg/mL ampicillin. The plates were incubated ovemight ( 12 
to 16 h), and ampicillin resistant colonies of cells containing the desired plasmid were then 
visible. 
2.9 Cloning of ptsl  genes 
Polymerase chain reaction (PCR) was used to amplify the ptsl genes from the S .  
typhimurium strains SB 1476, SB 168 1, SB 1690, and SB3507, containing ptsIl7, ptsiM, 
and ptsi34, and wild type ptsl, respectively. PCR was also used to amplify the wild type 
E. coli ptsl gene. The amplified fragments were subsequently cloned into the pT7Blue 
vector, and further transferred to the plasmid pT7-7. 
2.9.1 Isolation of ptsZ from S. typhimurium 
A crude preparation of bacterial chromosomal DNA was obtained by suspension of 
one colony from an LB-agar plate into 0.05 mL H,O, and adding 1 pL of this suspension 
into a PCR reaction tube. The DNA was denatured by a 5 min incubation at 95°C. 
followed by rapid cooling on ice. Reagents were then added to give: 20 mM Tris-HC1 
buffer (pH 8.8), 10 rnM KCl, 10 rnM (NH,),SO,, 2 rnM MgSO,, 0.1% Triton X- 100, 
0.2 mM each WTP, 10 pmol of each primer ptsI. 1 and pts1.2, and 0.5 U Deep Vent DNA 
polymerase in a total volume of 25 pL. The PCR program used was 30 cycles of 30 s at 
95OC (denaturation), 30 s at 52°C (annealing), and 90 s at 72°C (primer extension). The 
PCR reaction product, 1750 bp, was separated on a 1% agarose gel and purified by the 
Agarose Gel DNA Extraction Kit (Roche/Boehringer-Mannheim). This isolated DNA was 
then cloned by blunt end ligation into pT7Blue using the Perfectly Blunt Cloning Kit 
(Novagen). The resulting plasmids were then digested with Nde I and BamH 1 restriction 
endonucleases and the 1750 bp ptsI gene fragment was then ligated into the plasmid pT7-7 
using standard techniques (Section 2.8). This gave the plasmids pT7-7(EIst), pT7- 
7(EIstI 16), pT7-7(EIstI 17), and pT7-7(EIstI34). 
2.9.2 Isolation of E. coli ptsl 
The E. coli ptsl gene was first amplified from the plasmid pTSHIC9 which 
contains the E. coliptsHlcrr operon (Mao et al., 1996). The PCR reaction contained, in a 
total volume of 50 pL: 1 0 ng pTSHIC9, 10 pmol of each primer EIS' and EI3', and other 
reagents as described previously (Section 2.8.1 ). The 1750 bp DNA fiagment was then 
cloned into pT7Blue and subcloned into pT7-7 as described for the S. typhimuriurn gene 
cloning, to give pT7-7(EIec). 
2.10 Construction of enzyme I fragments 
Several fiagments of E. coli enzyme I were created in this thesis work in order to 
separately investigate the function of the N- and C-terminal domains. 
2.10.1 Construction of C-terminal enzyme I fragments 
In E. coli enzyme I ,  residue 334 is a methionine and part of an Nco I site in ptsl. 
The Nco I - BamH I hgrnent digested fiom pT7-7(EIec) was ligated into the vector 
pETl1 d to give pET11 (EIecC334), which encoded the C-terminal27 kDa (residues 3 34 - 
575) of enzyme I. 
Residue 239 of E. coli enzyme I is also a methionine, and site directed mutagenesis 
(Section 2.1 1) was used to change the DNA sequence in order to create an Nde I site at 
that position. The 1020 bp Nde I - BamH I fragment from the resulting plasmid was 
excised and ligated into pT7-7. This gave the plasmid pT7-7(EIecC239), which encoded 
the C-terminal37 kDa (residues 239 - 575) of enzyme I. 
2.10.2 Construction of N-terminal enzyme I fragments 
The S e n d  hgrnents of E. coli ptsl necessary for the production of N-terminal 
fkagments of enzyme I were amplified from pTSHIC9 by PCR in a manner similar to that 
previously described (Section 2.9.2), using two 3' end primers that provided for a BamH 
I restriction site and termination at residues 220 and 250. The PCR products were ligated 
into pT7-7 using the Nde I and BomH I restriciton sites. The two plasmids pT7- 
7(EIecN219) and pT7-7(EIecN249), produced enzyme I N-terminal fiagments fkom 
residues 1-219 and 1-249, respectively. The construction of these plasmids was 
performed by James Talbot. 
2.1 1 Site-directed mutagenesis 
Construction of site-directed mutants of HPr has over the years been done by 
several different procedures (Kunkel et al., 1987; Landt et al., 1990), but most recently 
has been done by the QuikChange site-directed mutagenesis protocol from Stratagene. All 
site-directed mutants of HPr and enzyme I in this thesis have been prepared by the 
QuikChange methodology. 
Site-directed mutagenesis by the QuikChangc protocol involves the synthesis of a 
set of two mutagenic primers, complementary to each other, to mutate each strand of the 
template plasmid. Primer extension, and thus synthesis of new mutant plasmid, is carried 
out through thermal cycling reactions, much like polymerase chain reaction (PCR). Each 
mutagenesis reaction contained, in a total volume of 50 pL in a 0.2 mL microfuge tube: 20 
mM Tris-HC1 buffer (pH 8.8), 10 mM KCl, 10 mM (NH&SO,, 2 mM MgSO,, 0.1 % 
(v/v) Triton X- 100, 0.1 mg/rnL nuclease-free bovine serum albumin (BSA), 0.4 rnM of 
each dNTP, 20 ng plasmid DNA template, 125 ng of each mutagenic primer, and 2.5 U 
Pfu DNA ploymerase. This polymerase is thermostable and is not able to displace the 
mutagenic primer after complete extension of the primer around the plasmid. The 
mutagenesis reaction consisted of sixteen cycles of 30 s at 95°C (denaturation), 60 s at 
55°C (annealing), and 60 s per kilobase of template at 68°C (primer extension). 
Following this reaction, 10 U of Dpn I restriction enzyme was added, and the 
solution was incubated at 37°C for 1 h. The restriction enzyme Dpn I is able to digest the 
parental, methylated, template DNA but not the newly synthesized unmethylated mutant 
DNA. Following this incubation, one pL of the mixture was added to 50 pL prechilled 
(4°C) Epicurian Coli supercompetent cells in a Falcon 2059 polypropylene tube. The cells 
were incubated on ice for 30 min, followed by a 42°C heat shock for 45 s, followed by a 2 
min incubation on ice. Then 0.5 mL of prewarmed (42°C) LB broth was added to the cells 
and the tube was incubated at 37OC, with shaking at 300 rpm, for 30 rnin. Following this 
incubation, 0.2 rnL of cells were plated onto an LB-agar plate containing 1 0 0  pg/mL 
ampicillin. The plates were incubated for 12 - 18 h at 37°C and resulting colonies 
contained the desired mutant plasmid DNA with a typical success rate of 80 - 90%. 
2.12 DNA Sequencing 
Plasmids created by site-directed mutagenesis or ligation reactions had to be 
confirmed by identification of the DNA sequence. AU sequencing procedures used the 
dideoxy termination method initially devised by Sanger et al. ( 1977). Some sequencing 
was done by the method described in Section 2.12.1. Most sequencing was done as 
described in Section 2.12.2, and in all cases the entire gene or plasmid insert was 
sequenced to be assured that no unwanted mutations occurred during PCR or mutagenesis 
reactions. 
2.12.1 Sequencing with radioisotope labeling 
2.12.1.1 Sequencing reactions 
In this laboratory, sequencing reactions were performed using the 'I7 Sequenase 
kit (Amersham-Pharmacia) using a modified protocol. In a total volume of 7 pL, 1-2 
pmol double stranded DNA template and 5 pmol of the appropriate primer were combined. 
Then 1 pL of dimethyl sulfoxide @MSO) was added, and the solution was incubated at 
9S0C for 3 min to separate the DNA strands. This solution was then frozen quickly by 
plunging into a -80°C ethanol bath, and thawed at room temperature. Then 2 pL of 
annealing buffer was added, followed by a room temperature incubation of 5 rnin. Then 
7.5 pL of labeling mix (1 pL of 0.1 M D m ,  1 pL DMSO, 3 pL labeling mix 'A'. 1 pL of 
[ a - 3 5 ~ ] d ~ T P  (500 Ci/mmol), 2 U T7 DNA polymerase, and water to 7.5 pL) was added. 
Following a 5 min room temperature incubation, 4.3 pL of this reaction mix was 
dispensed into each of four prewarmed (37°C) termination tubes containing the sequencing 
termination mixes (T, C, G, A), and allowed to incubate for 2 - 3 rnin. 'T' mix contained 
840 p M  each of dATP, dCTP, and dGTP, 93.5 pM dTTP, 14 pM ddTTP, 40 rnM Tris- 
HCl (pH 7.6), 50 rnM NaC1, and similarly for the other termination mixes 'C', 'G'. and 
'A .  Reaction mixtures were terminated by the addition of 5 pL stop buffer, which 
contained 0.3% (wh)  each of bromophenol blue and xylene cyanol, 10 rnM EDTA (pH 
7 . 3 ,  and 97.5% deionized forrnamide to each tube. The reactions were immediately 
subjected to electrophoresis or frozen for later use. 
2.12.1.2 Urea-polyacrylamide gels 
DNA sequencing reaction mixtures were analyzed by urea-polyacrylamide gel 
electrophoresis. A glass sequencing plate was cleaned using 95% ethanol and lint-free 
kimwipes, and assembled into the pouring tray for use with the Sequi-Gen GT DNA 
Electrophoresis cell (Bio-Rad). A mixture containing TBE buffer (45 rnM Tris-borate 
buffer, pH 8.0, ImM EDTA), 6% acrylamide (acrylamide:bisacrylamide, 19: I ) ,  and 7.7 
M urea in a total volume of 100 mL was prepared. Polymerization was started by the 
addition of 200 pL 25% (w/v) ammonium persulfate and 100 pL N,N,N9,N'- 
tetrameth y lehy lenediarnine (TEMED). This solution was injected into the space between 
the glass plate and the tray with a 120 rnL syringe, and a sharktooth or sawtooth comb 
was immediately applied. Polymerization was allowed to take place for 30 min, and then 
the gel was used immediately or sealed with plastic wrap and stored at room temperature 
for later use. 
2.12.1.3 Electrophoresis and autoradiography 
The acrylamide gel was assembled into the Bio-Rad apparatus according to 
manufacturer's instructions. The upper and lower chambers were filled with TBE buffer, 
and the gel was warmed with an electrophoresis pre-run of approximately 30 min with 
constant power (80 W). During this time, the DNA sequencing reaction samples were 
incubated in a 95OC water bath for 3 min and placed on ice. The samples were loaded into 
the preformed wells of the sawtooth comb, or in the wells formed by the sharktooth comb 
and the gel. Once applied, the gel was electrophoresed until the bromophenol blue dye 
reached the end of the gel, about 3 h. The sequencing apparatus was then disassembled 
and the glass plate was pried apart from the electrophoresis assembly. The exposed gel 
was then transferred to a Whatman 3M filter paper. This was placed onto a Savant gel 
drier, and covered with plastic wrap. The gel was dried under vacuum for 2 h at 80°C. 
The gel was then placed into a film cassette with Kodak X-Omat AR X-ray film, and 
exposed for 16 - 24 h at room temperature. The film was developed using an AFP 
Imaging MiniMed/90 automatic X-ray film processor. 
2.12.2 Automated DNA sequencing 
Automated DNA sequencing, using fluorescent labeled reactions, was performed 
by the DNA Services Unit of the Plant Biotechnology Institute, National Research Council 
of Canada, Saskatoon SK. An Applied Biosystems 373 (Stretch) DNA sequencer was 
used. 
2.13 Protein purifications 
Several types of protein were purified during this thesis work. namely HPr, 1 1 ~ ~ ' '  
enzyme I, and enzyme I C- and N-terminal fragments. Purification of each protein will be 
discussed separately. 
2.13.1 Purification of HPr proteins 
Wild type and mutant HPr proteins were purified by established procedures 
(Waygood and Steeves, 1980), with modifications (Brokx et at., 1999). Either of the E. 
coli strains ESK108 or TP28 1 1 were transformed by pUC(HPr). The pUC(HPr) plasmid 
contains the open reading frame of ptsH, the gene encoding HPr, as well as the 5 ' 
promoter region, inserted into the Cla I and Srna I sites of pUCl9. Cells harboring this 
high copy number pUC(HPr) plasmid constitutively express large amounts of HPr 
protein. A colony of transformed cells was used to inoculate 5 rnL of LB broth containing 
100 pg/rnL ampicillin, and this was grown overnight at 37°C with shaking at 300 rpm. 
This culture was used to inoculate 150 rnL LB-ampicllin broth in a 500 mL Erlenmeyer 
flask, which was incubated with shaking until mid-log phase. This culture was used to 
inoculate four 6 L flasks containing 1.5 L each of Terrific Broth containing ampicillin. 
These flasks were grown for 16 - 20 h at 37°C with shaking at 300 rprn. The cells were 
harvested by centrifugation with a GS-3 rotor in a Sorvdl RC2-B refrigerated centrifuge. 
The cell pellets were combined into one centrifuge bottle and washed with 0.85% (wlv) 
NaCl and recentrifuged. The cells were stored at -20°C until needed for crude extract 
preparation. 
The cells (20-30 g wet weight) were resuspended in 0.01 M Tris-HCl buffer (pH 
8.0) buffer at a ratio of 3.0 mL buffer to 1.0 g cells. This suspension was passed through 
a cooled French press cell (Aminco) at a pressure of 1000 psi for two to three times. 
Unbroken cells and cell debris were removed by initial centrifugation at 10,000 g for 10 
min at 4°C. This supernatant was then centrifuged at 200,000 g in a Beckman Ti60 rotor 
for 1.5 h at 4°C in order to remove cell membranes. 
This supernatant (-100 mL) was loaded onto an AcA54 Ultragel gel filtration 
column ( 10 cm x 100 cm) equilibrated with 10 m M  Tris-HC1 buffer (pH 8.0). Buffer was 
pumped through the column at a rate of -300 mUh, and -450 mL fractions were collected. 
Isoelectric focusing gels (described in proceeding text) were used to determine which 
fractions contained HPr. HPr, at a molecular mass of 9 100 Da, is a small protein which is 
relatively easy to separate by this method. As a result, the fraction(s) containing HPr were 
often of sufficient purity to be used without further purification. in some cases, however, 
the fraftions were pooled and loaded onto a Q-Sepharose anion exchange column (150 
mL) equilibrated with 10 rnM Tris-HCl buffer (pH 8.0). HPr was eluted by using a 
gradient of 0 to 0.3 M NaCl in the same buffer (1L each). The pure HPr fractions 
obtained from either chromatography step were pooled and dialyzed (Spectrapor tubing, 
pore size 4,500 Da) against three changes of double distilled water. Samples were then 
frozen and lyophilized. Lyophilized protein samples were stored airtight at -20°C. 
Purification of Phe2Cys HPr was carried out as described, except 0.2 mM 
dithiothreitol (Dm) was included in all buffers in order to keep the protein as a monomer. 
The protein was stored at -20°C in a solution containing 10 mM Tris-HC1 buffer (pH 7.5) 
and 1 mM DTT instead of lyophilized. 
2.13.2 Purification of enzyme I 
Enzyme I has been overexpressed from two different sources for the purposes of 
purification for this thesis work. Enzyme I, along with HPr and IIA~", was originally 
overexpressed from TP28 11 cells containing the plasmid pTSHIC9. More recently, and 
for the bulk of wild type and all mutant protein purifications, enzyme I has been purified 
from ESK238 cells containing pT7-7(EI) overexpression plasmids. Large scale growth 
and overexpression protocols were similar. One colony was used to inoculate 5 mL LB 
broth with 1 0 0  pg/rnL ampicillin, and this was grown to mid-log phase (8-10 h). This 
culture was then used to inoculate 100 mL LB-ampicillin broth in a 500 rnL Erlenmeyer 
flask, which was grown to stationary phase (14-18 h). Four 6 L Erlenmeyer flasks 
containing 1.5 L terrific broth with ampicillin were each inoculated with 25 mL of 
overnight culture. These cultures were grown to late log phase (ODm, = 0.8 - l ) ,  and 
protein overexpression was induced by the addition of isopropyl-0-D- 
thiogalactopyranoside (IPTG) to a final concentration of 0.5 rnM. The cultures were 
grown for a further 4 h to allow for protein overexpression. The cells were then 
harvested by centrifugation with a GS-3 rotor in a Sorvall RC2-B refrigerated centrifuge. 
The cell pellets were combined into one centrifuge bottle and washed with 0.85% (w/v) 
NaCl and recentrifuged. The cells were stored at -20°C until needed for crude extract 
preparation. 
Crude extract preparation and purification of enzyme I was carried out as described 
(Brokx et al., 2000). The cells (15 - 25 g wet weight) were suspended in 3 rnL buffer A 
(10 rnM potassium phosphate buffer, pH 7.5, IrnM EDTA, 0.2 mM Dm) per gram of 
cells. The cells were then broken by two passages through the French pressure cell at 
1000 psi. Unbroken cells and cell debris were removed by initial centrifugation at 10,000 
g for 10 min at 4°C. This supernatant was then centrifuged at 200,000 g in a Beckman 
Ti60 rotor for 1.5 h at 4°C in order to remove cell membranes. 
The resulting supernatant was adjusted to the pH and conductivity of buffer A by 
the addition of 1 N NaOH and distilled water. The extract was then loaded onto a 150 mL 
Q-Sepharose anion exchange column, a 1 L + 1L gradient of 0 to 0.5 M KC1 was applied, 
and fractions were coliected. Enzyme I adhered strongly to the resin and eluted at -0.4 M 
KCl. Purity of fractions was analyzed by sodium dodecyl sulfate polyacrylamide 
electrophoresis (SDS-PAGE; see proceeding text), and fractions containing essentially 
homogeneous enzyme I were pooled. This pool was phosphorylated by the addition of 
phosphoenolpyruvate (PEP) to 2 rnM and MgCl, to 5 rnM and incubation at 37°C for 10 
min. The enzyme I preparation was then concentrated by passage through a PM-10 
membrane using an Amicon ult.rafiltration cell at 4°C. Part of the preparation was often 
dialyzed against three changes of buffer A and used directly. The rest of the preparation 
was dialyzed against three changes of double distilled water, frozen, lyophilized, and 
stored airtight at -20°C. 
2.13.3 Purification of enzyme I N-terminal domain proteins 
Protein overexpression of 24 kDa or 27 kDa E. coli enzyme I N-terminal proteins 
from plasmids pT7-7(ElecN219) and pT7-7(EIecN249). respectively, and preparation of 
crude extract was as described (Section 2.13.3). The crude extract was applied to a 150 
rnL Q-Sepharose column and a 0 - 0.5 M KC1 gradient was applied. Fractions containing 
the N-terminal protein, either EIN24 or EIN27, were identified by SDS-PAGE. The 
fractions were pooled and concentrated to -20 rnL by passage through a PM- 10 membrane 
using the Amicon concentrator. This solution was then loaded onto an AcA44 Ultragel 
column (5 x 1 0 0  cm) equilibrated with buffer A plus 0.1 M KC!, 5 mM MgCl?. and 20 
mM e-arnino-caproic acid (a protease inhibitor). Fractions which contained the desired 
protein were again identified by SDS-PAGE, concentrated by Amicon. and dialyzed 
against buffer A or lyophilized, as described previously (Section 2.13.2). 
2.13.4 Purification of enzyme I C-terminal domain proteins 
The 27 kDa C-terminal protein was expressed from ESK238 cells carrying the 
plasmid pET1 l(EIecC334) by IPTG induction, and the cells were harvested and broken 
by passage through the French press as described previously. However, the protein was 
found in the pellet of the initial low speed (10,000 g) centrifugation, indicating that the 
protein was expressed but formed insoluble inclusion bodies. This protein aggregate was 
solubilized in buffer A containing 3 M ure.a, and celi debris was removed by centrifugation 
at 10,000 g. This protein solution was then dialyzed against three changes of fresh buffer 
A without urea, and the EIC27 protein remained soluble. The protein was further purified 
by passage through a Q-Sepharose column, but the protein did not adhere to the column. 
This preparation was judged to be about 50 - 75% pure by SDS-PAGE. 
The 37 kDa C-terminal enzyme I protein (EIC37). was expressed from ESK238 
cells containing the plasmid pT7-7(EIecC239). This protein remained soluble in the cell 
extract, prepared as described (Section 2.13.2) and remained in the supernatant after the 
centrifugation at 200,000 g. The supernatant was applied to a 150 mL Q-Sepharose 
column and a gradient of 0 - 0.4 M KC1 was applied. The fractions which contained the 
EIC37 protein were eluted with -0.2 M KCl, as judged by SDS-PAGE. The relevant 
fractions were pooled, concentrated by Amicon filtration, and applied to an AcA44 gel 
filtration column (5 x 100 cm) equilibrated with buffer A with the additions of 0.1 M KCl, 
5 rnM MgCl,, and 20 mM E-amino-caproic acid. Fractions which contained the EIC37 
protein were pooled, concentrated by Amicon filtration, dialyzed against three changes of 
buffer A, and stored at -20°C. This protein formed a precipitate when dialyzed against 
water, so lyophilization was not performed. 
2.13.5 Purification of 11~""  
Enzyme IIA8" was originally overexpressed in TP28 1 1 cells transformed with the 
plasmid pTSHIC9, and more recently in ESKlO8 cells containing pT7-7.crr, a plasmid 
with crr, the gene encoding 1 1 ~ ~ ' ~ .  inserted into the vector pT7-7. In either case, large 
scale overexpression of HAg" and preparation of crude extracts was as described (Section 
2.13.2). The supernatant from the high speed centrifugation was applied to a 200 rnL Q 
Sepharose column equilibrated with 10 rnM potassium phosphate buffer (pH 7.3, 1 mM 
EDTA, and 0.2 mM DTT. A gradient of 0 to 0.5 M KCl, in the same buffer, was applied, 
and fractions containing 1 1 ~ ~ ' ~  as identified by SDS-PAGE were collected. The pool was 
concentrated by Amicon ultraf~ltration using a PM 10 membrane, and applied to an AcA44 
gel filtration column (5 x 100 cm) equilibrated with the same buffer with the addition of 
0.1 M KCl. Fractions containing homogeneously pure IIAg" were pooled, concentrated, 
and either dialyzed against the same buffer and stored at -20°C or lyophilized. 
2-14 SDS-PAGE 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was 
performed with gels made as described by Laemmli (1970), and run in a discontinuous 
buffer system as given in Sambrook et al. (1989). Gels were 80 mm x 100 rnm x 0.75 
mm with a final acrylarnide concentration of 10 - 15%, depending on the nature of the 
experiment. The stacking gel always contained 5% acry lamide. A Bio-Rad Mini-Protean 
I1 electrophoresis apparatus was used for the electrophoresis. Most gels were 
electrophoresed at 200 V for approximately 60 rnin at room temperature. For analysis of 
protein phosphorylation reactions, electrophoresis was carried out at 150 V for 90 rnin at 
4°C due to the heat lability of phosphohistidines. 
Gels were stained for 15 min in SDS-PAGE stain (0.25% [wh] Coomassie 
Brilliant Blue R250, 45% [v/v] methanol, and 10% [vlv] acetic acid), and then destined 
in a solution containing 25% (vlv) methanol and 7.5% (v/v) acetic acid for 1 - 18 h, with 
several changes of the destaining solution. With protcins phosphory lated with ["PI PEP, 
the gels were not stained, but rather the gel, while adhered to one glass plate, was covered 
with plastic wrap and exposed with Kodak X-Omat X-ray film in an autoradiography 
cassette at -80°C. 
2.15 Isoelectric focusing (IEF) gels 
Isoelectric focusing gels were constructed using a Bio-Rad capillary tray as 
described by Mattoo et al. (1984). A cleaned 10 cm x 10 cm glass plate was placed on the 
tray one the side with the 0.8 mm thick spacers. A solution containing 1.1 g sucrose, 4.8 
mL deionized water, and 5.5 mL acrylamide solution (24.25 g acrylamide and 0.75 g bis- 
acrylamide in 250 rnL deionized water) was prepared in a 125 rnL sidearm flask. This 
solution was degassed for 1 min, and then 0.75 mi ampholyte mixture (1:2:2 of pH 3.5- 
10.0: pH 3.5-5.0: pH 5.0-7.0) was added. Polymerization was initiated by the addition of 
25 pL 10% (wlv) ammonium persulfate, 25 pL riboflavin-5-phosphate (2.5 mg/rnL), and 
5 pL TEMED. This solution, containing 6.0% acrylamide, was poured between the glass 
plate and the casting tray, and allowed to polymerize for 30 min under a fluorescent lamp. 
Electrode wicks, soaked in 1 N NaOH (cathode) and 1 N phosphoric acid (anode) 
were added, one to each end of the polymerized gel after it was removed from the casting 
tray. A plastic sample applicator was placed near the cathode wick, and samples, 
generally -5- 10 pg protein in -20 pL, were applied. The gel was electrophoresed on a 
presooled (4OC) flat bed Phannacia IEF gel apparatus for 2 h at 8 W with a limit of 1000 
v. 
Gels were fixed and stained for 30 rnin as described by Crowle and Cline (1977) 
in a solution containing 5.0 g CuSO,, 0.4 g Coomassie Brilliant Blue R250, and 0.5 g 
Croecein Scarlet dissolved in 270 mL isopropanol, 100 mL acetic acid. and 630 mL 
distilled water. Gels were destained overnight in several changes of a solution containing 
140 mL acetic acid, 240 rnL isopropanol dissolved in 1620 mL distilled water. 
2.16 Protein determinations 
HPr protein concentrations were determined by the spectrophotometric method of 
Waddell ( 1956) where 1 A( A,,,,,-A,,,,) = 0.144 mg/mL. However, the most accurate 
HPr concentrations were determined by the lactate dehydrogenase depletion assay 
(Waygood et ol., 1979). These assays were performed using a Gilford 2400 recording 
spectrophotometer at 340 nm. A cuvette with 1.0 mL of a solution containing 0.1 M N-2- 
hydroxyethylpiperazine-N-2-ethane sulfonic acid (Hepes) buffer, pH 7.0. 0.15 rnM 
NADH. 10 mM PEP, 5 rnM MgCl,, 35 U lactate dehydrogenase, and an unknown 
amount of HPr was prepared. A basal activity was recorded, and then 5.0 pL (-5 pg) 
enzyme I was added. The reaction was allowed to proceed until all HPr in the solution 
was phosphorylated, about 5 min. 
Enzyme I protein concentrations were determined by the method of Waddell 
(1956). and the extinction coefficient of A,,, (10 m g M )  = 4.4 (Waygood and Steeves, 
1980). Concentrations of all other proteins used in this thesis were determined by the 
method of Waddell (1956), and in some cases the Bradford protein assay (Bradford, 
1976) was used. 
2.17 Assays for enzymatic activity 
A number of enzyme assays have been used to measure the enzymatic activity of 
enzyme I and the phosphocamer activity of HPr. These assays have been used to monitor 
purification, as well as to determine characteristics of wild type and mutant proteins under 
different conditions. 
2.17.1 LDH coupled assay 
A spectrophotometric assay to measure the interaction between enzyme I and HPr, 
coupled to the reaction catalyzed by rabbit muscle lactate dehydrogenase (LDH) has been 
used extensively in this work. As enzyme I catalyzes the phosphorylation of I-IPr, PEP is 
converted to pyruvate. This pyruvate is converted by LDH to lactate, with the concomitant 
conversion of NADH to NAD. If LDH is in large excess in the reaction, the amount of 
NADH converted to NAD, monitored spectrophotometrically by a decrease in absorbance 
at 340 nm, is directly proportional to the amount of HPr converted to P-HPr. In this 
assay, Hfr  is used as a substrate for enzyme I, and V- and K,,, values for this interaction 
can be obtained. However, large amounts of HPr protein are needed, so reaction 
solutions are often pooled together and the HPr repurified. In addition, if a large excess of 
HPr is used, the amount PEP may be varied, and an enzyme I K, for PEP can then be 
obtained. 
Assays were carried out in 1 mL reaction volumes in quartz cuvenes, and a Gilford 
2400 recording spectrophotometer at 340 nm was used to monitor activity. In general, 
reactions contained 0.1 M N-2-hydroxyethylpiperazine-N-Zethane sulfonic acid (Hepes) 
buffer (pH 7.0). 0.15 mM NADH, 5 rnM MgCl,. 35 U lactate dehydrogenase, with 
varying concentrations of PEP andlor HPr, depending on the nature of the experiment. 
All reagents and proteins were filtered through syringe filters (maximum 0.5 p pore size) 
in order to minimize noise in the assay. Commonly, a basal level of PEP conversion was 
monitored, and then a small volume (5 pL) of enzyme I, of a concentration to allow ease 
of monitoring in the assay, is added, and activity is measured. The enzyme I is usually 
diluted to an appropriate concentration at room temperature in a buffer containing 10 mM 
potassium phosphate (pH 7.5), 1 mM EDTA 0.2 rnM Dm, 5 rnM MgCI,, and 2 rnM 
PEP and left at room temperature before addition to the assay. This filtered enzyme 
preparation is stable for several days at room temperature. 
2.17.2 Sugar phosphorylation assays 
Sugar phosphory lation assays were carried out as described by Waygood et al. 
( 1979). Cell membranes from S. typhimurium strain SB2950 were first isolated as a 
source of enzyme Hrnm to be used in the assay. The cells were grown at 37°C with 
shaking at 300 rpm until early stationary phase (- 18 h) in 1.5 L minimal salts A media 
with 0.2% (wlv) glucose in a 6 L Erlenmeyer flask. The cells were harvested by 
centrifugation at 8000 g with a GSA rotor in a Sorvall RC2-B refrigerated centrifuge. The 
cells were then washed with 0.85% (wlv) NaCl and the cell pellet collected. The cells 
were resuspended in 3 rnL of a buffer containing 10 mM Hepes buffer (pH 7.5), 1 mM 
EDTA, and 0.2 mM D'IT per gram of cell paste. This suspension of cells was frozen until 
needed, or used immediately. Approximately 10 mL of the suspension was passed twice 
through a French press cell at 1000 psi. Unbroken cells and cell debris were removed by 
low-speed centrifugation at - 10,000 g for 10 min. The membranes were then collected by 
centrifugation at 200,000 g in a Beckman Ti60 rotor for 1.5 h at 4OC. This pellet was 
resuspended in 5 mL of the same buffer as the cells were originally suspended. The 
membranes were homogenized using a tissue homogenizer with a Teflon pestle. This 
homogenate was recentrifuged for 1.5 h at 200.000 g, and the pellet was again 
homogenized in 1-2 mL of the same buffer. This membrane preparation containing 
enzyme IIm, to be used in assays of HPr and enzyme I, was stable for approximately two 
weeks when stored on ice. The optimal amount of SB2950 membranes to be used was 
determined in a sugar phosphorylation assay (see next section) with varying amounts of 
membranes, but with both HPr and enzyme I present in excess. 
2.17.2.1 Sugar phosphorylation assay of HPr 
Sugar phosphorylation assays were performed as described by Waygood et al. 
(1979). Assays were performed in a total volume of 0.05 mL in microtitre wells 
containing 0.05 M potassium phosphate (pH 7.5). 10 mM [U- glucose ( 10' cprn/mol), 
2.0 rnM DTT, 12.5 rnM KF, 10 rnM PEP, 5 mM MgCl,, 10 U of enzyme I, and 0.4 to 1 
U of enzyme IIm, from SB2950 membranes, as well as a varying amount of HPr. When 
monitoring HPr purifications, 10 - 20 @ of a chromatography fraction was commonly 
used. The assays were incubated for 30 min at 37OC, and stopped by the addition of 0.1 
rnL ice-cold water. The mixtures were loaded onto 1.5 mL columns containing AG 1 X2 
(50- 100 mesh, C1- form) anion exchange resin equilibrated with water. The columns were 
washed twice with 5 mL distilled water, and then the phosphorylated sugar was eluted 
with two washes of 1.5 rnL of 1 M LiCl, into scintillation vials fitted with 10 mL Nalgene 
fdrnware bags. Six rnL of liquid scintillation cocktail was added, and the bags were 
sealed, capped, shaken, and counted in a liquid scintillation counter. 
2.17.2.2 Sugar phosphorylation assay of enzyme I 
Assays were carried out as described for the measurement of HPr by the sugar 
phosphorylation assay, except for the following modifications. The amount of HPr was 
kept constant at 5 pg per assay. The amount of enzyme I, either in a cell extract or a 
chromatography fraction, was varied depending on the assay, typically in a volume of 5 - 
20 pL. If a cell extract was investigated in the assay, 10 m M  [U-'%]a-methyl-D-glucose 
(10' cprn/mol) was used in place of [U-"C]glucose, because the glucose-bphosphate 
would be further metabolized by other enzymes in the extract. 
2.17.3 Phosphorylation of PTS proteins using [ 3 2 P ] ~ ~ ~  
PTS proteins were phosphorylated with ["PIPEP and analyzed by SDS-PAGE 
and autoradiography in several experiments. In a total volume of 20 pL, a solution was 
prepared with 50 mM Hepes buffer (pH 7.5) and 5 mM MgCl,, with enzyme I andor 
other PTS proteins (-1-20 pg) and 2 pL of ["PIPEP (prepared as described in Section 
2.18). The reaction was incubated at 37°C for 5 min, and then stopped by the addition of 
20 pL SDS loading buffer. The proteins were then separated by SDS-PAGE (Section 
2.14) using a 12% acrylamide gel. The unstained gel, attached to one glass plate. was 
covered in plastic wrap and exposed for 12 - 24 h at -80°C with Kodalc X-Ornat AR film. 
2.18 Preparation of ['*PI PEP 
The preparation of [ 3 2 ~ ] ~ ~ ~  was carried out essentially as described (Mattw and 
Waygood, 1983). In a total volume of 250 pL, a solution containing 50 nllM Hepes (pH 
7 . 9 ,  1 mM oxaloacetate, 5 rnM MgC12, 0.2 rnCi of [ y - " ~ ] ~ ~ ~  (3000 Ci/mmol). 12.5 
mM KF, 1 mM ATP, and 20 pg E. coli phosphoenolpyruvate carboxykinase was 
prepared. The mixture was incubated for 10 min at 37°C. This preparation was used 
without further purification, and was stored at -20°C. 
2.19 Western blotting 
The mouse monoclonal antibody Je145, specific for E. coli enzyme I purified from 
E. coli strain P650 (Waygood and Steeves, 1980) was used for Western blots. Protein 
samples were separated on an SDS-PAGE gel using a Bio-Rad minigel apparatus as 
described (Section 2.14). The proteins were transferred to a nitrocellulose filter with a 
Bio-Rad transblot apparatus using a buffer containing 25 mM Tris base, 190 mM glycine, 
20% (vlv) methanol, and 0.1 % (w/v) SDS for 2 h at 4°C. The membrane was placed in a 
glass petri dish and blocked with 10 mL 4% (w/v) nonfat skim milk powder (Bio-Rad) in 
TBST buffer (50 mM Tris-HC1 buffer, pH 8.0,O. 15 M NaCI, 0.02% [v/v] Tween-20) for 
1 h at room temperature with shaking. Then 1-2 pL of Je145 antibody was added, and the 
mixture incubated for a further 1 h. The membrane was then washed with three changes 
of TBST buffer without skim milk powder. A solution of goat anti-mouse 
immunoglobulin G conjugated with horseradish peroxidase (Bio-Rad) in TBST buffer 
containing 1% (w/v) skim milk powder was added, and the mixture was incubated for 1 h 
at room temperature with shaking. The membrane was then washed with two changes of 
TBST buffer, and once with TBS buffer (50 rnM Tris-HCI buffer, pH 8.0, 0.15 M 
NaCI). Then a suitable amount (1-2 rnL) of chemilurninescent blotting substrate (Roche) 
was added, and the bands were detected by exposure to Kodak X-Omat AR 
autoradiography film at room temperature for - 10 s to 5 min. 
2.20 Gel filtration chromatography 
Gel filtration chromatography was used analytically to estimate the molecular 
weight of enzyme I constructs under various conditions. For room temperature molecular 
weight determinations, a Superose-12 column was used, attached to a Pharmacia 
GradiFrac apparatus. The column was equilibrated with a buffer containing 0.05 M 
potassium phosphate buffer (pH 7.5). 0.1 M KCl, 1 mM EDTA and 0.02% (w/v) sodium 
azide. Samples (0.2 rnL) were applied with a syringe using a loading loop. The column 
was first calibrated with molecular weight standards ( I  mg/rnL each) of blue dextran, -2 x 
lo6 Da; enzyme 1, 1 2 7 , W  Da; ovalburnin, 45,000 Da; soy bean trypsin inhibitor, 2 1,000 
Da. The column was run at 0.2 mUmin and protein elution was detected at 280 nm. 
Enzyme I preparations (0.2 mL of 1-2 mg/mL) were applied, and 0.5 mL fractions were 
collected when necessary. For molecular weight determinations at 4OC, a Sephadex-75 
column was used with the identical conditions, except the buffer did not contain sodium 
azide, and the enzyme I standard eluted at a position corresponding to 63,000 Da. For 
molecular weight determinations of enzyme I C-terminal domain proteins, conditions were 
identical to those used for enzyme I. However, for molecular weight determinations of the 
N-terminal domain proteins, the Superdex-75 column was used at both room temperature 
and 4°C. 
2.21 Fluorescein labeling of Phe2Cys HPr 
Fluorescein-5-maleirnide reacts specifically with tho1 groups (Majima er al., 
1995). This fluorescein derivative is non-fluorescent prior to reacting with thiols, and 
thus labeling was monitored by changes in fluorescence polarization and intensity 
(Smallshaw, 1997). The optimized labeling reaction contained 2-5 mg Phe2Cys HPr in 1 
mL of a solution containing 50 rnM Tris-HC1 (pH 7.5) and 0.2 mM DTT. Then 
fluorescein-5-maleirnide was added to a final concentration of 0.45 mM, and the solution 
was incubated for 30 min in the dark at 0°C. The labeled HPr was separated from other 
reaction components using a 1 cm x 30 cm Sephadex G25 desalting column eluted with 50 
rnM Tris-HCl (pH 7.5). A small amount of unlabeled HPr, -5- 10% of total HPr, was 
often present in the final preparation, but did not interfere with binding determinations. 
Total HPr concentration of this HPr preparation was determined by the LDH assay. 
2.22 Determination of binding of HPr with IIAg" and enzyme I 
Binding determinations of fluorescein labeled Phe2Cys HPr with 1 1 ~ ~ ' '  and 
enzyme 1 were similar to those described for binding determinations of HPr-specific 
antibodies and antibody fragments (Smallshaw, 1997). Assays contained 50 rnM 
potassium phosphate buffer (pH 7.3, 100 mM NaCI, -2 nM labeled Phe2Cys HPr, and 
varying 1 1 ~ ~ ' '  /enzyme I concentrations in a total volume of I rnL, using 12 x 75 mm glass 
tubes. The tubes were analyzed on a BEACON Fluorescence Polarization System 
(PanVera Corp.). 
3.1 Binding interactions with Phe2Cys HPr and PTS proteins 
An attempt was made to develop an assay to determine binding constants for the 
HPr:enzyrne I interaction and the H P ~ : L I A ~ ' ~  interaction. The technique of fluorescence 
polarization was employed, using the BEACON Fluorescence Polarization analyzer. 
This technique is capable of detecting the difference in size resulting when a small 
protein, labeled with a fluorescent tag, is bound by a larger unlabeled protein. Plane 
polarized monochromatic light (488 nm wavelength in this case) is directed at the 
sample and excites the fluorescein tag. A very short time later (4 ns), the fluorescein 
emits a photon at a different wavelength (520 nm). During this time, the fluorescein- 
labeled protein molecule has rotated, or tumbled, in solution. Larger molecules tend to 
tumble more slowly than smaller ones. The intensity of the emitted light is measured by 
a detector at two positions, each at a 68.5' angle from the beam of excitation light, with 
one position in the same plane as the plane polarized light, the other in a perpendicular 
plane. A larger proportion of light reaching the perpendicular plane would indicate a 
faster tumbling rate, and thus a smaller molecule or complex. Fluorescence polarization 
(P) is defined by the equation: 
where 1 - i ~  is the intensity of the emission light parallel to the excitation light plane 
and Iperpendicvlar is the intensity of the emission light perpendicular to the excitation light 
plane. P has no units and is commonly expressed as a millipolarization (mP) value. In 
the absence of any binding protein, labeled HPr would have a relatively low rnP number, 
and upon addition of an HPr-binding protein, the mP of the solution would increase, and 
thus a binding constant for the interaction can be obtained. 
3.1.1 Rationale for choice of Pbe2Cys HPr 
Wild type E. coli HPr has no cysteine residues, so the mutation of one residue to 
a cysteine would result in a single specific location for attachment of a thiol-specific tag, 
in this case fluorescein-5-maleimide. HPr cysteine mutants already available in the 
laboratory included Phe2Cys and Arg l7Cys. Arg 1 7 is in the active site of HPr, and its 
mutation to cysteine severely affects kinetic parameters, and thus binding interactions, 
for enzyme I and several enzymes I1 (Anderson et al., 1993). Residue 17 was thus not 
considered as a suitable site for fluorescein labeling. However, kinetic and structural 
data indicated that Phe2 was a surface residue, but not involved in the interaction of  HPr 
with other PTS proteins. The Phe2Cys HPr mutant was therefore used for labeling with 
the thiol-specific fluorescein-5-maleimide. 
3.1.2 Purification of Phe2Cys HPr 
The Phe2Cys pUCHPr plasmid was transformed into ESK108 cells and 
overexpression and purification of Phe2Cys HPr were performed as described in 
Materials and Methods. All buffers used during extract preparation and protein 
purification contained 0.2 mM DTT as a reducing agent, in order to ensure that the 
protein existed as a single monomeric species. In the absence of DTT. Phe2Cys HPr 
readily formed disulfide linked dimers or oligomers with lower isoelectric points than 
the wild type protein (Figure 3.1 ), which hindered purification by both gel filtration and 
ion exchange chromatography. 
3.1.3 Fluorescein labeling of Phe2Cys HPr 
The labeling of Phe2Cys HPr with fluorescein-5-maleimide was performed as 
described in Materials and Methods. Figure 3.2 illustrates the results of a typical 
labeling reaction. This labeled HPr was then purified from excess DTT-reacted 
fluorescent label, which would interfere with the polarization assay, by Sephadex G-25 
gel filtration ("desalting") chromatography. This labeled HPr preparation was used in 
fluorescence polarization assays. 
3.1.4 Interaction of labeled HPr with HPr binding proteins 
The labeled PheZCys HPr was used in titrations with Je1323, an anti-HPr 
monoclonal antibody, and the PTS proteins enzyrne I and enzyme 1 1 ~ ~ ' '  (Figure 3.3). 
The Je1323 antibody bound HPr with a high affinity, with a Kd of approximately 5 nM, 
and a complete binding curve was obtained with the titration. This labeled Phe2Cys HPr 
was also used to further examine the binding of Je1323 antibody and its Fab fiagrnent to 
HPr (Smallshaw, 1997; Smallshaw er a/., 1998). Both enzyme I and 11~''' bound the 
labeled HPr with much lower affinities. Complete titrations were not accomplished 
since the very high concentrations of enzyme I or 1 1 ~ ~ ' '  that would be necessary for 
Figure 3.1 Isoelectric focusing gel showing disulfide-linked oligorner formation of 
PheZCys HPr. Lane 1 : Wiid type HPr standard (20 pg). Lane 2: Purified Phe2Cys HPr 
(10 pg) in the presence of 0.2 mM DTT. Lane 3: The same Phe2Cys HPr preparation 
(1 0 pg) in the absence of DTT. The gel is depicted with the cathode at the top. 
Figure 3.2 Isoelectric focusing gel of Phe2Cys labeling reaction with fluorescein-5- 
maleimide. Lane 1 : Wild type HPr standard (20 pg). Lane 2: Unlabeled Phe2Cys HPr 
(10 pg) Lane 3: Phe2Cys HPr (10 pg) after 30 min. reaction with fluorescein-5- 
maleimide. The gel is depicted with the cathode at the top. 
concentration of Jel323 (nM) 
concentration of enzyme I or I m l c  (w) 
Figure 3.3 Titration of fluorescein labeled PheZCys HPr with HPr binding proteins. 
Labeled Phe2Cys HPr (2 nM) was titrated with increasing amounts of either Je1323 
antibody, enzyme I, or IIAg" in separate experiments. 0: Titration with Je1323 antibody 
(concentration of  Je1323 given in nM). A: Titration with IIAg" (concentration of 11Ag1' 
given in pM) 0: Titration with enzyme I (concentration of enzyme I given in pM). 
hrther data points to complete the titration were to difficult to achieve. Nevertheless, an 
approximate binding constant of I0 - 100 pM was estimated for both the HPr:enzyme I 
interaction and the HP~:IIA~" interaction, with the interaction with enzyme I likely of 
slightly higher affinity. The very low affinity of binding interactions with HPr a i d  its 
partner PTS proteins has been reported by other laboratories (Chauvin et ai., 1996; 
Wang et ai., 2000), which severely limits attempts to quantify the interaction. It was 
originally hoped to develop a competition assay, whereby unlabeled mutant HPrs would 
be added to a complex of labeled HPr with enzyme I or IIA'", in order to determine 
which residues were important for the interactions, but this assay was determined to be 
unfeasible. 
3.2 Enzyme I binding site on HPr 
The interaction site between enzyme I anc 1 HPr has been determined with PI 
chemical shifi experiments (van Nuland et al., 1995; Wang er a/., 2000). In these 
studies, NMR spectra were taken with lSN labeled HPr alone in solution, and then again 
after the addition of excess enzyme I. The spectra were compared, and HPr residues 
which undexwent a chemical shift upon complexation with enzyme I were identified. 
These residues represented an enzyme I binding site on HPr. The HPr:enzyme I 
interaction was determined more conclusively with the NMR solution structure of the 
complex of EM with HPr (Garrett el aL, 1999). However, this structure did not utilize 
intact enzyme I, nor did it involve phosphorylation of either protein. It was decided to 
hrther determine the residues on HPr which interact with enzyme I using an assay more 
similar to physiological conditions - namely a kinetic assay. A large number of HPr 
mutants were available for this study, and other mutants were created and purified 
especially for this investigation. Each HPr mutant was assayed as a substrate for 
enzyme I, and the kinetic parameters V,, and K, were determined. Mr. Ahmad Mina  
prepared and assayed several of the HPr mutants as part of an undergraduate research 
project in the Waygood laboratory. HPr mutants which affect both kinetic parameters 
for enzyme I indicate catalytically important residues. HPr mutants which affect only the 
& for enzyme I indicate residues important for binding enzyme I, but not catalysis. 
Thus these residues delineate an enzyme I binding site on HPr. 
3.2.1 Reliability of kinetic data 
The kinetic data indicate that some of the HPr mutations do not result in a 
dramatic change in K, for enzyme I. Thus the concentration of each HPr preparation 
must be determined with a large degree of certainty. The method of Waddell (1956) is a 
convenient method for determination of protein concentration. The lactate 
dehydrogenase coupled depletion assay (Waygood et al., 1979) was also always used for 
determination of HPr concentration. This determination is specific for the amount of 
HPr in a preparation that can be phosphorylated. However, both the quantitation of HPr, 
as well as the kinetic assay itself, have inherent errors (Anderson et al., 1991). Such 
errors may be minimized by many measurements of both HPr concentration as well as 
HPr kinetic data, but that would require excessive amounts of each HPr preparation to be 
used. Thus all Y, and V, values during kinetic measurements of HPr mutants have 
been rounded to the nearest whole number for K,,, values, and to the nearest 5% for V, 
measurements. In the kinetic assay the K,,, determinations were reproducible with 
acceptable variation (plus or minus lo%), and >2-fold changes indicate significant 
residues in the enzyme I binding site. 
For these assays, a commercially available rabbit muscle lactate dehydrogenase 
was used, which was supplied as a suspension in a concentrated ammonium sulfate 
solution. This solution was dialyzed against water before use, because sulfate ion is a 
competitive inhibitor for HPr. In the presence of 16 mM sulfate, as would be the case if 
undialyzed LDH was used, the enzyme I K, for HPr increases to - 12 pM, as opposed to 
6 p M  in the absence of sulfate (E. B. Waygood, unpublished observations). The V, for 
enzyme I also varied with each preparation, so the assay conditions were standardized 
with wild type HPr for each set of kinetic assays of HPr mutants. The enzyme I was 
phosphorylated by the addition of 2 mM PEP and 5 mM M$ and incubation at room 
temperature. If this enzyme I preparation was sterilized using a 0.22 p n  syringe filter, it 
was stable for several days if left at room temperature. 
3.2.2 Enzyme I kinetic parameters of HPr mutants 
The lactate dehydrogenase coupled enzyme I assay was used to examine the 
effects of mutation of many HPr residues. Typical assay results are shown in Figure 3.4. 
The results of the entire kinetic study, including results from previous publications for 
ease of reference, are summarized in Table 3.1. Through this study residues which are 
important for the kinetic interaction of HPr with enzyme I were identified. These 
residues are compared to the HPr residues that were concluded to be involved in the 
interaction by examination of the NMR structure of the complex of HPr with the enzyme 
l/[H Pr], pM-I 
Figure 3.4 Examples of Lineweaver-Burk plots of kinetic data of enzyme I with mutant 
HPrs as substrates, using the lactate dehydrogenase coupled assay. (a): AlaZOThr, with 
the same kinetic parameters as wild type HPr. (b): Leu47Ala, with a higher &, but an 
identical V,, as wild type. 
Table 3.1 Kinetic parameters of E.coli enzyme I with HPr mutants. 
HPr Residue Enzyme HPr-Enzyme I Reference 
And Mutantsa k, mf v,% interactionc (HPr mutation) 
Wild type 
Am12 
Asn 12Ala 
Asn 1 2Asp 
Asn 12Ser 
Asn 1 2Thr 
His15 
His 1 SAsp 75 0.1 
His 1 SGlud No activity 
Tbrl6 
6 100 
Not found. Garrett et al., 1999 
Implicated in catalysis Napper et a!., 1 999 
Napper er al., 1 999 
Sharma et a!., 1993 
Napper er al., 1 999 
Napper et al., 1 999 
Site of phosphorylation 
Napper et a/., 1 999 
Napper er al., 1999 
Hydrogen-bond Asp 129 Garrett et al,. 1 999 
Hydrophobic IIe72, His76 
This study 
Involved in phosphotransfer Anderson er al., 1993 
Hydrophobic Ala7 1 ,His76 Garrett et a/.   1 999 
Salt bridges Glu67,Glu68 
Anderson et al.. 1 993 
Table 1 continued.. . 
Arg 1 7Gly 
Arg 1 7His 
Arg 1 7Lys 
Arg 17Ser 
Ah20 
Ala20Thr 
Gln2l 
Gln2 1 Ala 
Gln2 1 Glu 
Lys24 
Anderson et al., 1993 
Anderson et a!. , 1 993 
.Anderson et a[. , 1993 
Anderson et al., 1993 
Hydrophobic Ala7 1 ,  Ile72. Garrett et a1 1999 
Glu74, Gly75, Met 78 
Hydrophobic Ala7 1 
Salt bridge Glu74 
Hydrophobic Met78 
Salt bridge Asp82 
Not identified 
This study 
Garrett et a/., 1 999 
This study 
This study 
Garrett er al., 1999 
This study 
This study 
This study 
Garrett et al.. 1999 
This study 
This study 
Garrett et al.. 1999 
This study 
This study 
Table 1 continued.. . 
Ser4 I 
Ser4 1 Lys 
Set46 
Gln5 1 Ala 6 
GlnS 1 Glu 20 
Not identified Garrett et al., 1999 
This study 
H-bond Glu84 Gmett et al., 1 999 
Hydrophobic His76 
Napper er al., 1 996 
Napper er al., 1 996 
Napper er al. , 1 996 
Napper et al., 1 996 
Napper et al., 1 996 
Napper et al.. 1996 
Hydrophobic His76, Val 130 Garrett et al., 1999 
This study 
Hydrophobic Ile lo8 ,Gln 1 1 1, Garrett et al., 1999 
Val 130 
This study 
Salt bridge Glu84 Garrett et al., 1 999 
Hydrophobic Leu 1 15 
This study 
H-bond Arg 126 Garrett er al. , 1 999 
Hydrophobic Leu1 1 5,Leu 1 1 8 
This study 
Shanna et al., 1993 
Table 1 continued. . . 
Gln5 1 Thr 6 
Thr52 
This study 
Hydrophobic Leu 1 1 5, Garrett et a/.. 1999 
Leu1 18, Leu123 
This study 
Hydrophobic Tyr 1 22, Leu 123 Garrett et al.. 1 999 
This study 
Hydrophobic Tyr 1 22 Garrett et al., 1999 
This study 
This study 
This study 
a. Mutations at several other HPr positions had no effect on kinetic parameters. The mutants were: 
Pro 1 1 Ser; Ser3 1 Ala, Asn38Asp, Gln57Glu, Glu70Ala, Glu70Lys, Gln7 1 Glu, Glu83Ala, Glu85Gln, 
Glu85Lys, Deletion Glu85, and Glu83Asp,Gln and Lys in Deletion Glu85. 
b. Kinetic parameters have been rounded as previously described (Anderson et of.. 1 99 1 ). 
c. The residues given are in enzyme I. The residue and the type of interaction is taken from Garrett et aL. 
(1 999). 
d. The following His15 mutants are also inactive: alanine, asparagine, cysteine, serine, threonine, and 
tyrosine. 
I N-terminal domain (Garrett er ai., 1999). That report identified residues in the 
interaction site on the basis of intermolecular nuclear Overhauser effects (NOES). 
Mutations to the two key catalytic residues, His15 and Argl7, produce 
significant changes to V,,. Modest perturbations to enzyme I V,, were also observed 
with mutations to Asnl 2, Thrl6, Lys24, and Gin5 1, indicating their potential minor 
importance for catalysis. Although Asnl2 was not identified as an interacting residue in 
the HPr-enzyme I domain complex (Garrett et al., 1999), it is believed to form a 
hydrogen bond with the N" atom of Hisl 5 (van Nuland et a/., 1995; Prasad et a/.. 1998). 
Kinetic analyses of Asnl2 mutants do indicate that it plays a minor role in catalysis 
(Sharma et al., 1993; Napper st al., 1999). The HPr mutants Ser46Asp and Ser46Glu 
both gave an extremely high K, for enzyme I, and these K, values must be considered 
estimates since it was impossible to assay the mutant HPr in concentrations above the 
K, values. The mutant HPr Val23Ala was purified but contained a small contaminating 
'WADH oxidase" activity which compromised kinetic results. However, kinetic assays 
indicated that this mutant HPr did not have any significant defect in either K, or V,, for 
the enzyme I interaction. 
3.2.3 Description of enzyme I binding site on HPr 
The altered residues of HPr mutants which have an affected K, but not V,, for 
enzyme I are concentrated on one face of the HPr structure (Figure 3.5). Argl2, Hisl 5, 
and Argl7, the active site residues, are clustered on one side of the enzyme 1 binding site 
on HPr. Some mutations seemingly within the enzyme I binding site did not produce 
significant changes to enzyme I K,,, for HPr. These residues include Gln2 1, Val23, 
Figure 3.5 Enzyme 1 binding site on E. coli HR. The spacefilling representation is of 
the structure of E. coli HPr from the Je142 Fab-HPr complex (Prasad el al., L998). The 
active site residues Asnl2, HislS, and Argl7 are coloured red. Residues that, when 
mutated, led to an altered HPr K, for enzyme I are blue. Residues which gave no 
change in HPr K, for enzyme I are preen. Residues that were previously identified as 
making contacts with the enzyme I N-terminal domain (Garrett et al.. 1999) and have 
not been mutated in this study are coloured yellow. Numbers identify the residues. 
Thr52, and Leu55 This might be explained in two ways; either the residues are not 
important for interaction, or the mutations that were made were not severe enough to 
alter the interaction. In the NMR structure of the HPr:enzyme I N-terminal domain 
complex (Garrett et al., 1999), several other residues were identified through NOEs as 
important for the interaction with enzyme I. For various reasons these residues were not 
mutated here. For instance, the interaction with Leu14 is with the a-carbon, and residue 
54 is a highly conserved glycine. In addition, Ala19, Phe22, and Leu50 have single 
intermolecular NOEs and are buried within the HPr moleculet so these residues were 
also not mutated. 
3.3 Functional characterization of enzyme I 
The study of HPr mutants, most of which are site-directed mutants, has proven 
essential to the characterization of the structure and fbnction of the protein. However, 
even though there has been extensive research involving the structural and biophysical 
characteristics of enzyme I, there has been very little study on single amino acid mutants 
of enzyme 1. This section of the thesis will provide some key information about the 
structure, function, and in vivo role of enzyme I through some of the initial studies of 
enzyme I mutants. 
33.1 Original S. typhimuriun ptsl mutant strains 
Several mutants of ptsl from S. typhimurium have been ordered by deletion 
mapping (Cordaro and Roseman, 1972). Two of the mutants, strains SB1476 (allele 
number ptsll7) and SB 1 68 1 (ptslI6), produced "leaky" low level enzyme I activity 
relative to wild type. The physiological consequences of the ptsIl7 mutation have been 
described (Saier and Roseman, 1972). Briefly, this mutant is more sensitive to 
catabolite repression than wild type, because in the presence of even low amounts of 
PTS-substrate sugars, enzyme 1 1 ~ ~ ' '  is dephosphorylated more rapidly than it is 
phosphorylated, leading to a loss of the binding and activation of adenylate cyclase by P- 
1 1 ~ ~ ' .  It was later determined that the I16 and 11 7 mutant enzymes did not form dimers 
at room temperature, unlike wild type enzyme I, as judged by gel filtration 
chromatography of crude extracts. In addition, it was discovered that the low enzyme I 
activity of these mutants could be complemented by the addition of enzyme I from crude 
extracts of either S. typhimurium strain S B  1690 @ts134) or SB2227 @ts139). These two 
strains by themselves had no detectable enzyme I activity, but did dimerize as 
detennined by room temperature gel filtration chromatography (E. B. Waygood, J. C. 
Cordaro, and S. Roseman, unpublished results). In this present work, these S. 
ryphimuriwn strains were resurrected from agar stabs and the crude extracts of these 
strains were assayed for enzyme I activity. Similar results to those originally determined 
were observed. It was then decided to further study these enzyme 1 mutants, beginning 
with the isolation of the mutant ptsl genes. 
33.2 PCR cloning of ptsl genes 
The ptsl genes were isolated and cloned from S. typhimurium strains SB 1476, 
SB 168 1, SB1690 and the wild type strain SB3507 by amplification of ptsl from 
chromosomal DNA using the polymerase chain reaction as described in Materials and 
Methods. The attempts to clone the mutant gene pts139 from strain SB2227 have so far 
been unsuccessful. Both strands of the cloned genes were sequenced, and single point 
mutations were identified in each of the mutant pis1 genes (Table 3.2). In addition, the 
sequence of wild type ptsl (Li Calsi et a/., 199 1 ) was confirmed. 
Table 3.2 Characterization of S. vphirnuriurn ptsl mutations. 
enzyme I strain, allele DNA sequence change protein sequence change 
SB 1 68 1, pfsll6 residue 1066GjA Gly356+Ser 
SB 1476, pts117 residue 1 I23C-T Arg375jCys 
SB 1690, ptsl34 residue 3 76C +T Arg 126+Cys 
Wild type E. coli ptsl was also isolated by polymerase chain reaction, using the 
plasmid pTSHIC9 as a source of template DNA, as described in Materials and Methods. 
3.3.3 Overexpression and purification of enzymes I 
The wild type and mutant ptsl genes were subcloned into the vector pT7-7 for 
use in protein overexpression. The E. coli host strain for the overexpression of these 
mutant enzyme I proteins was ESK238, which is a derivative of the common strain 
BL21 with the production of wild type enzyme I eliminated (Section 2.3). This strain is 
a spontaneous ptsl mutant selected by streptozotocin resistance. Each pT7-7.EI plasmid 
was transformed into ESK238 and a three litre culture of bacteria was prepared. Protein 
was overexpressed after the addition of 0.5 mM isopropylthiogalactoside (IPTG), as 
described in Materials and Methods. The protein overexpressed well, as judged by 
sodium dodecyl sulfate polyaclylamide gel electrophoresis (SDS-PAGE; Figure 3.6). 
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Figure 3.6 Time course of overexpression of S. typlrimurium Gly3 56Ser enzyme I. 
Cells of strain ESK238 were transformed with the Gly356Ser pT7-7.EI plasmid and 
grown in culture to late log phase (OD, = 0.8). Then isopropylthiogalactoside 
(IPTG) was added to the culture to a final concentration of 0.5 mM. Aliquots of the 
culture were taken at set times after addition of IPTG and analyzed by SDS-PAGE. 
Lane 1,0 h after IPTG addition; lane 2, 1 h; lane 3, 2 h; lane 4,3 h; and lane 5 ,4  h after 
IPTG addition. Lane labeled 'M' contains protein molecular weight markers: 66 kDa, 
bovine serum albumin; 45 kDa, ovalbumin; 31 kDa, carbonic anhydrase; 21 kDa, 
soybean trypsin inhibitor; 12 kDa, cytochrome c. The protein band corresponding with 
enzyme I is indicated with an arrow. 
A high-speed centrifugation supernatant crude extract of each enzyme I 
overexpression was prepared, and the proteins were purified by Q-Sepharose anion 
exchange chromatography. This chromatography step was in most cases sufficient to 
obtain a preparation of enzyme I that was essentially homogeneous (Figure 3.7). In 
some cases an extra AcA44 gel filtration step was needed to produce a sufficiently pure 
preparation. These enzyme I preparations were used for subsequent kinetic and physical 
characterizations. 
33.4 Overexpression and purification of enzyme I fragments 
Overexpression and crude extract preparation of enzyme I N-terminal and C- 
terminal fiagments were as described in Materials and Methods. The N-terminal 
fiagments of 24 kDa and 27 kDa, referred to as EN24 and EIN27, respectively, were 
relatively facile to purify by Q-Sepharose chromatography using identical conditions as 
described for enzyme I. The N-terminal fiagments adhered strongly to the resin and 
were eluted with -0.4 M KCl, well after the elution of most contaminating proteins. 
Further purification by AcA44 gel filtration chromatography was still necessary. 
The C-terminal fiagments were more difficult to purify. The smaller 27 kDa 
fragment (EIC27) had moderate levels of overexpression and formed insoluble inclusion 
bodies. The inclusion bodies were solubilized by the addition of urea, and after dialysis 
against buffer without urea a Q-Sepharose chromatography step provided some level of 
purification. This preparation was acceptable for the work that was needed. The 37 kDa 
fiagment (EIC37) provided very good levels of overexpression, and did not appear to be 
sensitive to proteolytic digestion during crude extract preparation, in contrast to the 
Figure 3.7 Purification of S. typhimurium Argl26Cys enzyme I. Lane I ,  crude extract 
before ultracentrifugation (20 pg); lane 2, crude extract after ultracentrifugation (20 pg); 
lane 3, enzyme I pool after Q-Sepharose purification (10 pg); lane 4, enzyme I pool after 
firther purification by AcA44 gel filtration chromatography (5 pg). Lane labeled 'M' 
contains protein molecular weight markers, as described in Figure 3.6. 
characteristics reported for a similar C-terminal construct (Fomenkov et al., 1998). 
However, the protein did not adhere strongly to the Q-Sepharose resin, as it eluted at 
-0.2 M KC1 along with many other protein impurities, so complete purification needed 
the addition of an AcA44 gel filtration chromatography step. Indeed, it appears that the 
relative ease of purification of full size enzyme I is due to the strong overexpression of 
the protein, and the strong adherence of the protein to Q-Sepharose and other anion 
exchange resins, which is a characteristic of the N-terminal domain. 
A Western blot of enzyme I mutants and fiagments was performed (Figure 3.8), 
using the monoclonal antibody Je145, which was raised against E. coli enzyme I .  Both 
E. coli and S. typhimurium enzyme I react with Je145, again indicating the large degree 
of similarity between the two proteins. The Je145 epitope is apparently on the C-  
terminal domain, as both EIC27 and EIC37 react with Je145, while the N-terminal 
fiagments do not (not shown). 
33.5 Gel fitration chromatography and temperature dependent dimerization 
Preliminary experiments with crude extracts of S. typhimurium p t d  mutants 
indicated that the enzymes I encoded by the mutant alleles pzsll6 and pzsll7 failed to 
form dimers. Similar gel filtration experiments with purified proteins of wild type and 
mutant forms of enzyme I were performed in this study in order to determine the 
molecular weight and association of the subunits. All enzyme I proteins consisted of a 
single protein species which migrated at M, = 63 kDa on a denaturing SDS 
polyacrylamide gel. Furthermore, all wild type and mutants of enzyme I eluted at a 
position corresponding to = 70 kDa from a nondenaturing gel filtration column at 4°C. 
Figure 3.8 Enzyme I immunoreactivity. Enzyme I wild type, enzyme I mutants, and 
the C-terminal fragments were separated by SDS-PAGE. transferred onto a 
nitrocellulose filter, and reacted with the enzyme I-specific monoclonal antibody Je145. 
Lane 1,  E. coli enzyme 1; lane 2, 27 kDa C-terminal fragment from E. coli enzyme I; 
lane 3 , 3 7  kDa E. coli C-terminal fragment; lane 4, S. typhimurium Gly356Ser; lane 5, S. 
typhimurium Arg375Cys; lane 6, S. typhimuriurn Argl26Cys; lane 7 ,  S. ryphimurium 
wild type enzyme I. The amount of protein in each lane was 50 ng. This particular 
Western blot was performed by James Talbot. 
Gel filtration chromatography at room temperature showed that Argl26Cys enzyme I 
formed dimers in a manner similar to wild type (Figure 3.9). Gly356Ser enzyme I had 
impaired dimerization and eluted in a single peak corresponding to a molecular weight 
of -80-90 kDa. Arg375Cys enzyme I was susceptible to proteolytic degradation and 
aggregation at room temperature, but contained a major broad peak eluting at a 
molecular weight of 70 - 85 kDa (not shown). Addition of 10 mM PEP and 5 mM 
MgCl, to the column buffer did not significantly change the elution profile of any 
enzyme I protein. The separately purified 37 kDa C-terminal domain eluted at a position 
corresponding to a dimer (75 kDa). Thus the C-terminal domain contains the subunit 
interaction site, and it alone is necessary and sufficient for dimerization at room 
temperature. However, the smaller 27 kDa C-terminal domain protein did not dimerize 
as judged by Superose- 1 2 chromatography (not shown), as this protein does not contain 
all sequences necessary for binding PEP and dimerization. 
The apparent molecular masses of the N-terminal enzyme I fragments were 
estimated by gel filtration chromatography to be 43 kDa and 44 kDa for the EIN24 
fiagment, and 36 kDa and 40 kDa for the EIN27 fiagment at 4OC and 22°C respectively 
(not shown). The structure of the N-terminal domain is an elongated ellipsoid (Liao et 
aL, 1996, Garrett et al., 1997a; Figure 1.9), which explains the apparent high molecular 
weight determined by gel filtration chromatography. These results indicate that the N- 
terminal domain by itself cannot form dimers. A similar aberrant molecular weight, 
3SkDa, and the lack of dimerization, has been determined for the N-tenninal fragment of 
269 residues (Chauvin et a/., 1996b). 
Figure 3.9 Gel filtration chromatography at room temperature. Proteins were eluted 
fiom a Sepharose-12 column calibrated with standards of 127, 45, and 21 kDa as 
indicated. Chromatographs are traces of Alsonmr which show that: (a) Argl26Cys 
enzyme I eluted at -127 kDa; (b) Gly356Ser enzyme I eluted at -80-90 kDa; (c) EIC37 
C-tennind fkagment eluted at 75 kDa, the position expected for a dimer. Detection was 
at 280 mn; peak height maximum was -0.1 A for (a) and (b), and -0.05 A for (c). 
33.6 Kinetic characterization of enzymes I 
The enzyme I assay in which pyruvate production was coupled to lactate 
dehydrogenase (LDH) was extensively used to characterize wild type and mutant 
enzyme I species, not only to determine their kinetic parameters of V, and &,, but also 
to determine the role of the enzyme I monomer:dimer equilibrium in the activity of these 
enzymes. 
3.3.6.1 PEP and HPr kinetic parameters 
The enzyme I catalyzed reaction, HPr + PEP * HPr-P + pyruvate, was measured 
by the LDH-coupled spectrophotometric assay. Enzyme I preparations were kept 
phosphorylated and at room temperature, conditions which lead to maximal activity 
(Waygood et a/., 1979; Weigel et a l ,  1982a; Waygood, 1986), and kinetic properties of 
the enzymes were obtained (Table 3.3). It is important to note that in these assays, as 
well as all subsequent assays, undialyzed LDH was used, so 16 mM sulfate was present 
in the assay. Under these conditions, wild type enzyme I has an HPr Km of 12 p M  (see 
Section 3.2.1). Thus all enzyme I mutants have an HPr & identical to wild type (12 
pM). However, PEP K,,,s differed, with Gly356Ser and Arg375Cys mutants showing a 
similar increase of approximately 30-fold fiom wild type PEP K, to 3.0 mM and 3.1 
mM, respectively. Thus, PEP-binding is affected by these mutations. Argl26Cys 
enzyme I had a PEP K, substantially lower than wild type, but this difference was likely 
due to the extremely low activity of the enzyme. Argl26Cys had a very low V, of 
0.04% of wild type, which is consistent with the lack of measurable activity in the crude 
extract of the original SB1690 S. typhimuriun strain. The activity of Gly356Ser and 
Table 3 3  Kinetic properties of enzyme I mutants. 
v,, ( p o l *  
enzyme I HPr K,,, (pM) PEP Km (mM) min-'emg-') v, (%) 
wild type 
Arg 126Cys 
Gly356Ser 
Gly356Ser + 
Arg 126Cys 
Arg375Cys + 
Arg 1 26Cys 
a These are estimates. Activity at lower PEP concentrations was dependent on 
association of subunits in the heterodimer (see Section 3.3.6.3). b The protein molar 
ratio during the assays of the complementation mixtures was I :2, with either Gly356Ser 
or Arg375Cys at 1 .  c EIC37 is the 37 kDa C-terminal fragment. 
Arg375Cys enzymes I, with V, values of 4% and 2% of wild type, are as expected for 
"leaky" mutants. 
3.3.6.2 In vitro intragenic complementation 
Activity complementation between purified proteins of two different enzyme I 
mutants, presumably through heterodimer formation, was investigated by the LDH- 
coupled spectrophotometric assay. The assay conditions used included 30 p M  HPr and 
20 mM PEP, which would give near maximal activities for all of the enzyme I mutants. 
In order to demonstrate effective complementation between Argl26Cys and either 
Gly356Ser or Arg375Cys purified proteins, the enzymes had to be combined together 
while on ice. This low temperature leads to monomer formation. The mixtures were 
then diluted to appropriate concentrations using room temperature buffer containing 10 
mM potassium phosphate buffer, pH 7.5, 1 m M  EDTA, 0.2 mM DTT, 5 mM MgC12, and 
2 mM PEP, and preincubated at room temperature for 5 min. before addition to the 
assay. These conditions would lead to the formation of dimers, presumably either 
composed of the same or different subunits. The in vitro intragenic complementation 
between Argl26Cys enzyme I and either Gly356Ser or Agr375Cys enzyme I is shown in 
Figure 3.10. If the two enzyme I mutants were preincubated separately at room 
temperature, leading to the formation of homodimers of at least the Argl26Cys enzyme 
I, and after this preincubation the enzymes were combined, effective activity 
complementation was not demonstrated (data not shown). This indicates that 
heterodimers form optimally when two enzymes are first preincubated separately under 
conditions which favour monomers, and conditions are changed to those favouring 
0 0 8 0 0 0 
CV d 'e 
Arg 1 26Cys enzyme I, ng 
Figure 3.10 In vitro complementation of Gly356Ser or Arg375Cys enzymes I with 
Argl26Cys enzyme I. Gly356Ser or Arg375Cys enzyme I (50 pg/mL) was 
preincubated at room temperature for 5 min with increasing concentrations of 
Argl26Cys enzyme I in separate tubes. Then 5 pL of each preincubation mixture was 
measured by the LDH assay with 30 p M  HPr and 20 mM PEP, so thus 250 ng of either 
Gly356Ser or Arg375Cys enzyme I was assayed with increasing amounts of Argl26Cys 
enzyme I. The amounts of Argl26Cys enzyme I added to the assay did not yield any 
measurable activity if assayed alone. 0: Assay of complementation of Gly356Ser 
enzyme 1. A: Assay of complementation of Arg375Cys enzyme 1. 
dimers only after the two mutants are combined. Furthermore, if the assay displaying 
poor complementation was allowed to proceed for as long as 30 min, still no activity 
increase was observed. This suggests that at saturating PEP concentrations no 
dissociation of the subunits occurs during enzyme turnover, which could lead to 
heterodimer formation. No complementation was observed between Gly356Ser and 
Arg375Cys enzymes I, as is expected since both mutants have impaired dimerization 
(not shown). 
The extent of complementation for Gly356Ser enzyme I is much greater than 
Arg375Cys enzyme I, likely either because Gly356Ser is more active in a heterodimer, 
or because Gly356Ser is more able to form heterodimers. In both cases, not only was 
there an increase in V,,, but also a decrease in PEP K, for the active Gly356Ser or 
Arg375Cys subunit of the heterodimer (Table 3.3). However, the PEP K, for the 
heterodimers must be considered an estimate, because of the instability of the 
heterodimers in the assay (see Section 3.3.6.3 for explanation). 
3*3.6.3 Mutant enzyme I heterodimer instability 
The activity of the heterodimers was influenced by the degree of association of 
the subunits in the assay. At saturating PEP concentrations (20 mM), the enzyme I 
activity of the complementing mixtures was stable, and similar in this respect to wild 
type enzyme I (Figure 3.1 l a  and b). However, at a concentration of 1 mM PEP, the 
activity of the heterodimer decreased over time (c), much more than could be accounted 
for by simple substrate utilization. This rapid decline in activity was even more 
pronounced at lower PEP concentrations, so much so that an accurate determination of 
1-1 2 min. 
Figure 3.1 1 Enzyme I activity in an assay, demonstrating heterodimer instability. The 
recording chart traces of the assay are shown. Each enzyme I was measured with the 
standard assay, which included preincubation for 5 min at room temperature in buffer 
containing 2 mM PEP and 5 mM MgCl,, and measurement in the assay with 30 pM HPr 
and 20 mM PEP. The enzymes assayed were: 50 ng wild type enzyme I (a), 2 pg 
Gly356Ser enzyme I (b), or the Gly356Ser/Argl26Cys heterodimer, 250 ng of each 
subunit (c). The amount of each enzyme used was chosen in order to give roughly the 
same rate for all of the measurements. 
the initial velocity could not be obtained. Thus the value of 4 0  pM for the PEP & for 
the heterodimer mixtures of either Gly356Ser or Arg375Cys with Argl26Cys must be 
considered an estimate. Nevertheless, there is a dramatic improvement in PEP K, for 
the Gly356Ser and Arg375Cys subunits from the original values of 3 mM. 
It was still unclear as to whether the instability of the heterodimers was due to 
the dissociation of  subunits during the enzyme I catalytic cycle and phosphorylation of 
HPr, or due to the dissociation of the subunits following the dilution of  the heterodimers 
from the preincubation mixture to the assay mixture. A simple experiment was 
performed to investigate these two potential answers. A heterodimer mixture was added 
to an assay cuvette containing 20 m M  PEP but no HPr. Then, after a 10 min. incubation 
at room temperature, HPr was added to start the reaction (Figure 3.12b). The activity 
observed was nearly as high as when the heterodimer mixture was added to a cuvette 
which already contained HPr (a). If the identical experiment was performed, but in both 
cases 1 mM PEP was used instead of 20 rnM PEP, the results were different. In the 
assay cuvette which was preincubated for 10 min. without HPr, no activity was initially 
detected after addition of HPr, although after a short time a constant low activity was 
observed (d). If the heterodimer was added to a cuvette with 1 mM PEP and HPr 
present, there was strong initial activity which decreased over time (c), as previously 
observed. Together these results indicate that dilution of the enzyme into the assay 
conditions causes subunit dissociation, and that this dissociation is dependent on PEP 
concentrations. Turnover of  the enzyme does not appear to cause significant 
dissociation. 
H 
2 min. 
Figure 3.12 Recording chart traces of enzyme I activity in an assay, demonstrating the 
effect of dilution. The Gly356Ser/Arg126Cys heterodimer (250 ng each subunit) was 
measured with 20 mM PEP either immediately (a) or after 10 min. in the assay without 
HPr, which was then added to start the reaction (b). Similarly, the heterodimer was 
measured with 1 mM PEP either immediately (c) or after 10 min. without HPr (d). 
3.3.6.4 Kinetic stPdy of mutant enzyme I homodimerization 
It remained to be determined if the Gly356Ser and Arg375Cys enzyme I mutants, 
when assayed alone, were active as monomers or dimers. The effects of dilution and 
temperature change on enzyme I activity are shown in Figure 3.13. If wild type enzyme 
I was preincubated alone at room temperature with 2 mM PEP and 5 mM MgC12 before 
addition to the assay, a stable dimeric species with high activity was obtained (a). 
However, if wild type enzyme I was preincubated in a cold dilute condition before 
addition to the assay, very low activity was observed which slowly increased over time 
(b). This hysteretic behaviour of the enzyme is due to the slow association of subunits to 
form active dimers in the assay, afier transfer from the initial cold incubation which 
favoured monomer formation. When Gly356Ser enzyme I was subjected to the same 
warm and cold preincubation treatments, the measured activity showed no dependence 
on preincubation condition (c and d). No hysteretic behaviour of slow association of 
subunits was obsewed. Thus the activity of Gly356Ser enzyme I, with a PEP K, of 3 
mM and a V, of 4% of wild type, can be attributed to the monomeric form of enzyme 
I. Similar experiments showed that Arg375Cys enzyme I did not exhibit hysteresis, and 
was active as a monomer (not shown), whereas all indications are that Argl26Cys 
enzyme I is active as a dimer, although the activity of the protein was too low to test the 
dependence on preincubation conditions. 
33.7 Chromatographic isolation of enzyme I heterodimers 
A Gly3 56SedArg 126Cys heterodimer mixture was prepared and analyzed by gel 
filtration chromatography. However, results were different fiom expected (Figure 3.14). 
Figure 3.13 Recording chart traces of enzyme I activity in an assay, demonstrating the 
effect of temperature of preincubation. Wild type enzyme I (50 ng) was assayed after 
preincubation at room temperature (a) or on ice (b). Gly356Ser enzyme 1 (2 pg) was 
assayed after preincubation at room temperature (c) or on ice (d). Arg375Cys enzyme 1 
had similar behaviour to Gly3 56Ser. 
Figure 3.14 Room temperature gel filtration chromatography of heterodimer mixtures. 
Chromatographs are traces of protein elution as detected by absorbance at 280 nm. 
Different ratios of Argl26Cys and Gly356Ser enzymes I were combined on ice, 
incubated at room temperature for 5 min. with 2 mM PEP and 5 mM MgCl?, and then 
loaded and eluted on the room temperature Superose-12 column. Arg126Cys:Gly356Ser 
ratios were (a) 1 : 1 ; (b) 4: 1 ; (c)  7: 1 ; all with the column equilibrated with normal buffer 
(see Section 2.20); and (d) 4: 1 with column equilibrated with buffer containing 10 mM 
PEP and 5 mM MgCl,. Maximum peak heights were -0.1 A (280 nm) except for (d) 
which was -0.15 A. In all cases, the first peak (left) and second peak (right) correspond 
to an estimated apparent molecular weight of -1 27 kDa and -70 kDa, respectively. 
It appears that there is a dynamic monomerdimer equilibrium between the two enzyme I 
species as the proteins are eluting from the column. The net effect of this equilibrium 
was that more of the Argl26Cys enzyme I protein eluted at a lower molecular weight 
than the expected 127 kDa, through interaction with the Gly356Ser subunits. This 
indicates that heterodirners do form. The assay results (Section 3.3.6) indicate that the 
heterodimer was more stable in the presence of high concentrations of PEP. The gel 
filtration column was equilibrated with a buffer containing 10 mM PEP and 5 mM 
MgCl,, and the heterodimer mixture was applied. Under these conditions, more protein 
eluted at 127 kDa (Figure 3.14d). Thus the chromatography results also show that the 
heterodimer stability is dependent on PEP concentration. 
It was also attempted to examine the chromatographic separation of the 
Gly356Ser/Arg126Cys heterodirner by analysis of enzyme I activity in the collected 
fractions (Figure 3.15). The position of the heterodimer, indicated by the original peak 
of enzyme I activity without any added mutant enzyme I subunit, is at a position 
intermediate between monomer and dimer. However, the majority of Gly356Ser 
subunits, indicated by the enzyme I activity profile with 250 ng Argl26Cys enzyme 
added to the assay, are more near the monomeric position. Similarly, the majority of 
Argl26Cys subunits, detected with the addition of extra Gly356Ser enzyme I to the 
assay, are at the dimeric position. The position of the 'heterodimer' activity could be 
simply explained as the position during the elution where the trailing edge of the 
Argl26Cys enzyme I peak and the leading edge of the Gly356Cys enzyme I mix, and 
that heterodimers really do not form on the column. However, the previous 
chromatographic separations with different ratios of the subunits had already shown that 
Figure 3.15 Enzyme 1 activity of Gly356Ser/Arg126Cys heterodimer separated by 
Superose-12 chromatography, using buffer with no added PEP or MgCl?. A 4: 1 mixture 
of Arg126Cys:Gly356Ser enzyme I was incubated at room temperature for 5 min. with 2 
rnM PEP and 5 mM MgCl,, and then 100 pL (0.05 mg total protein) was loaded onto the 
column and 1 mL firactions were collected. The protein elution profile is not shown, but 
is similar to that shown in Fig. 3.16b, in that the size of the monomer and dimer peaks at 
-70 kDa and at -1 30 kDa are approximately equal. The approximate positions of those 
peaks are labeled 'M' and 'D', respectively. The enzyme I activity of 5 pL of each 
fraction was determined by the enzyme I PTS assay, with no additions (0) or with 250 
ng Argl26Cys enzyme I added (A), or with 125 ng Gly356Ser enzyme I added (0). The 
background activity of the added enzymes was subtracted. 
there is a dynamic formation and dissociation of heterodimers occuning. The enzyme I 
activity of a similar separation of heterodimer, but in this case with 2 mM PEP and SmM 
MgCI, added to the column buffer, indicated that the heterodimer was still at an 
intermediate position between monomer and dirner (not shown). 
3.3.8 Examination of the structure of PPDK 
The structure of the C-terminal domain of C. sy.nbioszim PPDK was used as a 
model to help explain the effects of the Gly356Ser and ArgS75Cys mutations in enzyme 
I. Figure 3.16 shows a direct amino acid sequence alignment between enzyme I and C. 
symbiosum PPDK. When this alignment is compared to the structure of the C-terminal 
domain of PPDK (Herzberg et aL, 1996), the sequence segments which are deleted in 
enzyme I (deletions A to E) correspond for the most part to exposed loops in the 
structure of PPDK. In this study, the interaction site between the subunits of PPDK was 
determined from the tertiary structure using a standard method (Sheriff et al., 1987). 
The residues involved in subunit interaction are described in detail in Table 3.4. This 
information is summarized in Table 3.5. The residues involved in subunit interaction 
form a set of five sequences, numbered I to 5 in Tables 3.4 and 3.5, which are fairly 
well conserved between enzyme I and PPDK (Figure 3.16). In these sequences, several 
residues interact with the same residue in the other subunit (called "self interacting" in 
Table 3 S). 
After determination of the subunit interaction site of PPDK, the sequence 
segments that are missing in the sequence alignment of enzyme I and PPDK (deletions 
Pyruvate phosphate dikinase 505 I Y K G D I E T  Q E A S V S G  519 
Enzyme I 23 9 M / L R A V Q E Q V A S / T " A E L A  25 4 
I16 
~ T M G L T L A E V K A K V D [ E L H E F N M M M H H G  c C R ~ V T J Y  P 67 6  
DelC M N [ F P K E E N P  f ' , G J E A  I / V ~ I & M D ]  R R / K Q  3 6 9  
F L D S Y Y K A K I ] Y E S D ? F A R L [ D Q T G ~ G Q L ~ J E M A V K K ] G R Q T R  823 
S H L Y Q P M S P  ] D e l E  [ S ~ L N L I K Q V I D A ] S H A E  4 9 5 
L A A A Q A A L N N K  8 7 4  
K I I R N T N F E D A K V L A E Q A L A Q P T T D E L M T L V N K F I E E K T I C  575 
Figure 3.16 PEP-binding domain sequence alignment. The sequence deletions, DelA-E in 
this alignment, are deleted in the model of the structure of the enzyme I C-terminal domain 
(Figure 3.17). The enzyme I sequences from E. coli and S. typhimurium differ at five residues 
and are indicated, for example, as M/L, respectively. Residues conserved between PPDK and 
enzyme 1 are underlined. Bolded residues are those identified as involved in PEP-binding 
(Herzberg et al., 1996). Residues in square brackets are those involved in the subunit 
interaction site of PPDK. I16 and 117 identify the enzyme I residues Gly356 and Arg375, 
respectively. The number 338 identifies GIy338, the residue which when mutated, impairs 
dimerization (Seok er al., 1996b). 
Table 3.4 Pyruvate phosphate dikinase residues in contact at the subunit interaction site. 
Residue Residue vdw"  bond^ Residue 2 Enzyme I 
Subunit 1 Subunit 2 number or ion pairc Seq-wnce Residue 
A. Sequence 1 
Pro660 
Met66 1 
Met 662 
Seq. 4 (Phe347)' 
Seq. 4 (Pro348) 
Seq. 4 Glu350 
Seq. 1 GluX 1 
Seq. i 
Seq. 4 
Seq. 4 
Seq. 1 
Seq. 1 
Seq. 1 
Seq. 4 
Seq. 1 
Seq. 1 
Seq. 1 
Seq. 1 
Seq. 1 
Seq. 1 
Seq. 4 
Seq. 4 
Seq. 4 
Seq. 4 
Seq. 4 
Seq. 4 
Seq. 4 
Seq. 4 
Seq. 4 
Seq. 4 
Seq. 4 
Seq. 4 
Seq. 4 
Seq. 4 
Seq. 4 
Seq. 4 
Seq. 4 
Table 3.4 continued 
-- -- 
Residue Residue v d d  H-bondb Residue 2 Enzyme I 
Subunit 1 Subunit 2 number or ion  air' Seuuence Residue 
B. Sequence 2 
C. Sequence 3 
Ite746 
D. Sequence 4 
Gln772 
Met 773 
Ile794 
Lys793 
Ile794 
Tyr789 
IIe794 
Thr774 
Phe775 
Gly776 
Met773 
m 7 7 4  
Thr774 
Phe775 
Asp804 
Thr774 
Gly807 
Gln8 10 
Leu8 1 1 
Thr806 
Met662 
Pro747 
Met 7 73 
Gly776 
Ile746 
Pro747 
Arg748 
Leu75 1 
kg668 
Ile746 
Arg748 
Met662 
kg668 
Ile746 
Met773 
H-bond 
H-bond 
Ion pair (3) 
H-bond 
H-bond 
H-bond 
H-bond 
H-bond (2) 
Seq. 4 
Seq. 4 
Seq. 4 
Seq. 4 
Seq. 4 
Seq. 4 
Seq. 4 
Seq. 4 
Seq. 4 
Seq. 4 
Seq. 4 
Seq. 4 
Seq. 5 
Seq. 4 
Seq. 5 
Seq. 5 
Seq. 5 
Seq. 5 
Seq. 1 
Seq. 3 
Seq. 4 
Seq. 4 
Seq. 3 
Seq. 3 
Seq. 3 
Seq. 3 
Seq. 1 
Seq. 3 
Seq. 3 
Seq. 1 
Seq. 1 
Seq. 3 
Seq. 3 
Table 3.4 continued 
Residue Residue vdw" H-bondb Residue 2 Enzyme I 
Subunit 1 Subunit 2 number or ion pairc Sequence Residue 
D. Sequence 4 continued 
E. Sequence 5 
Met662 
k g 6 6 8  
Met662 
Phe658 
Glu657 
Phe658 
Asn659 
Gly663 
Glu654 
Leu655 
His664 
Gly663 
His664 
Arg668 
Thr672 
-72 
Arg668 
Val67 1 
Glu7 1 3 
Lys7 12 
Val67 1 
Glu7 10 
Lys7 12 
Glu7 13 
Phe7 16 
Arg748 
Thr752 
Leu75 1 
Leu75 1 
Lys8 1 8 
Leu 75 1 
Met814 
Gln8 10 
vdw (2) 
vdw 
vdw (2) 
vdw (5) 
vdw (2) 
vdw (3) 
vdw 
vdw (2) 
Seq. 1 Val463 
Seq. 1 
H-bond Seq. 1 Asp464 
Seq. 1 Gly466 
Seq. 1 Asn467 
H-bond Seq. 1 
H-bond Seq. 1 
Seq. 1 
Seq. 1 
H-bond Seq. 1 
Seq. 1 
Seq. 1 
Seq. 1 
Seq. 1 
Seq. 1 
Seq. 1 
Seq. 1 
Seq. 1 
H-bond Seq. 2 
Seq. 2 
Seq. 1 
Seq. 2 
Seq. 2 
Seq. 2 
Seq. 2 
Ion pair (3) Seq. 3 
Seq. 3 
Seq. 3 Ser480 
H-bond Seq.  3 Asn483 
H-bond (2) Seq. 5 
Seq. 3 Leu484 
Seq. 5 Gln487 
H-bond (2) Seq. 5 Ala491 
Table 3.4 continued 
a. vdw, van der Wads interactions: Total number = 148. b. Total number of H bonds = 
15 c. Total number of ion pairs = 3. d. There are five sequences in which interacting 
residues are found. e. Residues in parentheses are the next in the sequence, but were not 
aligned. f. Bolded residues are conserved between C. symbiosurn pyruvate phosphate 
dikinase and enzyme I from both E. coli and S. typhirnurium. g. Italicized residues 
interact with the same residue in the other subunit. h. Pyruvate phosphate dikinase 
residues 784-794 do not align well with enzyme I. 
Table 3.5 Summary of the subunit site of interaction in pynrvate phosphate dikinase 
Description Sequence Grouping 
1 2 3 4 5 
Residues in 654-672 710-716 
PPDK 
Residues in 347-365 403-409 
enzyme 1 
Number of I3 4 
residues making 
contacts: 
Conserved 7 2 
residuesb 
Self-interacting Phe658 
residuesC Asn659 
Met662 
Interacting Seq. 1 & 4 Seq. 
sequence 
numb& 
Numbef of: 
vdw 98(10) 15 
H-bonds 12(1) 1 
Ion pairs 
Seq. 4 & 5 Seq. 1,2 & 3 Seq. 3 & 5 
a. The alignment of enzyme I with C. symbiosum pyruvate phosphate dikinase is 
uncertain after residues 470 and 784 respectively. The sequences of all the enzymes I 
show a deletion in this part of the sequence. 
b. Residues conserved between C. symbiosum pyruvate phosphate dikinase and enzyme I 
in the interaction sequences. 
c. Residues in each subunit which interact with the identical residue. 
d. Does not include "self-interacting" residues. 
e. Except for the bonds involving the "self-interacting" residues, each bond reported is 
given twice, once in each sequence. The numbers in parentheses are those involving the 
"self-interacting*' residues. The total number of interactions: van der Waals, 154; H- 
bonds, 1 5; ion pairs 3. 
A to E in Figure 3.16) were deleted tiom the PPDK structure. Then energy 
minimization was performed using the X-PLOR structural analysis program (Briinger, 
1993) to create a model of the structure of the C-terminal domain of enzyme I. The 
resulting stnrcture (Figure 3.17) was similar to the original PPDK structure, and resulted 
in only one significant structural change to the subunit interaction site. Deletion E, 
residues 794-803, led to the convergence of subunit interaction sequences 3 and 4. This 
resulted in both movement and local disruption of structures on either side of the 
deletion, which would affect the subunit binding site. The PPDK subunit interaction 
sequences are shown in yellow, with residues conserved with enzyme I in amber, on the 
structure of the model of the enzyme I C-terminal domain (Figure 3.17). These 
sequences do not overlap with the residues of the putative PEP-binding site of PPDK 
(Herzberg et a/., 1996; residues in purple in Figure 3.1 7), but they are clearly very close. 
The deletions in this analysis did not significantly affect the orientation of the conserved 
residues of the PEP-binding site. 
Gly663 of PPDK, which is Gly356 in enzyme I, is within interaction sequence 1 
(Table 3.5) which is at the axis of two-fold symmetry between subunits of the PPDK 
crystal structure (Herzberg et ul., 1996). The conserved PPDK residue analogous to 
k g 3 7 5  of enzyme I is Arg682. This residue is not in a subunit interaction sequence in 
PPDK and is located at some distance away from both the subunit interaction site and 
the PEP-binding site. Both the Arg and Gly residues occupy approximately the same 
location and orientation in the model of the structure of the C-terminal domain of 
enzyme I (Figure 3.1 7). From the position of Gly663/Gly3 56, it is readily apparent why 
Figurn 3.17 The structure of the model of the C-terminal domain of enzyme I, 
originating from the structure of C. symbiosum PPDK, beginning at residue M S .  The 
residues colour coded in this structure are identified in the sequence alignment in Figure 
3.16.. Purple. conserved residues that form the PEP-binding site of PPDK (Herzberg et 
al., 19%); yellow, sequences involved in subunit interaction with amber those conserved 
between enzyme I and PPDK; pale blue, other residues that are conserved between the 
two enzymes; black, the residues of characterized mutants - Gly is Gly356, Arg is 
Arg375, and Leu is Gly338 in enzyme I. 
mutation of this residue may cause disruptions of subunit interaction. However, it is less 
obvious why mutation of Arg682/Arg375 would result in impaired dimerization. 
The mutations Gly663Ser and Arg682Cys were made to the original structure of 
PPDK, followed by energy minimization. Neither mutation resulted in a significant 
disruption of the structure or the subunit interaction site. Thus after the structural 
comparisons presented in this thesis it still remains relatively unclear why the Gly356Ser 
and Arg375Cys mutations in enzyme I produce the observed effects of impaired 
dimerization. Further in vitro work was then performed to further investigate the 
subunit interactions of enzyme I. 
3.3.9 Enzyme I fragments and activity complementation 
Using the LDH-coupled spectrophotometric assay, activity complementation 
between the cloned 37 kDa C-terminal domain and GIy356Ser or Arg 126Cys enzyme I 
has surprisingly been demonstrated. Kinetic parameters for the Gly356SerlEIC37 
heterodimer were obtained (Table 3.3), and are similar to those of the Gly356Ser/ 
Arg 126Cys heterodimer. The fact that the EIC37 protein is capable of complementation 
conclusively demonstrates that the only active subunit in the heterodimer is the 
Gly356Ser subunit. This complementation also shows that the dimerization activity of 
enzyme I resides within the C-terminal domain, and that this domain alone is necessary 
and sufficient for dimerization. The EIC27 protein, lacking potentially important PEP- 
binding and subunit interaction sequences, is understandably not able to complement 
Gly356Ser enzyme I. 
Using the in vitro LDH-coupled enzyme I assay, no activity complementation 
between separately cloned and purified N-terminal and C-terminal enzyme I fragments 
could be demonstrated, even with relatively large amounts of protein. However, 
Fomenkov et al. (1 998) demonstrated activity complementation between the cloned N- 
terminal and C-terminal domains of enzyme I, by in vivo PTS-sugar fermentation 
properties of cells transformed with overexpression plasmids, and by phosphorylation of 
proteins with [ 3 2 ~ ] ~ ~ P .  Later, Zhu et al. (1999) also showed activity complementation 
between cloned N-terminal and C-terminal domains, albeit at a severely reduced rate 
compared to intact enzyme I, using the in vitro sugar phosphorylation assay. It was then 
decided to try to show activity complementation between the 27 kDa N-terminal and 37 
kDa C-terminal constructs in this work, using the more sensitive in vitro 
phosphorylation of proteins with [ 3 2 ~ ] ~ ~ ~ .  
Figure 3.18 illustrates the results of the phosphorylation experiment. It was 
conclusively shown (lane 5) in that there is a phosphoryl transfer between full length 
enzyme I and the 27 kDa N-terminal enzyme I fragment (EIN27). More importantly, the 
phosphorylation of the Em27 fiagment was also shown in the presence of the 37 kDa C- 
terminal fiagment of enzyme I (lane 4). Thus complementation between separate 
domains can be demonstrated, if enough protein and a sensitive method of detection are 
used. Not surprisingly, phosphorylated EM27 is capable of phosphorylating HPr (lane 
7), as had previously been shown by several laboratories. 
Figure 3.18 in vitro phosphorylation of PTS proteins with [32P]PEP. Phosphorylation 
reactions were prepared and separated by SDS-PAGE as described in Materials and 
Methods. Lane 1, 0.5 pg wild type E. coli enzyme I (El); lane 2, 2.5 pg EN27 + 5 pg 
EIC37; lane 3, 2.5 pg EIN27 + 0.5 pg EI; lane 4, 0.5 pg El + 1 pg HPr; lane 5 ,  2.5 pg 
EIN27 + 5 pg EIC37 + 1 pg HPr. There is no phosphorylation of E N 2 7  when assayed 
alone (not shown). 
33.10 Characterization of other enzyme I mutants 
A great deal of information regarding the structure and function of enzyme I has 
been gained fYom the study of the three S. typhimurium enzyme I mutants Argl26Cys, 
Gly356Ser, and Arg375Cys. In order to progress fbther in the understanding of enzyme 
I, several site-directed mutants of E. coli enzyme I were created and studied. Firstly, the 
same three mutants as just described for S. typhimurium were created in E. cofi enzyme 
I .  Although the proteins were not purified, similar reductions in V,,, compared to wild- 
type, and activity complementation between mutants was found with assay of crude 
extracts (not shown). This work was camed out by Mr. Alastair MacFadden as an 
undergraduate research project. Subsequently, other site-directed mutants of E. coli 
enzyme I were created. The rationale for creation of each of these mutants will be 
discussed. 
33.10.1 As11352 mutants 
Enzyme I mutants of Asn352 were created in order to investigate the potential 
importance of this residue in dimerization, and in order to potentially create a stable 
monomeric form of enzyme I. Asn352 is conserved in all enzymes I, E. cofi P E P  
synthetase, and all pyruvate phosphate dikinases identified to date, 41 sequences in total 
(Pfam website <http://~fam.wustl.edu/cri-bin/getdesc?name=PPD N term>: Reizer et 
aL, 1993; Figure 1.8). Asn352 is conserved as Asn659 in C. symbiosum PPDK, and 
using the structure of this protein (Henberg et al., 1996), detailed analysis shows that 
Asn659 makes several contacts with residues of the other subunit of the dimer, including 
the other Asn659 residue (Table 3.4). Thus it was decided to mutate Asn352 of E. coli 
enzyme I to Glu and Ala and determine the effects on the monomer:dimer equilibrium. 
The Asn352Ala and Asn352Glu mutants were created by site-directed 
mutagenesis, and dimerization and kinetic parameters of the mutants were investigated. 
When subjected to gel filtration chromatography at room temperature, both mutants 
exhibit an impaired dimerization equilibrium compared to wild type (Figure 3.19), but 
appeared to have a slightly higher dimerization potential than Gly356Ser enzyme 1. 
Both mutants also exhibited a significant decrease in V,, and a significant increase in 
PEP &, compared to wild type enzyme I (Table 3.6). These characteristics are similar to 
those found for Gly356Ser and Arg375Cys enzymes I. However, the Asn352Glu 
mutant, although more active than Asn352Ala with V,,, values of 8.3% and 1.3% of 
wildtype, respectively, has a much higher Y, for PEP than Asn352Ala, with values of 
8.4 mM and 2.2 mM, respectively. 
The activity of Asn352Ala and Asn352Glu enzyme I mutants while combined 
with Argl26Cys enzyme I in an activity complementation assay was then investigated. 
Asn352Glu enzyme I is capable of activity complementation with Argl26Cys enzyme I 
(Figure 3.20). However, the complementation of Asn352Ala by Argl26Cys enzyme I 
was not nearly as high, with only a -2-fold stimulation compared to a &-fold 
stimulation of Asn352Glu enzyme I. Kinetic analysis was performed on the 
Asn352Glu/Arg126Cys complementation mixture in order to estimate a PEP Y, for the 
heterodimer. The activity of the heterodimer was very unstable at low PEP 
concentrations, perhaps even more so than that seen with the Gly356Ser/Arg126Cys 
heterodimer. The PEP Y, did not appear to be as low as 0.01 mM as had been 
Figure 3.19 Analysis of wild type and mutant enzymes I by Superose-12 
chromatography at room temperature. In all separations, ovalbumin (45 kDa) was used 
as an internal standard. The first peak in each chromatograph corresponds to the elution 
position of the enzyme I protein, labeled with a number signifying the apparent 
molecular weight of  the enzyme I species. The proteins analyzed were (a) wild type 
enzyme I; (b) Gly356Ser enzyme I; (c) Asn352Glu enzyme I; (d) Leu3SSAla enzyme I. 
Asn352Ala enzyme I eluted at a similar position to Asn352Glu, and similarly with 
Leu35SAla and Leu35SGlu. 
Table 3.6 Kinetic analysis of mutants of enzyme I. 
El species 
wild type 
Asn352Ala 
Asn352Glu 
Leu355Ala 
Leu35SGlu 
Arg296Leu 
Kinetic parameters were obtained using the LDH coupled spectrophotometric assay. 
Arg l26Cys enzyme I added (ng) 
Figure 3.20 in  vifro complementation of Asn352Ala or Asn352Glu enzyme I with 
Argl26Cys enzyme 1. Asn352Ala or Asn352Glu enzyme 1 (50 pg1mL) was preincubated 
for 5 min with increasing concentrations of Argl26Cys enzyme I. Then 250 ng 
Asn352Ala (0) or Asn352Glu (U) enzyme I with increasing amounts of Argl26Cys 
enzyme I, corresponding to 5 pL of each preincubation mixture, was assayed with 30 
p.M HPr and 20 mM PEP. The amounts of Argl26Cys enzyme I added to the assay did 
not yield any measurable activity if assayed alone. 
determined for the Gly356SedArg126Cys heterodimer, and was estimated to be 0.5 - 1 
mM, although accurate kinetic data were difficult to obtain (results not shown). The 
differences in properties of the Asn35Ala and Asn352Glu mutants, namely kinetic 
parameters and in vitro complementation, are important to note in that they provide 
some information as to the role of the Asn352 residue in wild type enzyme I. 
3.3.10.2 Leu355 mutants 
Leu355 fairly well conserved between all enzymes I and other enzymes of this 
PEP-utilizing class (Reizer er al., 1993; Figure 1 .a). However in C. symbioszim PPDK, 
the residue analogous to Leu355 is Met662. Met662 in PPDK is part of a residue 
segment that is important for subunit interaction, and, like Asn659, is a 'self interacting' 
residue, in that both Met662 residues form contacts with each other in the dimer (Table 
3.4). Also, Leu355 in enzyme I is obviously very close to the Gly356 residue previously 
identified as important in dimerization. Thus the enzyme I mutants Leu355Ala and 
Leu355Glu were created to investigate the importance of Leu355 in enzyme I 
dimerization, and perhaps create a stable monomeric form of enzyme I. 
The chromatographic analysis and kinetic parameters of Leu355Ala and 
Leu355Glu enzymes I have previously been presented in Figure 3.1 9 and Table 3.6, 
respectively. Again, both mutants exhibit impaired dimerization, and have kinetic 
parameters characteristic of 'leaky' mutants with a V, of 6-12% of wild type, and a 
PEP K, of 1.6-1.8 mM, compared to a wild type K,,, of 0.1 mM. Both mutants were also 
capable of  activity complementation when assayed in combination with Argl26Cys 
enzyme I, but the degree of complementation was smaller than that seen for other 
heterodimers, roughly a two- to four-fold increase in activity (Figure 3.2 1 ). Also, the 
complementation activity did not reach a plateau level at approximately a one- to two- 
fold excess of ArglMSer enzyme 1, as had been seen with other complementation 
studies. Rather, the slight increase in complementing activity increased, up to at least an 
eight fold excess of Argl26Cys enzyme I, even when the very slight activity of the 
Argl26Cys enzyme I when measured alone was subtracted (not shown). Thus Leu355 
enzyme I certainly appears to be important for dimerization of enzyme I, but the Leu355 
mutants have characteristics which are slightly different than the characteristics of the 
Gly356Ser mutant of S. ryphimuriurn enzyme I. However, it does not appear that the 
Leu355 mutants which have been created are stable monomers. 
33.103 Arg296Leu mutant 
The residue Arg561 in C. symbiosum PPDK has been identified as important for 
PEP catalysis, in that the Arg561 Leu mutant was incapable of the interconversion of 
PEP and pyruvate (Yankie el al., 1995). PPDK Arg561 is conserved in the PEP- 
utilizing family (Reizer et at., 1993; Fig. 1.8), and the analogous residue in E. coli 
enzyme I is Arg296. The analogous mutant Arg296Leu in E. coli enzyme I was created 
in this study in order to investigate the importance of the Arg296 residue in interaction 
with PEP, and also perhaps to further clarify the role of PEP binding in the 
monomerdimer equilibrium of enzyme I. 
The Arg296Leu mutant enzyme I protein was analyzed by room-temperature 
Superose-12 chromatography, but the protein, although >95% pure as judged by SDS- 
PAGE, eluted from the column in several peaks. However, the major protein species 
Argl26Cys enzyme I added, ng 
Figure 3.21 i n  vitro complementation of Leu355Ala or Leu355Glu enzyme I with 
Argl26Cys enzyme I. Leu355Ala or Leu355Glu enzyme I (50 pg/mL) was preincubated 
for 5 min at room temperature with increasing concentrations of Argl26Cys enzyme I. 
Then 250 ng Leu355Ala (O)  or Leu355Glu (e) enzyme I with increasing amounts of 
Argl26Cys enzyme I, corresponding to 5 pL of each preincubation mixture, was 
assayed with 30 pM HPr and 20 rnM PEP. The amounts of Argl26Cys enzyme I added 
to the assay did not yield any measurable activity if assayed alone. 
eluted at -90 kDa, with several lower molecular weight peaks (not shown). Thus the 
Arg296Leu mutant appeared to have an impaired monomerdimer equilibrium, relative 
to wild type. The Arg561Leu mutant of PPDK showed a susceptibility to proteolytic 
hgmentation during storage (Yankie et a!., 1999, so perhaps the Arg296Leu enzyme I 
mutant was also susceptible to proteolytic degradation during room temperature 
chromatographic separation. 
The Arg296Leu enzyme I mutant was also analyzed by enzyme assay, and 
kinetic parameters were obtained (Table 3.6). The mutant had a very low activity, 
0.04% of wild type, as expected, although the k g 5 6 1  Leu PPDK mutant did not have 
any detectable activity (Yankie et al, 1995). However, the PEP K, for the mutant was in 
fact similar to that of wild type (0.05 rnM vs. 0.1 mM, respectively). 
Gel filtration chromatography indicated that Arg296Leu enzyme I eluted at a 
position intermediate between monomer and dimer, and had impaired dimerization. In 
vitro complementation enzyme assays were then performed using Arg296Leu enzyme I 
(Figure 3.22). Arg296Leu enzyme I appears to behave similarly to Argl26Cys enzyme 
I, in that both have impaired catalytic activity but are capable of complementation of 
other C-terminal enzyme I mutants. Furthermore, there is no direct complementation 
between the two enzymes. It appears then that Arg296Leu enzyme I is capable of 
forming heterodimers with other enzyme I mutants, although the stability of the 
heterodimers is likely very low. 
Arg296Leu enzyme I, ng 
Figure 3.22 In vitro activity complementation involving Arg296Leu enzyme I with 
other enzyme I mutants. S. typhimurium Gly356Ser or E. coli Asn352Glu enzyme I (50 
pg/mL) was preincubated for 5 min at room temperature with increasing concentrations 
of Arg296Leu enzyme I. Then 250 ng Gly356Ser (A) or Leu355Glu (0)  enzyme I with 
increasing amounts of Arg296Leu enzyme 1, corresponding to 5 pL of each 
preincubation mixture, was assayed with 30 pM HPr and 20 mM PEP. Note: an assay of 
Arg296Leu enzyme I in combination with either S. typhirnurium ArglZbCys, E. coli 
Asn352Ala, Leu355Ala, or Leu355Glu enzymes I shows little or no activity 
complementation. 
3.3.10.4 His189 mutants 
HPr is phosphorylated at the atom of the Hisl 5 residue. It has been shown 
that the HislSAsp mutant of HPr is still capable of phosphocanier activity, albeit at a 
greatly reduced activity (Napper et nl., 1999). Enzyme I is phosphorylated at the N" 
position of histidine 189. and as previously discussed in the Introduction, by analogy to 
HPr the Hisl 89Glu mutant of enzyme I may also have some catalytic activity. To 
investigate this possibility, His189 mutants of enzyme I were created. To date, the 
enzyme I mutants Hisl89Asp and His189Glu have been made, and investigated for 
catalytic activity by in vitro phosphorylation with ["PIPEP (Figure 3.23). Other His1 89 
mutants are presently being created by Dr. Napper. His l89Glu enzyme I is indeed 
phosphorylated after the addition of [ 3 2 ~ ] ~ ~ ~  (lane 3), whereas phosphorylated 
Hisl89Asp enzyme I is not visible under the same conditions (lane 2). However, the 
degree of autophosphorylation of His1 89Glu enzyme I in this experiment is about ten- 
fold lower than wild type, since ten times as much Hisl 89Glu enzyme I was loaded onto 
the SDS polyacrylarnide gel in order to get a band of similar intensity of wild type on the 
autoradiogram. Phosphorylated His 1 89Glu enzyme I is also capable of phosphotransfer 
to HPr (lane 6) ,  again at a greatly reduced efficiency compared to wild type. 
Unexpectedly, phosphorylated HPr also appears when incubated with ["PIPEP and 
Hisl89Asp enzyme I (lane 5). This experiment has been repeated with the same results 
(not shown). However, at no time was a band visible indicating phosphorylated 
Hisl89Asp enzyme I, perhaps due to very weak autophosphorylation activity andlor 
poor stability of the acyl phosphate during the experiment. Acyl phosphates in proteins 
are unstable at both acid and alkaline pH (Stock et a/., 1989), and the half lives of such 
Figure 3.23 Phosphorylation of mutant enzymes I and phosphotransfer to HPr. Proteins 
were incubated with [ 3 2 P ] ~ ~ ~ ,  electrophoresed, and subjected to autroradiography as 
previously described (Section 2.20). Lane 1 ,  0.5 wild-type enzyme I (EI); lane 2, 5 pg 
Hisl89Asp EI; lane 3, 5 pg Hisl89Glu El; lane 4, 0.5 pg wild-type El + 1 pg HPr; lane 
5 , s  pg His1 89Asp EI + 1 pg HPr; lane 6 ,5  pg Hisl89Glu EI + 1 pg HPr. 
acetyl phosphates vary widely, ranging from 4 min. for the P-Asp of NtrC (Keener et 
al., 1988) to a few seconds for the P-Asp of CheY (Hess et a/., 1988) or  the P-Glu 
residues of prothymosin a (Tnunbore et a/., 1997). 
The phosphotransfer activity of the Hisl 89Asp mutant is surprising, since 
schematically the carboxyl oxygen of aspartate does not mimic the position of 
histidine, but rather best mimics the N" atom. However, this should be taken as a real 
result, since Hisl 89Asp enzyme I was purified from a prsHIcrr bacterial strain deficient 
in wild type enzyme I, while purified HPr is not phosphorylated in the absence of any 
added enzyme I, and this experiment was performed repeatedly in part to assure no 
phospho-HPr contamination or "spillover" into the sample lane containing His l89Asp 
enzyme I. 
It was attempted to assess the catalytic activity of Hisl 89Asp and Hisl 89Glu 
enzyme 1 mutants using the LDH-coupled spectrophotometric assay. However, even 
when relatively large amounts of protein were used, and under conditions which gave 
maximal activity for the wild type enzyme, no activity for either mutant was detected, 
and no kinetic parameters could be obtained. Both mutant enzymes were capable of 
activity complementation of Gly356Ser enzyme I, in a manner similar to the Argl26Cys 
active site mutant (not shown), as expected. 
4.1 Binding constants of HPr with other PTS proteins 
Phe2Cys HPr was purified fkom a cell extract most optimally when 0.2 mM DTT 
was included in all buffers, in order to limit dimerization of the protein. Other cysteine- 
containing mutants of HPr, namely Argl7Cys (Smallshaw, 1997; Smallshaw et al., 
1998) and Glu83Cys (Liu el al., 1998) were also able to form disulfide-linked dimers, 
and 0.2 mM DTT was used in purifications of these proteins as well. During ion 
exchange chromatography it was observed that disulfide-linked dimers of Phe2Cys HPr 
had a lower apparent isoelectric point (pl) than the monomeric fom, which was also 
observed by isoelectric focusing gel (Figure 3.1 ). A similar charge difference was also 
observed with monomeric and dimeric forms of Argl7Cys HPr (Smallshaw, 1997). 
Interestingly, Phe2Cys HPr dimers seemed to have two distinct forms, which was not the 
case with Argl7Cys HPr. A possible explanation is that some charged amino acid side 
chains would be masked in a dimer, due to interactions of each HPr molecule, and these 
interactions would differ depending on the arrangement and attachment of the two HPr 
proteins. 
Purified cysteine-containing mutants of HPr have proven relatively easy to label 
with the thiol-specific fluorescein-5-maleimide. These labeled HPrs have been used 
effectively in fluorescence polarization binding studies involving anti-HPr antibodies 
(Smallshaw, 1 997; Liu ef al., 1998; Smallshaw et al., 1 998). However, using this 
technique, only an incomplete binding curve of labeled Phe2Cys HPr with either enzyme 
I or 1 1 ~ ~ ' '  was obtained (Figure 3.3). The interaction of  HPr with its partner PTS 
proteins is of very low relative affinity. Very weak interactions between HPr and 
enzyme I or enzymes I1 are easily rationalized, since these interactions must be transient 
in order to sustain the flow of phosphoryl transfer reactions in the PTS. The 
physiological concentrations of these proteins in E. coli or S. typhimurium are relatively 
high: 2-5 p M  for enzyme I (Misset et al., 1 980: Mattoo et al., l983), 20- 1 00 pM for HPr 
(Waygood et a l ,  1979), and 25 - 50 p M  for 1 1 ~ ~ ' '  (Scholte et aL, 1982) Conversely, 
antibody-antigen interactions are for the most part high affinity interactions. The 
fluorescence polarization technique did not prove completely useful in the study of the 
interactions of HPr with enzyme I and 1 1 ~ ~ " .  
4.2 Enzyme I binding site on HPr 
A kinetic assay of wild type and site-directed mutants of HPr as substrates for 
enzyme I was undertaken. This proved to be a useful method for delineating the enzyme 
1 binding site on HPr, and complemented NMR chemical shift studies of the binding 
interaction (van Nuland et aL, 1995; Wang et al., 2000) as well as the NMR solution 
structure of the complex of HPr with the N-terminal domain of enzyme I (Garrett et al., 
1999). This approach is similar to the "epitope mapping" mutagenesis investigation of 
the interaction sites between HPr and a number of monoclonal antibodies (Sharma et al., 
1 99 1 ; Smalishaw et a/. , 1998). 
This kinetic study identified the key catalytic residues of the active centre of 
HPr, His1 5 and Argl7, as expected (Table 3.1). These active centre residues of HPr are 
clustered on one side of the HPr molecule (Figure 3.5). Mutations to Ser46 also 
produced drastic effects on the K, and V,, of enzyme I.  Ser46 is the residue of 
phosphorylation by a regulatory kinase in Gram-positive bacteria such as B. subtilis, and 
this phosphorylation severely reduces the phosphoryl transfer activity of HPr. The 
structure of the Ser46Asp mutant of E. coli HPr indicates that the mutation produces 
significant alterations to the electrostatic surface potential of the molecule (Napper et al., 
1996). In this kinetic study, other residues were identified which, when mutated, 
affected the Y, but not V, for enzyme I. These residues form a distinct binding site for 
enzyme I on HPr (Figure 3.5). The Thrl6Ala mutation produces a significant increase 
in K,,, of enzyme I, which is an important finding because Thrl6 is not a conserved 
residue and many Gram-positive bacteria such as B. subtilis have an alanine at residue 
16 (Reizer et al., 1993). Also, E. coli enzyme I is less effective with B. subtilis HPr 
(Reizer et al., 1 992). 
4.2.1 Comparison with the NMR structure of the HPr:EM complex 
Ganett et al. (1999) identified several residues of HPr which made one or more 
contacts with residues of the N-tenninal domain of enzyme I (EIN), as observed by 
intermolecular nuclear Overhauser effects (NOES). The key HPr residues, making three 
or more contacts with EM, were identified as Thrl6, Argl7, Ala20, Leu47, Phe48, and 
Thr52. In this kinetic study, the mutations Thrl6Ala, Argl7Gly, and Leu47Ala produce 
significant changes in 9, indicating a role for these residues in binding. However, little 
or no change was observed with the mutations AlaZOThr, Phe48Met in a Lys49Gly 
background, and Thr52Ala. The other HPr residues identified by Garrett et al. (1999) 
which made one or two contacts with EM are Leul4, Alal9, Gln2 1, Phe22, Va123, 
Lys27, Lys45, Ser46, Lys49, LeuSO, GlnSi, Leu53, Gly54. and Leu55 Of these, the 
mutations Lys27Ala, Ser46Ala, and Lys49Gly produced significant changes in enzyme I 
. However, mutation of either Gln2 1, Gln5 1, or Leu55 to alanine produced little or 
no effect. The other residues in the list of residues making one or two contacts were not 
mutated, for the reasons previously described (see Results). 
In the structure of the HPr:EIN complex, Ser46 of HPr participates in a hydrogen 
bond with Glu84 of E N ,  which also helps to explain the drastic effect of mutation of 
Ser46 of HPr. Garrett et a!. (1999) did not identify Lys40 of HPr as a residue in the 
enzyme I binding site. However, the Lys40Ala mutation resulted in a significant 
increase in K,,, for enzyme I (Table 3. I), and Lys40 is closely associated with other 
residues of the enzyme I binding site (Figure 3.5). This increase in K, may be indirect, 
in that mutation of the lysine to the smaller alanine may result in some structural 
fieedom which allows for movement of nearby residues which are important for enzyme 
1 binding. The Lys40Phe mutation produced no significant change in enzyme I binding, 
which indicates that lysine itself may not be essential at that position. In the structure of 
the HPr:EIN complex (Garrett et al., 1999) the side chain of Gin51 of HPr was shown to 
participate in a hydrogen bond with the side chain of Arg126 of enzyme I. In this 
kinetic study, the mutation of GlnS1 to Glu produced significant changes in enzyme I 
kinetics, but the Gln5 1Ala mutation, which would eliminate any potential of hydrogen 
bonding, surprisingly had no effect. Other sections of this thesis postulate a role for 
Arg126 of enzyme I in catalysis, and not necessarily binding of  HPr. Thus, it must be 
considered that the Gln5 1 -kg1 26 interaction may not be significant under physiological 
conditions. 
Indeed, there may be two reasons as to why the interaction site as identified by 
the solution structure of  the complex of EIN and HPr (Garrett et a[., 1999) may not 
totally agree with that found physiologically. Firstly, the structure of the complex was 
obtained in the absence of phosphorylation of either protein. The two proteins may be 
able to bind to each other in the absence of phosphorylation, but this complex is by 
definition inactive in the PTS. Secondly, the N-terminal domain of enzyme I, not the 
intact protein, was used in the structure of the complex. While it is obvious that the 
isolated N-terminal domain is perfectly able to interact with HPr, a slightly different 
binding site during the physiological interaction of HPr and intact (and phosphorylated) 
enzyme I cannot be ruled out. Indeed, previous biochemical work fiom the same 
laboratory that published the structure o f  the HPr:EIN complex emphasized the 
importance of the C-terminal domain of enzyme I of E. coli enzyme I for phosphoryl 
donor specificity to E. coli HPr, in that isolated phospho-EIN was capable of more 
general phosphotransfer to HPrs from several bacterial species (Seok et of., 1996). 
4.3 Structure and function of enzyme I 
The remainder o f  this Discussion will be dedicated to examining the role of 
several amino acid residues in the function of E. coli and S. pphimurium enzyme I. 
Determination of the roles of  these residues will be aided by the examination of the 
structure of the N-terminal domain of enzyme I, as well as comparison to the structure of 
C. symbiosum pyruvate phosphate dikinase (PPDK), which will serve as a model for the 
unknown structure of the C-terminal domain of enzyme I. The properties of these 
enzyme I mutants will also lead to firrther insight into the role of the monorner:dimer 
transition of enzyme I in enzyme I activity, and the potential importance that this 
transition plays in the in vivo regulation of the PTS and overall metabolism of E. coli 
and S. typhimurium. 
4.4 Role of Arg126 in phosphotransfer 
The Arg 1 26Cys mutation of S. typhimurium enzyme I has a large effect on V,,,, 
which is 0.04% of wild type (Table 3.2), but is no apparent detriment to HPr or PEP 
binding, in that the K,,, for each of these substrates was unchanged. The residue Arg 126 
is located in the N-terminal domain of enzyme I, across the active site cleft from His1 89, 
where phosphoryiation occurs (Figure 4.1 ). Arg126 is conserved in all enzymes I, but 
not in PPDK sequences (Reizer et al., 1993; Figure 1.8). Thus Arg126 likely plays a 
specific role in catalysis and phosphotransfer to HPr. 
In the solution structure of the complex of HPr with EIN (Garrett et a/., 1999), it 
was found that Arg126 of enzyme I formed hydrogen bonds with the backbone carbonyl 
of Leu1 4 and the side chain of Gln5 1 of HPr. It is interesting to note that Arg l26Cys 
enzyme I has a wild type Y, for HPr, indicating that this mutation has no effect on 
binding. The Gln5 1 Ala mutation to HPr also does not affect binding, as previously 
discussed. Arg126 may then have a different interaction in the presence of a P- 
histidine(s) than that observed in the structure of the complex. In the unphosphorylated 
form, His189 exists as an N6'H tautomer, with the unprotonated N" atom 
F i i r e  4.1 Crystal structure of enzyme I N-terminal domain active site, shown in the 
same orientation as Figure 1.9. Arg126 is identified in blue, acidic residues are red, and 
Thrl48 is shown in amber. Glu167 is not labeled due to crowding. 
participating in a hydrogen bond with Thr168. Upon phosphorylation (or protonation) 
of the N~~ atom, the hydrogen bond to Thr168 is lost, and the side chain conformation of 
His 189 is altered fiom a g' conformer to a g- conformer, such that the phosphoryl group 
is more solvent accessible (Garrett et al., 1 998). Lys69, which is not conserved amongst 
all enzymes I, was proposed as the residue which would interact with the phosphorylated 
His1 89 (Garrett et al., 1998). It is proposed here that Arg 126 may instead play this role 
in aiding catalysis and phosphotransfer by interaction with phosphorylated His 1 89. 
Dirnerization is not affected in the Argl26Cys enzyme I mutant, which is 
expected fiom all evidence regarding the properties of isolated N-terminal and C- 
terminal fragments reported here and elsewhere, and from comparison to the s t ruc~ral  
homolog pyruvate phosphate dikinase. 
4.5 Roles of Gly356 and Arg375 
The structure of the C-terminal domain of enzyme I is not known. Instead, 
comparisons must be made to the sequence and known structure of the enzyme I 
homolog C. symbiosum PPDK (Herzberg et a[. , 1996). Using these comparisons (Figure 
3.1 6 and Figure 3.17; Tables 3.4 and 3 . 9 ,  it is easy to see why the Gly356Ser mutation, 
identified in this work, would affect dimerization. Gly663, the PPDK residue analogous 
to Gly356 of enzyme I, is an important residue in the subunit interaction site of PPDK. 
Addition of a serine side chain to Gly356 of enzyme I would result in a larger side chain, 
which could potentially compromise interactions with residues of the other subunit. 
Arg375 is conserved as Arg682 in C. syrnbiosum PPDK, and the location of this residue 
is indicated in Figure 3.17. However, Arg682 does not appear to be within either the 
subunit interaction site or the PEP-binding site, so the reason for the impaired 
dimerization of Arg375Cys enzyme I remains unclear. A three dimensional structure of 
the C-terminal domain of enzyme 1 would be needed to further elucidate the possible 
role of Arg3 75 in dimerization. 
4.5.1 Gly356Ser and Arg375Cys kinetics and dimerization 
The enzyme I mutants Gly356Ser and Arg375Cys behave similarly in that they 
do not readily form dimers, and that they have an impaired PEP K,,, of 3 mM, -30-fold 
higher than wild type, and a 'leaky' enzyme activity of 2-5% of wild type. The question 
that must be asked is, "is the activity of these mutants due to a small population of 
highly active dimers, or a larger population of less active monomers?" Figure 3.13 
demonstrates the hysteretic behaviour of wild type enzyme I, in that when enzyme 1 is 
preincubated in a cold dilute soIution before addition to the room temperature assay, the 
activity is at firs very low, but slowly increases. This is attributed to the slow 
association of monomeric subunits into dimers. However, Gly356Ser and Arg375Cys 
enzymes I do not show this dependence on preincubation conditions, in that they are 
equally active whether they are preincubated at room temperature or on ice. The most 
plausible explanation of this is that Gly356Ser and Arg375Cys enzymes I are in fact 
active as monomers. All previous characterizations of enzyme I have assumed that the 
dimer is the only active form of enzyme I, and that the monomer is inactive. It is 
proposed here that the monomeric form of wild type enzyme I may have a low level of 
activity, with kinetic parameters similar to Gly356Ser or Arg37SCys enzyme I. 
4.6 Intragenic complementation 
As shown in Section 3.3 -6.2, activity complementation between Arg l26Cys 
enzyme I and either Gly356Ser or Arg375Cys enzymes I was demonstrated with 
purified proteins. However, this complementation only occurred under conditions which 
favoured heterodimer formation, which included mixing of the two enzymes on ice 
which would result in a large proportion of monomers, before incubation at room 
temperature which would favour dimer formation. Physical and structural 
characterizations of enzyme I, along with comparison of the structure of C. syrnbiosum 
PPDK (Herzberg et al., 1996), indicate that both subunits of the enzyme I dimer act 
independently, and there is no phosphoryl transfer across subunits. This is an important 
consideration when determining the mechanism of in vitro activity complementation. 
The active site mutant Argl26Cys would be essentially inactive in the heterodimer, so 
the only active subunit in the heterodimer would be the Gly356Ser or Arg375Cys 
subunit (Figure 4.2). Further proof of this is the fact that the isolated 37 kDa C-terminal 
domain of enzyme I is by itself sufficient to complement the activity of Gly356Ser or 
Argl26Cys enzyme I. It is proposed that the monomeric Gly356Ser and Arg375Cys 
enzymes I are poorly active in part because they do not have the optimal conformation 
of the PEP binding site which would result from subunit association. When this subunit 
is in the heterodimer form, interaction with the Argl26Cys subunit results in 
conformational changes of the Gly356Ser or Arg375Cys subunit, so that it is more able 
to bind PEP, and as a result has higher enzyme activity. 
Kinetic data help to further prove this hypothesis. The Gly356Ser or Arg375Cys 
subunits not only have an increased V,, but also the PEP K, is greatly decreased 
Wild-type enzyme I 
Gly356Ser enzyme I 
Gly356Ser + Arg l26Cys 
H - Active 
- Low activity 
(no dimerization) 
4 Active 
Figure 4.2 Schematic representation of the mechanism of in vitro intragenic 
complementation of enzyme I mutants. In this diagram the N-terminal domain of 
enzyme I is represented by the closed circle, and the C-terminal domain is represented 
by the arc. Addition of  the active site mutant Argl26Cys forces the Gly356Ser subunit 
into the more active dimeric form. 
(Table 3.3). Results have shown that the GIy356SedArgl26Cys heterodimer is 
unstable, both kinetically when analyzed by enzyme assay, and physically when 
analyzed by gel filtration chromatography. This heterodimer instability is not dependent 
on catalytic turnover of the enzyme, but rather is dependent on the concentrations of 
both the heterodimer itself and PEP. The stability of the wild type homodimer of 
enzyme I is very likely dependent on the same conditions, although it has previously 
been proposed that interaction with and phosphorylation of HPr also caused the enzyme 
to dissociate (Chauvin st al., 1996a). All evidence presented here indicates that 
interaction with HPr does not cause the dimer of wiid type enzyme I to dissociate. The 
activities of Gly356Ser and Arg375Cys enzymes I were also stable in the assay (Figure 
3.1 1). In this case, this observation again leads to the conclusion that the low but stable 
activity measurements of these mutants are due to the monomer, instead of an unstable 
dimer. 
4.7 Roles of other residues in the C-terminal domain of enzyme I 
When compared to the structure and function of PPDK (Figures 3.1 6 and 3.1 7), 
potential key residues involved in dimerization and PEP-binding capability of enzyme I 
can be identified. Several mutants of key amino acid residues were created by site 
directed mutagenesis, and the effects of these mutations were determined. Thus direct 
information about the roles of these residues in the structure and function of enzyme I 
was obtained. 
4.7.1 Role of As11352 
In C. symbiosum PPDK, Asn659 is the residue analogous to Asn352 of E. coli 
enzyme I (Figure 3.16). Asn659 is an important residue in the subunit interaction site in 
that the Asn659 residue fiom one subunit forms several van der Waals contacts with 
residues from the other subunit, including the other Asn659 residue. and in addition 
participates in hydrogen bonds with three residues from the other subunit (Table 3.4). 
The enzyme I mutants Asn352Ala and Asn352Glu were created, and room temperature 
gel filtration chromatography showed that both mutants had impaired monomerdimer 
equilibrium compared to wild type, much like Gly356Ser enzyme I (Figure 3.17). Each 
mutant had a decreased V,, relative to wild type, and a substantially larger PEP Y, 
(Table 3.6), although each mutant showed significantly different kinetics. Thus Asn352 
in enzyme I is required for dimerization, and may have at least indirect importance in 
PEP-binding and enzyme activity. 
There is a surprising difference between the Asn352Ala mutant and the 
Asn352Glu mutant in the formation of an active heterodimer with Arg126Cys enzyme I 
(Figure 3.1 8). A mixture of Asn3 52Glu and Arg l26Cys enzymes I displays effective 
activity complementation, whereas poor complementation between Asn352Ala and 
Argl26Cys enzymes I is demonstrated. Recall that in the subunit interaction of PPDK, 
the analogous residue Asn659 participates in hydrogen bonds with three residues of the 
second subunit (Table 3.4). However, the side chain of one Asn659 residue faces away 
fiom the side chain of Asn659 of the other subunit. It is then postulated that Asn352 of 
enzyme I also participates in hydrogen bonding during dimerization, and that mutation 
of A d 5 2  to Glu conserves at least some of this hydrogen bonding potential. Modeling 
of the Asn659Glu mutation of the PPDK structure indicates that this is likely possible, as 
there is space available for rotation of the side chain to the correct orientation (result not 
shown). In this orientation, there would very likely be no charge repulsion of the two 
glutamate side chains. Mutation of PPDK Asn659 to Ala, and enzyme I Asn352 to Ala, 
would eliminate any potential of hydrogen bonding, and may also disrupt van der Waals 
interactions. The poor PEP K,,, of Asn352Glu enzyme I, even higher than that of 
Asn352Ala, remains poorly understood, as it is very unlikely that Asn352 directly 
participates in PEP-binding. Perhaps the addition of the negative charge is enough to 
produce indirect charge repulsion of the PEP. 
One of the objectives of creating the Asn352 enzyme I mutants was the 
production of a stable monomeric form of enzyme I. The criteria for this are that the 
mutant would elute from a room temperature gel filtration column at the monomeric 
position of -65  ma, and would be incapable of activity complementation by Argl26Cys 
enzyme I. Thus neither Asn352 mutant is strictly a stable monomer. The potential that 
Asn352Ala is less able to f o m  dimers than Asn352Glu will be investigated in the future 
by more rigorous physical techniques, such as dynamic light scattering. 
4.7.2 Role of Leu355 
The enzyme I residue Leu355 is not strictly conserved in PPDK, as the 
analogous residue is Met662 (Figure 3.16). However, in PPDK Met662 is an important 
residue in the subunit interaction site, as it forms many van der Waals contacts with 
other residues, including several side chain-side chain interactions, and is also a "self 
interacting" residue. For this reason, and also because Leu355 is next to the Gly356 
residue which has been shown to be important for dimerization, it was decided to 
investigate Leu355 by mutagenesis. The mutants Leu355Ala and Leu35SGlu each 
exhibited impaired dirnerization (Figure 3.17), and enzyme kinetics similar to those of 
the other mutants with impaired dimerization (Table 3.6). Both mutants also exhibit 
slight complementation when assayed in combination with Argl26Cys enzyme I (Figure 
3.19), so again it appears that both mutants are not strictly stable monomers. Modeling 
of Met662Ala and Met662Glu mutations in the PPDK structure indicates that the Ala 
mutation may result in the loss of some van der Waals interactions, while the Glu 
mutation may result in charge repulsion in addition to disruption of van der Waals 
interactions. 
It should be noted that mutation of Gly356 to Ser results in an increase in size of 
the side chain, whereas for the most part other mutations identified so far result in a 
smaller or similarly sized side chain. It is possible that an increase, rather than decrease, 
in the size of the side chain of a residue at the dimerization intdace results in a greater 
disruption of van der Waals interactions which leads to a greater impairment of 
dimerization. However, the result of mutation of Arg375 to Cys (this work), as well as 
Gly338Asp (Seok et al, 1996a; Seok et al., 1998) and several other C-terminal mutations 
(Rizak et al., 2000) indicates that the C-terminal domain of enzyme I is extremely 
sensitive to mutations. Most mutations studied so far, even those apparently at some 
distance away from the dirnerization site, have at least a small effect on dimerization 
and/or PEP-binding. 
4.73 Role of Arg296 
The enzyme I residue Arg296 is conserved in C. syrnbiosum PPDK as Arg561 
(Figure 3.16). Through site-directed mutagenesis, Yankie et al. ( 1995) determined that 
kg561 of PPDK was essential for the turnover of PEP. The analogous enzyme I mutant 
Arg296Leu was created, and it was found that this mutant had a very low enzyme 
activity, 0.04% of wild type, but the PEP Y, of 0.05 mM was similar to the wild type 
PEP K, of 0.1 rnM (Tabie 3.6). The significance of this apparently unaffected PEP Y, 
remains unclear; perhaps Arg296 is not directly important for binding PEP, but for 
catalysis via PEP substrate strain and/or transition state stabilization. Other mutants of 
kg296  may be created in the h e  in order to fUrther elucidate the role of Arg296 in 
enzyme I activity. Room-temperature gel filtration chromatography shows that 
Arg296Leu enzyrne I has impaired dimerization potential. However, Arg296Leu is still 
to some extent capable of formation of active heterodimers with other C-terminal 
enzyme I mutants, as shown by activity complementation (Figure 3.20). Thus it appears 
that Arg296 of enzyme I does not play a direct role in subunit interaction, but rather it is 
essential for interaction with PEP and catalysis. Only through impaired ctalysis of PEP 
is the secondary effect of impaired dimerization realized. This is discussed fiuther in 
Section 4.8. 
Another enzyme I residue which is important for catalysis of PEP has been 
identified. Cyst33 1 is in the PEP binding site of PPDK (Herzberg et aL, 1996) and is 
conserved in enzyme I as Cys502 (Figure 3.16). Mutation of Cys502 results in 
significant decrease in Vma, but little change to the PEP K,,,, and only slight impairment 
to dimerization (Rizak et al., 2000), similar to mutation of Arg296. Thus Cys502 is 
likely involved in catalysis. The cr/B-barrel PEP-binding motif of C. symbioszm PPDK 
is shown in Figure 4.3. Arg561 and Cyst33 1, along with other residues implicated in 
PEP-binding (Herzberg et a l ,  1996) are concentrated within the centre of the dp-barrel. 
4.8 Requirement for histidine at residue 189 
Until recently, it was universally believed that enzyme I and HPr had an absolute 
requirement for histidine as the residue of phosphorylation. Unexpectedly, Napper el a/. 
(1999) showed that the HislSAsp mutant of HPr still had a low level of catalytic 
activity, whereas other His15 mutants did not. In this thesis, catalytic activity of both 
Hisl 89Asp and Hisl 89Glu mutants of enzyme I was demonstrated (Figure 3.2 1). Wild 
type enzyme I is phosphorylated at the N" atom of His189, and the structural 
comparison mentioned previously (Section 1.3.2; Napper, 1999) makes it surprising that 
the Hisl89Asp mutant of enzyme I has phosphotransfer activity. In the structure of the 
N-terminal domain of enzyme I, the unmodified N" atom of His 189 is the acceptor of a 
hydrogen bond from the side chain of Thr168. However, upon phosphorylation or 
protonation of the N" atom, the imidazole ring of His1 89 undergoes a ring flip 
conformational change. The ring flip upon protonation has to be fast because the neutral 
and protonated forms of His 189 are in fast exchange on an NMR time scale (Garrett et 
a/., 1998). Because of this apparent variability in the conformation of the His1 89 side 
chain, either during protonation or during phosphorylation and phosphotransfer, it is 
then more easily accepted that the Asp and Glu mutations may each have structural 
similarities to one or the other conformer of the His1 89 side chain. Thus, both mutants 
Figure 4.3 The a@-barrel PEP-binding motif of C. symbiosum PPDK. taken from the 
crystal structure. The residues necessary for binding PEP (Henberg et aL, 1996) are 
labeled, including Arg561, analogous to Arg2% of enzyme I, and Cys83 1, analogous to 
CysSM of enzyme I .  
could then have some degree of catalytic activity. The in vitro phosphorylation study 
indicates that His189Glu enzyme I may be more capable of autophosphorylation than is 
Hisl89Asp, whereas the reverse may be the case for phosphotransfer to HPr. Perhaps 
this is due to the fact that the side chain of each mutant mimics a different conformer of 
His 189. 
At any rate, the catalytic activity of an acyl phosphate in a PTS protein has once 
again been demonstrated. Much like Arg l26Cys enzyme I, these His 189 mutants are 
also capable of activity complementation of C-terminal enzyme I mutants, as expected. 
More precise characteristics of the Hisl89Glu and His l89Asp enzyme I, such as 
stability of the acyl phosphates, have yet to be determined. The potential catalytic 
activity of His90Asp and His90Glu mutants of enzyme 1 1 ~ ~ "  are also under 
investigation (S. Napper, personal communication). 
4.9 Enzyme I mechanism and in vivo regulation 
In this thesis, enzyme I mutants which are defective in dimerization, such as 
Gly356Ser, have been described, and these mutants have the secondary defect of poor 
PEP-binding. Conversely, Arg296Leu is an enzyme I mutant which cannot bind PEP, 
and as a secondary defect it has reduced dimerization potential, although not as poor as 
Gly356Ser. This and other evidence shows that PEP-binding and dimerization of 
enzyme I are cooperative events. It has also been demonstrated in this thesis that PEP 
concentrations can influence dimerization of enzyme I. 
For the purposes of explanation, Figure 4.4 presents three possible mechanisms 
for PEP-binding and dimerization of enzyme I. Scheme I illustrates a concerted 
Figure 4.4 A schematic diagram of possible mechanisms of dimerization and PEP- 
binding of enzyme I. 1 : Concerted mechanism. 2: Dimerization induced conformational 
change. 3: PEP induced conformational change. 
mechanism, whereby PEP-binding and dimerization occur simultaneously. Scheme 3 
illustrates a mechanism whereby PEP-binding must occur first, and results in a 
conformational change which allows for dimerization to subsequently occur. Scheme 2, 
dimerization induced conformational change, best represents what is occurring with wild 
type enzyme I, although the exact mechanism is likely more complex. Several points 
will help explain why scheme 2 is the most accurate of the three representations. 1.) A 
monomer:dimer equilibrium exists with wild type enzyme I in the presence or absence 
of PEP, but addition of PEP favours dimerization. In effect, the presence of PEP 
"draws" a greater proportion of enzyme I subunits to the dimeric form. 2.) Mutants 
which have severely reduced dimerization, such as Gly356Ser, also have a high K, for 
PEP. However, addition of PEP does not significantly increase the dimerization of 
Gly356Ser subunits. Conversely, Arg296Leu enzyme I interacts poorly with PEP but 
has lost only some of its dimerization potential. Thus it appears that dimerization of 
enzyme I results in a confonnational change which allows for effective PEP-binding. 3.) 
Addition of excess Arg 126Cys enzyme I to a population of Gly356Ser subunits results 
in an active Arg126Cys/Gly356Ser heterodimer. In essence, the poor monomer:dimer 
equilibrium of the Gly356Ser subunits is overcome, forcing the Gly356Ser subunit into 
the active dimer conformation which is better able to bind PEP. However, this is a 
dynamic monomer:dimer equilibrium in that addition of even small amounts of 
Gly356Ser to Arg 126Cys enzyme I may cause the Arg l26Cys subunits to dissociate into 
monomers, as shown by gel filtration chromatography. Again, addition of PEP can help 
stabilize the heterodimer. 4.) Phosphotransfer to HPr does not cause enzyme I dimers to 
dissociate, so  that the enzyme may still remain in the active dimeric form even in the 
absence of phosphorylation or bound PEP. Enzyme I activity is highly dependent on 
PEP levels, not only because PEP is a substrate for enzyme I, but also because PEP 
concentrations strongly influence the monomer:dimer equilibrium. 
The monomer:dimer equilibrium has been proposed as a target for regulation of 
enzyme I, and thus regulation of the PTS (Chauvin et aL, 1996a). However, no effector 
molecule has been identified. The K, for subunit association of enzyme I is 
approximately 3 x lo6 M-' (Chauvin ef al., 1994a). and in E. coli the concentration of 
enzyme I is in the range of 2-5 pM (Misset er al., 1980; Mattoo and Waygood, 1983). 
This suggests that in the absence of PEP and phosphorylation, about 1525% of enzyme 
I subunits would be monomers. In the presence of 2 mM PEP and 5 mM ~ g ? ' ,  k& 
increases on the order of one-hundred fold. Phosphorylation decreases &, and 
phosphorylated enzyme I in the absence of PEP would have an even greater proportion 
of subunits as monomers, up to 50% or more. In contrast, this study and others have 
kept enzyme I preparations phosphorylated during purification and storage as a 
"stabilizing" measure. Kinetic measurements, including measurement of in vivo enzyme 
I activity levels in crude extracts, have started with the addition of PEP and M ~ "  to the 
enzyme before measurement, which would force the enzyme I into the active 
phosphorylated dimer form. These measurements would not be sensitive to the 
monomer:dimer equilibrium in vivo, and because of this the activity measurements 
would not accurately reflect the real in vivo level of enzyme I activity. 
A closer examination of in vivo conditions is then necessary. The approximate 
physiological range of PEP concentrations in E. coli is 0.1 - 1 mM (Lowry et al., 197 1 ). 
The work presented in this thesis has led to the proposal that wild type enzyme I may 
exist in  vivo either in a dimeric form with a PEP K,,, of 0.1 mM, or in a monomeric form 
with a PEP K, of approximately 3 mM. The fact that the two ranges of PEP 
concentrations are similar may be coincidence, or it may have importance which would 
lead to a better understanding of the mechanism and regulation of enzyme I. 
Studies have been done to assess the flux determining step@) of the PTS (Ruyter 
et al., 1991; van der Vlag et al., 1995), and these studies showed that an increase of the 
total in vivo level of enzyme 1ICBp" resulted in a significant increase in PTS-mediated 
glucose transport. In contrast. overexpression of either enzyme I, HPr, or 1 1 ~ ~ ' '  did not 
significantly increase overall PTS activity. Thus it was determined that the IICB~" 
mediated reaction is the flux determining step of the glucose PTS. However, the 
experiments were biased by preincubation of extracts with PEP and Mg2', leading to a 
fully active enzyme I, before assay. In the later study, the authors acknowledged that 
cellular PEP levels, and PEPfpyruvate ratio, may affect the flux through the PTS (van 
der Vlag et al., 1995), presumably through modulation of enzyme I activity. Indeed. in 
vivo overexpression of PEP synthetase, leading to an increased PEPfpyruvate ratio, 
resulted in an increase in glucose consumption which was thought to be due to an 
increase in glucose transport by the PTS (Patnaik et al., 1992). Modulation of enzyme I 
activity would result in a more global regulation of all PTS-mediated sugar transport, not 
only that of glucose. 
The bacterial phosphoenolpyruvate:sugar phosphotransferase system (PTS) is an 
important system in many bacteria. The PTS is not only directly important for the 
transport of many sugars, but it also plays a key role in the regulation of many other 
processes of bacterial physiology and metabolism, including carbon metabolism, 
nitrogen metabolism, gene regulation, and chemotaxis. The first general, non sugar- 
specific, step of the PTS is catalyzed by enzyme I, and as such enzyme I has been 
viewed for many years as a potential regulatory target of the PTS. 
The research presented in this thesis has led to a greater understanding of the 
function and structure of enzyme I of Escherichia coli and Salmonella typhirnurium. 
Fluorescence polarization studies showed that the interactions of HPr with enzyme I, and 
also HPr with enzyme IIA~", are relatively low affinity interactions which may be 
important for the dynamic phosphocarrier ability of HPr. A kinetic study, through the 
assay of mutant HPr proteins as substrates for enzyme I, has elucidated the actual 
binding site on HPr for enzyme I. This binding site agrees very well with the binding 
site identified by various NMR experiments, however this study identifies certain key 
residues that were previously overlooked, such as Lys40, and indicates that other 
residues, such as Gln5 1, may not be as important for the interaction as fist thought. It 
should be noted that this kinetic study best mimics the physiological interaction of HPr 
with enzyme I. 
Most of this thesis has been spent studying single amino acid mutants of enzyme 
I. The catalytic activity of Hisl89Glu and Hisl89Asp mutants of enzyme I was 
demonstrated, and work is currently underway to more rigorously characterize these 
mutants. Arg 126 was identified as a residue important for the phosphotransfer ability of 
enzyme I. Gly356 and Arg375 were the first two residues shown to be necessary for the 
proper dimerization of enzyme I. The kinetic and physical study of these mutants, both 
alone and in combination using in vitro intragenic complementation, has led to a greater 
understanding of the monomer:dimer equilibrium of enzyme I. Temperature, enzyme I 
concentration, and PEP concentration all influence this equilibrium, but phosphotransfer 
to HPr does not. These studies have led to the assertion that the in vivo role of the 
monomeric form of enzyme I may be more important than first thought, in that 
monomers may exist in the cell in fairly high concentrations, and under certain 
conditions may have a small but significant activity. The monomer:dimer equilibrium of 
enzyme I is likely a key point of regulation of the enzyme, and thus of the PTS. 
Although the tertiary structure of the C-terminal domain of enzyme I is 
unknown, the structure of the C-terminal domain of the homolog pyruvate phosphate 
dikinase (PPDK) from Clostridium syrnbiosum was used as a model. From this model, 
other potentially important residues for the dimerization and PEP-binding capabilities 
were identified. Site-directed mutagenesis showed that Asn352 and Leu355 are both 
key residues for dimerization of enzyme I. Arg296 is important for binding and 
catalysis of PEP. PEP-binding and dimerization are cooperative events, in that 
dimerization induces conformational changes in the C-terminal domain of enzyme I 
which allows for better PEP binding, and an increase in PEP concentration results in an 
increased dimerization of enzyme I. 
The exact physiological role of the monomer:dimer equilibrium of enzyme I is 
still not very well understood. More precise physical characterizations of wild type and 
mutant enzymes I, either full-length or  the isolated C-terminal domain, using techniques 
such as  dynamic light scattering will be attempted in the future. This will lead to a 
greater understanding of the actual binding interactions, and K, values, of wild-type and 
mutant forms of enzyme I under a variety of conditions. The more precise contributions 
of each amino acid residue in enzyme 1, and of the factors of temperature and the 
concentrations of enzyme I, PEP, and HPr to the monomer:dimer equilibrium can be 
determined. Site-directed mutagenesis of other enzyme I residues is also currently being 
undertaken, which has shown that the monomer:dimer equilibrium of enzyme I is 
sensitive to perturbation by amino acid mutations in the C-terminal domain. In the near 
future, it is likely that the tertiary structure of the C-terminal domain of enzyme I may be 
known, which will also lead to more detailed knowledge of the importance of these 
identified residues. Mutagenesis studies are also underway to potentially create a stable 
monomeric form and a stable dimeric form of enzyme I. Investigations of these 
enzymes in virro and in vivo, perhaps by gene replacement, will help further elucidate 
the potential physiological importance of the monomer:dimer equilibrium of enzyme I. 
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